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   I 
ABSTRACT 
Clearance of apoptotic cells by professional, tissue resident macrophages is crucial during 
development, maintenance of tissue homeostasis and disease. Phagocytic cells can engulf and 
process several dying cells with high efficiency while still maintaining their dynamic behaviour 
and morphology. Effective intracellular processing of ingested cells is likely to be crucial for the 
phagocyte to function, but the underlying cellular mechanisms are poorly understood. Here, 
we investigate this by focusing on microglia, the tissue resident macrophages of the Central 
Nervous System (CNS). In particular, we take advantage of the optical transparency of the 
zebrafish embryo and apply a combination of genetic, chemical and imaging approaches to 
study phagocytosis of neurons in vivo.  
In this study we focus on bubblebrain (blb), a zebrafish mutant that has bloated microglia. The 
cell body of blb microglia is occupied by a single large vesicle that grows progressively. By 
comparing wild type and blb embryos we discovered that efficient processing of engulfed 
neurons depends on the shrinkage and packaging of phagosomes into the gastrosome, a 
unique cellular compartment with distinct ultra-structural and molecular features. Moreover, 
we show that the blb phenotype is caused by lack of Slc37a2, a putative glucose-6-phosphate 
transporter localized on phagosomes. Loss of Slc37a2 prevents phagosomal shrinkage, and this 
in turn results in the expansion of the gastrosome and in the dramatic bloating of the cell. 
Interestingly, we show that gastrosomal defects impact on microglial activities and affect the 
ability of these cells to engulf neurons and to migrate towards brain injuries. Thus, this work 
provides experimental evidence for the existence of the gastrosome, a critical new component 
of the phagocytic pathway that allows easy manipulation of key microglial activities in vivo.
  
  
 
 
 
   III 
ZUSAMMENFASSUNG 
Die Beseitigung apoptotischer Zellen durch professionelle, Gewebe-ansässige Makrophagen 
ist von entscheidender Bedeutung bei Entwicklungsprozessen, während der Aufrechterhaltung 
der Gewebehomöostase und der Ausprägung von Krankheiten. Phagozytische Zellen können 
mehrere sterbende Zellen mit hoher Effizienz aufnehmen und prozessieren, während sie ihr 
dynamisches Verhalten und ihre Morphologie beibehalten. Eine effektive intrazelluläre 
Verarbeitung aufgenommener Zellen ist vermutlich entscheidend für die Funktion der 
Phagozyten, wobei die zugrundeliegenden zellulären Mechanismen kaum verstanden sind. In 
dieser Arbeit untersuchen wir dies, indem wir uns auf Mikroglia konzentrieren, die Gewebe-
ansässigen Makrophagen des zentralen Nervensystems (ZNS). Insbesondere nutzen wir die 
optische Transparenz des Zebrafisch-Embryos und wenden eine Kombination aus genetischen, 
chemischen und bildgebenden Verfahren an, um die Phagozytose von Neuronen in vivo zu 
untersuchen. 
In dieser Studie charakterisieren wir bubblebrain (blb), eine Zebrafisch-Mutante mit 
aufgeblähten Mikroglia. Der Zellkörper von blb-Mikroglia ist von einem einzigen großen Vesikel 
besetzt, das progressiv wächst. Durch den Vergleich von Wildtyp- und blb-Embryonen haben 
wir entdeckt, dass die effiziente Verarbeitung aufgenommener Neuronen von der 
Verkleinerung und Verpackung der Phagosomen in das Gastrosom abhängt, einem 
einzigartigen Zellkompartiment mit ausgeprägten ultrastrukturellen und molekularen 
Merkmalen. Darüber hinaus zeigen wir, dass der blb-Phänotyp durch das Fehlen von Slc37a2, 
einem mutmaßlichen Glucose-6-Phosphat-Transporter, der auf Phagosomen lokalisiert ist, 
verursacht wird. Der Verlust von Slc37a2 verhindert die Verkleinerung des Phagosoms, was 
wiederum zur Expansion des Gastrosoms und zum dramatischen Aufblähen der Zelle führt. 
Interessanterweise können wir zeigen, dass gastrosomale Defekte Auswirkungen auf die 
Mikrogliaaktivität haben und die Fähigkeit dieser Zellen beeinflussen, Neuronen zu 
phagozytieren und zu Hirnläsionen zu migrieren. Somit liefert diese Arbeit einen 
experimentellen Beweis für die Existenz des Gastrosoms, einer entscheidenden neuen 
Komponente bei der Phagozytose, die eine einfache in vivo Manipulation von 
Schlüsselaktivitäten der Mikroglia erlaubt. 
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1 INTRODUCTION 
You make decisions, take actions, affect the world, receive feedback from the world, 
incorporate into yourself, then the updated “you” makes more decisions, and so forth, round 
and round (from “I am a strange loop”, Douglas Hofstadter).  
 
Every day, depending on the circumstances, we take actions that affect not only ourselves, but 
also people around us. In a similar way, cells of our body constantly interact with the 
environment and feedback on themselves and their surroundings to maintain homeostasis. 
Moreover, cells often serve multiple functions, being involved in complicated intracellular 
networks and feedback loops. Cells have different methods to communicate with each other, 
interact and work together performing essential processes necessary for survival and both 
multicellular and unicellular organisms heavily rely on cell-cell communication. Biologists have 
always been fascinated by these processes and the aim is to understand the mechanisms in 
place to coordinate these events at the cellular and tissue scale.  
A great model to study these mechanisms is the immune system, our line of defence against 
infectious organisms and other invaders. This is divided into two branches, the so-called 
adaptive immune system and the innate one; several cell types in each group work together 
and feed back to each other to maintain the homeostasis of the organism. The immune system, 
not only defends us from external pathogens, but also ensures the health of the organism by 
removing aged and damaged cells. By engulfing unwanted material, cells of our immune 
system, such as macrophages, eliminate potential harmful and infectious agents from our 
body. This process is highly regulated and improper uptake or digestion of the engulfed 
material can lead to severe cellular disfunctions that will inevitably reflect on the functioning 
of the whole tissue leading to a disease state. 
A great model to study this delicate equilibrium and sophisticated machinery is the removal 
and digestion of apoptotic cells, a fundamental process in development, homeostasis and 
disease.  
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1.1 APOPTOSIS  
Apoptosis (from Greek apóptōsis, “falling off”) is a sequence of well-defined and highly 
conserved molecular mechanisms also known as programmed cell death (PCD). First defined 
in 1972 (Kerr et al., 1972), apoptosis is an active process characterized by distinct 
morphological features and is considered a vital component of various processes including 
embryonic development, immunity and cell turnover (Cole and Ross, 2001; Elmore, 2007; 
Meier et al., 2000; Oppenheim, 1991; Yamashita, 2003). While during necrosis the integrity of 
the cell membranes is immediately lost leading to cell swelling with consequent content spilling 
and inflammation, during apoptosis, the cytoplasmic membranes and organelles remain intact. 
Already in the early process of PCD, as a result of the condensation of chromatin and 
organelles, the dying cell is subjected to shrinkage and then to blebbing. This process leads to 
the formation of the so called “apoptotic bodies”, a morphological hallmark of PCD which 
consist of cytoplasm with tightly packed organelles with or without a nuclear fragment. The 
mechanisms of apoptosis are highly complex, involving an energy-dependent cascade of 
molecular events. The intracellular machinery and the morphological changes associated with 
PCD are shared among different cell types and evolutionary conserved across species. 
Apoptosis ends with the final act of cellular disposal in which phagocytic cells engulf cellular 
corpses and associated debris. Importantly, apoptotic cells actively participate in the initial 
phases of this process by altering their morphology, displaying important modifications to their 
membranes and exposing specific signals that are important for recognition and uptake. 
1.1.1 PHYSIOLOGIC APOPTOSIS 
The process of apoptosis is as important as its counterpart, mitosis. Indeed, PCD has an 
opposite but complementary role to cell proliferation in the regulation of all cell populations. 
To maintain homeostasis in the adult human body, around 10 billion cells are estimated to 
undergo apoptosis daily (Renehan et al., 2001). Obviously, this number can significantly 
increase during development, aging or diseases.  
Apoptosis is necessary, for example, to get rid of pathogen-invaded cells and it is a vital 
component of wound healing. As shown by Greenhalgh, in fact, thanks to PCD inflammatory 
cells are removed and the granulation tissue that forms during the healing process can evolve 
into scar tissue (Greenhalgh, 1998). Dysregulated apoptosis during this process can lead to 
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pathologic conditions characterized by excessive scarring and fibrosis. Moreover, PCD also 
plays a central role in remodelling tissue during adulthood (Lund et al., 1996; Tilly et al., 1991) 
and it is an essential mechanism to control cell number especially in tissue with high turnover 
rate. Apoptosis is also needed to eliminate auto-aggressive immune cells during maturation in 
the central lymphoid organs (Osborne, 1996; Rathmell and Thompson, 2002). Furthermore, as 
an organism grows older, some cells begin to deteriorate at a faster rate and are eliminated 
without an inflammatory response thanks to PCD. 
It is clear that apoptosis has to be tightly regulated since too much or too little cell death may 
lead to pathological conditions. 
1.1.1.1 Developmental apoptosis 
Being a mechanism by which unwanted cells are eliminated, apoptosis has a tremendous 
relevance during embryogenesis. Our understanding of apoptosis actually transpired from the 
investigation of Caenorhabditis elegans development (Ellis and Horvitz, 1986; Horvitz, 1999; 
Sulston et al., 1983). In this animal, Sulston and colleagues showed that out of 1090 somatic 
cells, exactly 131 cells undergo cell death at particular points during the developmental process 
(Sulston et al., 1983). Hence the definition of “programmed cell death”, which involves the 
genetically determined elimination of cells. Genetic screens in C. elegans have been very 
effective in identifying key molecular players of apoptosis (Ellis and Horvitz, 1986; Knapp et al., 
1986; Raff et al., 1993). In particular, while loss of function of ced-3,4 and eng-1 genes abolish 
apoptosis, ced-9 mutants are characterized by excessive apoptosis (Lettre and Hengartner, 
2006). Remarkably, those mechanism are incredibly conserved across species, from 
nematodes to mammals (Lord and Gunawardena, 2012). 
Indeed, all developing organisms produce excess cells that are subsequently removed via 
apoptosis as a step of normal development. In this context, three different categories have 
been established (Glücksmann, 1951). “Phylogenic apoptosis” is the elimination of embryonic 
cells or structures characteristic of an evolutionary ancestor and that are no longer needed in 
the adult. In addition, this category includes the elimination of structures that are needed only 
transiently during development such as the tadpole’s tale. “Morphogenic apoptosis” instead, 
by removing unwanted cells, sculpts tissues and occurs mainly in areas of folding, cavitation or 
fusion of tissues. Here, a typical example is digit separation by the removal of interdigital cells 
(Chen and Zhao, 1998). Finally, “histogenetic apoptosis” is the removal of cells following tissue 
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remodelling or maturation, such as the loss of neurons typical of brain development. This in 
the central nervous system (CNS), is perhaps one of the most striking roles for apoptosis. Here, 
neurons are first produced in large excess and successively many of them undergo PCD (Knapp 
et al., 1986; Raff et al., 1993). It has been shown that neurons have to compete for a limited 
amount of target-derived neurotrophic factors, which they receive by forming functional 
synaptic connections with their targets. As a consequence, neurons that fail to connect are 
eliminated by apoptosis (Cowan et al., 1984; Elliott and Shadbolt, 1998; Oppenheim, 1991). In 
this sense, a classic example is the development of sympathetic neurons and oligodendrocytes 
that depend on nerve growth factor and platelet-factor, respectively (Barres et al., 1992; Levi-
Montalcini, 2005). 
1.1.2 PATHOLOGIC APOPTOSIS 
Inappropriate apoptosis (either too much or too little) is an important factor in many human 
conditions including many types of cancer, autoimmune disorders, neurodegenerative 
diseases and ischemic damage. In cancer normal mechanisms of cell cycle regulation are 
compromised and suppression of apoptosis during carcinogenesis is thought to play a central 
role in the progression of some cancers (Kerr et al., 1994). Moreover, tumour cells can acquire 
resistance to apoptosis by expression of anti-apoptotic proteins (Miyashita and Reed, 1995) or 
by alteration of various cell signalling pathways. In addition to cancer, not enough apoptosis 
can result in diseases such as autoimmune lymphoproliferative syndrome (ALPS) (Worth et al., 
2006). In general, insufficient apoptosis of auto-aggressive B or T cells results in multiple 
autoimmune diseases. On the other hand, excessive apoptosis can be a feature of 
neurodegenerative disease and ischemia-associated injury. For example, the Alzheimer’s 
disease (AD) is a neurodegenerative condition caused by mutations in amyloid precursors 
protein (APP) and presenilins. These mutations cause the deposition of amyloid beta in 
extracellular deposits known as plaques. Those are thought to be neurotoxic and also to induce 
apoptosis by causing oxidative stress or by triggering death ligand expression in neurons and 
glia (Ethell and Buhler, 2003). 
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1.2 IMPORTANCE OF APOPTOTIC CELL CLEARANCE 
Today, we know that the final step of apoptosis is the clearance of apoptotic cells, a process 
known as efferocytosis. Efficient efferocytosis contributes to sculpting organs, eliminate 
abnormal, non-functional or harmful cells and maintain homeostasis. Remarkably, even in 
tissues where cellular turnover is high - such as lung, intestine, thymus and bone marrow - 
uncleared apoptotic cells are rarely seen because of the impressive efficiency in apoptotic cell 
clearance (De Paepe et al., 2004; Elliott and Ravichandran, 2010; 2016; Elliott et al., 2009; Lee 
et al., 2016). Efferocytosis is an evolutionary conserved process, and early studies in C. elegans 
suggested that apoptotic cells are recognized and cleared even before they are fully dead 
(Hoeppner et al., 2001; Reddien et al., 2001). The engulfment of apoptotic cells, in fact, is 
performed by both professional phagocytes (such as macrophages and dendritic cells) and by 
non-professional phagocytes (such as epithelial cells, fibroblast and endothelial cells) while the 
plasma membrane integrity of the dying cell is still preserved. Metazoa have multiple 
mechanisms in place to handle cell clearance, often depending on the tissue and apoptotic cell 
type (Gregory, 2009), underlying the importance of this process to maintain immune tolerance 
and tissue homeostasis. Indeed, failure in clearing apoptotic cells causes the loss of membrane 
integrity over time, and the progress to secondary necrosis which can induce tissue 
inflammation due to the release of cellular contents or the exposure of otherwise sequestered 
intracellular molecules (Poon et al., 2014). This may provide the immunogenic impetus for the 
onset of some autoimmune disorders in humans, including rheumatoid arthritis and systemic 
lupus erythematosus (Gaipl et al., 2004). 
While the phagocytic machinery is highly conserved regardless the nature of the engulfed 
target, what distinguish the phagocytosis of apoptotic cells from the phagocytosis of most 
bacteria or necrotic cells is the lack of pro-inflammatory immune response. Indeed, Henson 
and Bratton (Henson and Bratton, 2013) provided early evidence that clearance of apoptotic 
cells by macrophages gives rise to anti-inflammatory effects. In response to efferocytosis, 
macrophages secrete cytokines, arachidonate metabolites as well as a range of pro-resolving 
mediators which have been shown to reduce LPS-induced inflammation both in vitro and in 
vivo (Henson and Bratton, 2013). Moreover, Weavers and colleagues recently showed that 
phagocytosis of apoptotic cells is able to prime macrophages for future inflammatory response 
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by creating a sort of molecular memory usually attributed to adaptive immunity (Weavers et 
al., 2016).  
Hence, it is clear that professional phagocytes such as macrophages, are not simple “garbage 
collectors” responsible for clearing the tissue from unwanted material, but rather scavengers 
coordinating and integrating cellular and tissue responses to different stimuli. As described in 
more details in the following chapter, during phagocytosis signal exchange between the 
phagocyte and its target is key to ensure efficient clearance. The mechanism of phagocytosis 
is itself a central regulator of how a cell responds to tissue changes, and contributes to tissue 
homeostasis.  
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1.3 PHAGOCYTOSIS: A MULTI-STEP PROCESS 
The first observation and description of phagocytosis dates back to 1883, when Elie 
Metchnikoff described in the starfish-larvae the presence of amoeba-like cells (which he 
named phagocytes, from Greek words meaning “devouring cells”) able to engulf foreign bodies 
such as bacteria (Gordon, 2008). Today, we still use the same terminology to describe the 
regulated uptake of large particulate material (such as bacteria or apoptotic cells) into cytosolic 
membrane-bound vesicles named phagosomes. Evolutionary conservation of this process 
from the starfish-larvae to mammals shows that this is an essential biological process which 
ensures both self-defence and homeostasis of the organism.  
Work from many groups has shown that phagocytosis is a multi-step process that can be 
divided in four major steps: attraction of the phagocyte to the target, formation of the 
phagosome, maturation and finally resolution (Figure 1.1); each of these steps involves 
multiple reactions that require extraordinary spatial and temporal coordination (Levin et al., 
2016). 
 
Figure 1.1. The steps of efficient apoptotic cell clearance. 
First, “find-me” signals released by the apoptotic cell are recognized by their cognate receptor on the surface 
of the phagocyte. This interaction triggers the phagocyte to migrate to the location of the apoptotic cell. 
Second, the phagocyte recognizes exposed “eat-me” signals exposed on the surface of the apoptotic cells 
via their phagocytic receptors. This induce the formation of a phagocytic cup around the target. As a 
subsequent step, the newly formed phagosome will undergo a series of fusion and fission events with other 
organelles of the phagocytic and endocytic pathways, a process known as “phagosome maturation”. Here 
the engulfed material is digested by the phagocyte. The last event, known as “phagosome resolution” is the 
less understood step of phagocytosis. Presumably, here the digested material gets recycled or disposed by 
the phagocyte. 
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Phagocytosis is initiated by engagement of the phagocyte surface receptors that recognize 
specific ligands exposed or released by the target. Phagocytic receptors initiate a signalling 
cascade that induces important cytoskeletal modifications which lead to the formation of 
pseudopod-like structures that surround the target. The newly formed phagosome undergoes 
a series of fusion and fission events with other cytosolic organelles to ensure degradation of 
the engulfed material. Finally, the phagocyte must digest and either dispose or recycle the 
phagosomal content.  
Since the first observation of phagocytosis in 1883 (Gordon, 2008), our knowledge has grown 
exponentially, but many aspects of this process remain unknown. Although receptor-ligand 
pairs (especially involved in the recognition of the target) might vary depending on the target, 
the phagocytic machinery is highly conserved and there is a considerable overlap with the 
endocytic process. In the next paragraphs, I will describe in details the different steps involved 
in phagocytosis by focusing in particular on the engulfment and processing of apoptotic cells.  
1.3.1 “FIND-ME”: ATTRACTION OF THE PHAGOCYTE TOWARDS THE TARGET 
The first and most obvious requirement for efficient apoptotic cell clearance is bringing the 
phagocyte in close proximity to its target. In some cases, this can happen passively, as for aged 
red blood cells which are brought in contact with spleen macrophages thanks to the vascular 
flow (Kohyama et al., 2012). In other circumstances, for example for pathogen engulfment or 
efferocytosis by non-professional phagocytes, the interaction with the target can be mediated 
by simple adjacency (Bray, 2001). However, more frequently, phagocytes must actively survey 
their environment and migrate towards the target and this is mediated by a signal exchange 
between the two cells. During efferocytosis, for example, it has been shown that apoptotic 
cells release so called “find-me” signals that stimulate long-range attraction, promoting the 
recruitment of the phagocyte to the site of death (Casano and Peri, 2015; Kettenmann et al., 
2011; Serhan, 2014). To date, several find-me signals released by dying cells have been 
reported (Figure 1.2). These include Lysophosphatidylcholine (LPC), Sphingosin-1-phosphate 
(S1P), fractalkine (CX3CL1) and nucleotides such as ATP and UTP (Elliott et al., 2009; Gude et 
al., 2008; Lauber et al., 2003; Truman et al., 2008). 
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Figure 1.2. Apoptotic stages and release of find-me signals.  
Generalized key features of apoptotic cells at different stages after induction of apoptosis. Blebbing, the 
typical morphological change of apoptosis, occurs between early and middle stages. The formation of 
apoptotic bodies is accompanied by the release of the so-called “find-me” signals (nucleotides, CX3CL1, LPC 
and S1P), necessary for the recruitment of phagocytes. 
 
By testing the ability of the cell culture supernatant from apoptotic cells to trigger 
macrophages chemotaxis, Lauber and colleagues were the first to identify LPC as a find-me 
signal. They suggested that this is released by apoptotic cells via the caspase-3-dependent 
activation of phospholipase A2 (Lauber et al., 2003). The binding of LPC to G2A (G protein 
coupled receptor 132) triggers chemotaxis of macrophages (Peter et al., 2008). However, 
recently it has been argued that this model is unlikely to work in vivo as the concentration of 
LPC required to induce chemotaxis (20-30 µM) is rather high and might never be reached 
physiologically (Hochreiter-Hufford and Ravichandran, 2012; Nagata et al., 2010). 
S1P is another lipid that is suggested to act as a find-me signal as it is able to induce phagocyte 
migration (Gude et al., 2008). However, only few reports have focused on the role of S1P in 
the context of cell death removal and no S1P receptor has yet been shown to mediate 
chemotaxis (Rosen and Goetzl, 2005).  
Fractalkine is the only chemokine shown to be acting as a “find-me” signal (Truman et al., 
2008). It is a membrane-associated protein and, upon induction of apoptosis, the extracellular 
domain is actively cleaved and released in the extracellular medium by neurons and apoptotic 
B cells. The released peptide binds its receptor CX3CR1 and induces microglia and 
macrophages chemotaxis.  
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Finally, secretion of nucleotides and binding to purinergic receptors has also been suggested 
to mediate phagocyte attraction towards apoptotic cells. The chemotactic nature of ATP and 
UTP has been largely described (Davalos et al., 2005; Honda et al., 2001; Sieger et al., 2012), 
however direct proof of their implication in efferocytosis in vivo is still limited. The 
Ravichandran group demonstrated that depletion of extracellular nucleotides by apyrase 
treatment or deletion of the purinergic receptor P2Y2 cause a delay in the clearance of 
apoptotic cells by macrophages in the murine thymus (Elliott et al., 2009). Similarly, UDP 
released by dying hippocampal neurons stimulates phagocytic clearance by microglia (Koizumi 
et al., 2007). Subsequent studies showed that release of nucleotides is mediated by pannexin 
channels, which open during apoptosis via caspase-dependent cleavage of their C-terminal tail 
(Chekeni et al., 2010). Nonetheless, since extracellular nucleotides are unstable and promptly 
degraded by nucleotidase, they have been suggested to be short-range chemoattractant for 
tissue resident macrophages rather than long-distance signals (Ravichandran, 2010). 
Hence, “find-me” signals can vary significantly and it is still unclear whether they function in an 
additive or synergistic manner and if different signals could be released at different stages of 
apoptosis and have alternative functions such as enhancing the phagocytic machinery or the 
ability to digest the ingested cargo. 
1.3.2 “EAT-ME”: FORMATION OF THE PHAGOSOME 
Phagocytes recognize their prey using receptors that specifically bind to ligands exposed on 
the surface of the target. During efferocytosis, in particular, apoptotic cells expose the so called 
“eat-me” signals which allow the phagocyte to sense damage and selectively recognize and 
remove the dying cells from the living-healthy tissue (Casano and Peri, 2015; Kettenmann et 
al., 2011; Medina and Ravichandran, 2016). Upon binding, the phagocytic receptors are 
activated to transmit an intracellular signalling which leads to the rearrangement of the actin 
cytoskeleton. This results in the formation of a phagocytic cup around the target to allow its 
engulfment. 
To date, numerous eat-me signals have been identified including binding of complement C1q 
to the apoptotic cell (Ravichandran and Lorenz, 2007), expression of intracellular adhesion 
molecule 3 (ICAM3) (Devitt et al., 1998) and exposure of intracellular proteins such as 
calreticulin and annexin I (Arur et al., 2003; Gardai et al., 2005). However, the first and best 
characterized eat-me signal is the membrane phospholipid phosphatidylserine (PS). PS is 
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normally confined to the inner leaflet of the plasma membrane but it is exposed to the outer 
leaflet after induction of apoptosis (Fadok et al., 1998a). The exposure of PS as an “eat-me” 
signal is found not only in mammals but also in Drosophila, C. Elegans and Zebrafish (Darland-
Ransom et al., 2008; Fadok et al., 1992; Hong, 2004; Segawa and Nagata, 2015). Extracellularly 
exposed PS is recognized by multiple membrane receptors such as T-cell immunoglobulin 
mucin receptor 4 (TIM4), brain specific angiogenesis inhibitor 1 (BAI1), stabilin-2 (Miyanishi et 
al., 2007; Park et al., 2007a; 2007b; Rodriguez-Manzanet et al., 2010) and bridging molecules, 
such as milk fat globule-EGF factor 8 (MGF-E8) and Gas6, that recognize PS and then engage 
phagocytosis cell surface receptors for engulfment (Ishimoto et al., 2000; Zizzo et al., 2012). 
More recently, live imaging in zebrafish has allowed to uncover the dynamics of apoptotic 
neuronal cell clearance by microglia. During brain clearance microglia, the resident 
macrophages of the brain, engulf single apoptotic neurons by extending highly dynamic 
branches with large phagocytic cups at their distal tips. Two PS-receptors, BAI1 and TIM4, are 
required for this process. In particular, while BAI1 has a role in forming the phagocytic cup 
around the target, TIM4 helps stabilizing this structure by polymerizing F-actin around the 
phagocytic cup (Mazaheri et al., 2014). 
In addition to detecting “eat-me” signals expressed on the apoptotic cells, phagocytes can 
further distinguish between live and dead target thanks to the exposure of so called “don’t-
eat-me” signals resent on the surface of living healthy cells. Those include adhesion-related 
proteins CD47 and CD31. CD47 is expressed on different types of cells and can interact with 
the inhibitory receptor SIRP1a on phagocytes to restrain the engagement of the phagocytic 
machinery (Willingham et al., 2012). Similarly, CD31 on viable cells can interact with CD31 on 
phagocytes to provide a spatially confined repulsion signal to prevent engulfment (Brown et 
al., 2002). The precise mechanism of action of such “don’t eat-me” signals is not yet fully 
understood, however their exposure has been studied in different contexts. For example, it 
has been shown that exposure of CD47 is a specific mechanism adopted by cancer cells to 
escape phagocytosis (Barkal et al., 2018; Brightwell et al., 2016). 
1.3.3 DIGESTION: PHAGOSOME MATURATION 
Following internalization, the newly formed phagosome undergoes a drastic transformation 
via a series of fusion and fission events with cytosolic organelles such as endosomes and 
lysosomes. During this step, known as “maturation”, gradual phagosomal acidification 
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generates a hostile and degradative environment that causes the digestion of the phagocytic 
cargo. This process has been studied extensively both in vivo and in vitro and many key 
molecular markers have been identified. By analogy with the endosomal compartments, 
phagosomal maturation can be divided into substages: early, late and the phagolysosomal 
stage (Figure 1.3).  
 
Figure 1.3. Phagosomal maturation: events and molecular markers. 
The lumen of nascent phagosomes strongly resembles the extracellular environment. Multiple molecules, 
such as PtdIns(3)P, Rab5, Rab7 and Lamp1/2, are produced/recruited on the surface of phagosomes at 
different stages, driving the stepwise phagosome maturation process. During phagosome maturation, 
nascent phagosomes sequentially fuse with early endosomes, late endosomes and lysosomes forming early 
phagosomes, late phagosomes and phagolysosomes respectively, and gradually acquiring the membrane 
and luminal properties of these organelles. The phagosomal lumen at every maturation step is also 
progressively acidified thanks to the acquisition of additional copies of the proton pump vATPase. 
 
1.3.3.1 The early phagosome 
First, the GTPase Dynamin is recruited to the apoptotic cell-phagocyte interface where it 
interacts with the kinase Vps34. This interaction leads to the recruitment to the surface of the 
phagosome of Rab5, a small GTPase broadly considered as an early marker of phagocytosis 
(Roberts et al., 2000; Vieira et al., 2003). Active Rab5 promotes membrane fusion events and 
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Vps34 itself is one of its effectors; accordingly, Fratti and colleagues showed that inhibition of 
Vps34 arrests phagosomal maturation (Fratti et al., 2001). The product of Rab5 and Vps34 
activity is PtdIns3P, the characteristic phosphoinositide of the early phagosome (Vieira et al., 
2001). While the cargo is targeted for degradation, several components are thought to be 
recycled especially during degradation of apoptotic cells. Although the mechanisms involved 
in these processes are still largely unknown, the Rab GTPases Rab4, Rab10 and Rab11 have 
been implicated in recycling and phagosome maturation (Cardoso et al., 2010; Cox et al., 2000; 
Damiani et al., 2004). 
1.3.3.2 The late phagosome 
The early phagosome then fuses with late endosomes, thereby becoming a late phagosome. 
This is characterized by a more acidic pH due to the acquisition of additional copies of the 
proton pump vATPase. A crucial step during the early-to-late phagosome transition is the 
switch from Rab5 to Rab7 on the phagosome’s membrane, which is therefore considered a 
molecular marker for this stage of maturation (Harrison et al., 2003; Kinchen et al., 2008; 
Nordmann et al., 2010; Plemel et al., 2011). At the Rab7 positive stage, the Homotypic fusion 
and vacuole Protein Sorting (HOPS) complex is recruited to the phagosome, leading to Rab7 
activation and, ultimately, fusion of the phagosome with the lysosomal network (Kinchen et 
al., 2008). 
1.3.3.3 The phagolysosome 
The phagolysosome is the final degradative compartment. It is generated via the fusion of late 
phagosomes with lysosomes. Live imaging in zebrafish has shown that phagolysosome are the 
most prevalent vesicular compartments in the phagocytic microglia and that the a1 subunit of 
the v0-ATPase complex is essential for the heterotypic fusion between phagosomes and 
lysosomes. In particular, its absence leads to failure in phagolysosome formation with a 
consequent accumulation of “undigested” material (Peri and Nüsslein-Volhard, 2008). 
Moreover, Kimberle Shen and colleagues showed that RagA and Lamtor4, two components of 
the Rag-Ragulator complex, are essential regulator of lysosomes in microglia. Indeed, RagA 
deficiency causes and expansion of lysosomal compartments in microglia leading to inefficient 
digestion of apoptotic neuronal debris (Shen et al., 2016). 
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The phagolysosome is enriched in lysosome-associated membrane proteins 1 and 2 (Lamp1 
and Lamp2), which are considered molecular markers of this stage. Phagolysosomes are highly 
acidic, oxidative and contain lytic enzymes (Harrison et al., 2003; Kinchen et al., 2008; Meehan 
et al., 2016). Finally, cargo digestion relies on the activity of several catalytic enzymes such as 
Cathepsins that function at acidic pH (Flannagan et al., 2012; Harrison et al., 2003; Kinchen et 
al., 2008). 
1.3.4 RESOLUTION: HOW DOES PHAGOCYTOSIS END? 
A fascinating but poorly studied step of phagocytosis is how phagosomes get reabsorbed or 
resolved. When a phagocyte ingests a prey, it is likely to double its protein, carbohydrate and 
lipid content, yet professional phagocytes manage to rapidly engulf multiple targets. In 
general, the phagolysosome can catabolize its content via the activity of a diverse arsenal of 
hydrolytic enzymes. However, the products of this breakdown must be processed to allow the 
phagocyte to return to homeostasis. Park and colleagues showed that the mitochondrial 
membrane protein UCP2 positively regulate the engulfment capacity of phagocytes. In fact, 
while overexpression of UCP2 enhances efferocytosis in vitro, loss of its expression reduced 
the phagocytic activity both in vitro and in vivo (Park et al., 2011). DNAse II is a lysosomal 
enzyme responsible for degrading ingested nucleic acids, and lack of this enzyme leads to 
accumulation of short DNA strands in abnormal storage structures (Kawane et al., 2001; 2003; 
Mukae et al., 2002). Proteins are degraded into polypeptides and further into amino acids that 
can serve as nutrients for the phagocytes. To this aim, Cathepsins (which are divided into 
serine, cysteine and aspartate proteases) are activated at specific maturation stages in 
lysosomes thanks to the acidic pH (Flannagan et al., 2012; Kinchen and Ravichandran, 2008). 
Among the different macromolecules, lipids serve several important functions within a cell and 
are therefore strictly regulated. Interestingly, few studies show that apoptotic-derived 
cholesterol becomes part of the cholesterol pool of the phagocyte which handle the additional 
lipid load by increasing their basal efflux mechanism via ABCA1 (Gerbod-Giannone et al., 2006; 
Kiss et al., 2006).  
Although we have some insights about the mechanisms responsible for the degradation of 
different macromolecules deriving from the engulfed target, our understanding of phagosomal 
resolution is still very limited. Different lines of evidence point to the existence of post-
lysosomal compartments, however -to date- we lack a clear understanding of this final stage. 
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1.3.5 THE IMPACT OF PHAGOCYTOSIS  
Efficient engulfment by motile phagocytes require the execution of two distinct but connected 
cellular functions: migration toward the target and its subsequent phagocytosis. Those are 
both energy intensive processes which involve large-scale reorganization of the phagocyte 
cytoskeleton and overlapping signalling pathways. To date, it is unclear how major cellular 
events are integrated. Recent studies suggest that events downstream from internalization 
significantly influence the phagocytic capacity of a cell to engulf additional targets (Krieser et 
al., 2002; Park et al., 2011; Schrijvers, 2005; Wu et al., 2000). Moreover, it has been shown 
that blocking digestion or degradation can lead to a variety of cellular and tissue disfunctions 
that are known as Lysosomal Storage Disorders (LSDs) (Berg et al., 2016; Peri and Nüsslein-
Volhard, 2008; Samie and Xu, 2014). Oram and colleagues also showed that impairments in 
cholesterol efflux are linked to dyslipidemia and atherosclerosis (Oram and Heinecke, 2005). 
There is evidence for positive and negative feedback loops that operate downstream of 
phagocytosis. Indeed, after efferocytosis, phagocytes may undergo functional changes and 
decrease the production of pro-inflammatory cytokines and increase secretion of anti-
inflammatory ones (Fadok et al., 1998b). 
Although the relevance of the final stage of phagocytosis is becoming more and more clear, 
the notion that phagosomes need to undergo resolution has not been given enough attention. 
Consequently, the molecular and tissue implications of resolution are still unexplored.  
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1.4 TISSUE RESIDENT MACROPHAGES 
More than a century ago, Elie Metchnikoff described for the first time the process of 
phagocytosis and its main player: the phagocyte. A phagocyte is any cell capable of engulfment, 
for instance, some amoebae behave like macrophage in vertebrates, which suggest that the 
capability to phagocytose appeared early during evolution. 
To date, it has become clear that animals have several distinct populations of phagocytes which 
are responsible for the homeostatic removal of cellular corpses, debris and pathogens. 
Classically, phagocytes have been categorized as professional and non-professional depending 
on how effective they are at phagocytosis. The main difference between the two categories, is 
that the professional phagocytes display specific receptors able to recognize their targets, 
therefore being highly efficient in clearing the tissue from unwanted material. 
Mononuclear phagocytes include circulating monocytes in the bloodstream as well as dendritic 
cells and macrophages. In particular, macrophages are the resident phagocytic cells in 
lymphoid tissues (lymph nodes, spleen) and nonlymphoid tissues, such as liver (Kupfer cells), 
lung (alveolar macrophages), kidney (kidney macrophages), skin (Langherans cells) and brain 
(microglia). At these sites, macrophages perform diverse roles in health and disease. They 
contribute to the steady-state tissue homeostasis via the clearance of apoptotic cells and the 
release of growth factors, but also upon infection they activate and engulf pathogens and 
produce pro-inflammatory cytokines (Davies et al., 2013).  
Several elegant studies suggest that embryonic yolk sac (YS) derived stem cells colonize most 
tissues and contribute to the resident macrophage pool (Gomez Perdiguero et al., 2014; 
Hoeffel et al., 2015). Although they share a common myeloid origin, tissue resident 
macrophages are characterized by distinct morphologies and functions. Interestingly, genes 
commonly found in all macrophages are differentially expressed within distinct populations, 
indicating that specific profiles are likely to result from the crosstalk between the cell ontogeny 
and the local environment (Gosselin et al., 2014; 2017; Heinz et al., 2010; Lavin et al., 2014). 
Moreover, cellular heterogeneity is not only observed among different subsets of resident 
macrophages, but also within the same population. This is, for example, the case of microglia, 
whose distribution and morphology within the brain is not uniform (Lawson et al., 1990). Also, 
their expression of surface receptors, as well as cytokines and trophic factors, is highly 
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heterogeneous both at mRNA and protein levels, reflecting a certain variety in housekeeping 
functions and responsiveness to stimuli (Hanisch, 2013).  
Thus, tissue resident macrophages are both extremely heterogeneous as they fulfil specific 
functions depending on the tissue they reside in, and highly plastic, able to adapt to different 
conditions and new environments (Gosselin et al., 2014; Lavin et al., 2014) and to react to 
multiple stimuli.  
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1.5 MICROGLIA: THE RESIDENT MACROPHAGES OF THE BRAIN 
Microglia are the tissue resident macrophages which orchestrate innate immune responses in 
the vertebrate CNS. Interestingly, in the brain, microglia fulfil both immune-related and glial-
functions by playing crucial roles during development, homeostasis and disease.  
The discovery of microglia dates back in the late 19th century. It was first Santiago Ramón Cajal 
who defined the existence in the brain of a “third element” distinct from astrocytes and 
neurons, but it was only Pío del Río-Hortega, in 1919, to introduce the term that we use today 
and to describe in detail both microglia and oligodendrocytes (Sierra et al., 2016). In the same 
year, Río-Hortega published a series of four papers in which he identified these new glial cells, 
highly ramified and with a small soma (hence the name “microglia”) which he characterized 
morphologically and functionally under physiological and pathological conditions. The author 
extensively studied microglia during both development and adulthood and across several 
different vertebrate species and it is astonishing how, in spite of the limited techniques 
available at that time, most of his hypothesis remain still true today. 
1.5.1 MICROGLIA ARE HIGHLY DYNAMIC AND PLASTIC CELLS  
In his first 1919 work, Río-Hortega described the protocol he developed to specifically stain 
microglia. He found that microglial cells were present in all regions of the brain even though in 
different densities, and he described those as cell with a reduced soma and long, thin processes 
which form complex protrusions. He also showed that microglia were able to undergo a 
hypertrophic transformation and acquire multiple shapes and elongated forms (Sierra et al., 
2016). After being neglected for more than 50 years, this cell population is now again subject 
of much attention. Classically, microglia have been divided in two subtypes: “resting” microglia, 
distinguished by ramified and highly branched morphology, and “activated” microglia, 
characterized by an amoeboid shape classical of pathological conditions. While it is true that 
microglia are highly dynamic and can acquire different morphologies, it is also clear that these 
descriptions are misleading oversimplifications. Live imaging in both mice and zebrafish 
embryos showed the very active nature of the so called “resting” microglia. These cells form a 
highly dynamic and non-overlapping network in the brain with their branched morphology, 
constantly scanning the surrounding tissue (Nimmerjahn et al., 2005; Peri and Nüsslein-
Volhard, 2008). Using live imaging in the intact mouse brain, branched microglia have been 
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shown to be highly active and to rapidly respond to different stimuli (Nimmerjahn et al., 2005). 
Transgenic lines in zebrafish further show that microglia continuously engulf neurons with their 
long processes and transport them back towards the cell body (Peri and Nüsslein-Volhard, 
2008). The term “resting” has been in fact substituted with “surveying” as suggested by 
Hanisch and Kettemann (Hanisch and Kettenmann, 2007).  
Microglia are not only very dynamic, but also exceptionally plastic. For example, works 
conducted in mice showed that brain macrophages have unique gene expression profiles 
during different phases of development to the extent that it has been proposed to divide 
microglia in three different groups: early (E10.4-14), pre-microglia [E14-postnatal day (P) 9], 
and adult microglia (P28 on) (Bennett et al., 2016; Matcovitch-Natan et al., 2016). While some 
genes which are considered canonical microglial markers (e.g. P2Y12) are expressed already 
very early during development, other are expressed only in adult microglia (e.g. MafB, 
Tmem119) (Bennett et al., 2016; Matcovitch-Natan et al., 2016). Recently, many groups got 
interested in studying the transcription profile of microglia with the aim of determining what 
defines microglia and how do they vary across time, space and individuals. What is clear from 
these studies is that the transcriptomic profile of those cells varies not only between different 
developmental stages, but also age, sex, brain regions and even gut microbiota (Grabert et al., 
2016; Matcovitch-Natan et al., 2016; Ransohoff and Khoury, 2016). Microglial functional roles 
are shaped by complex regulatory networks in their local milieu: many factors are released in 
discrete brain regions to drive specific microglia functions (Arnò et al., 1AD; Lelli et al., 2013; 
Mosher et al., 2012; Schafer et al., 2012; Wang et al., 2012). Interestingly, microglia gene 
expression is dramatically altered by removing microglia from their physiological environment 
to culture them (Bohlen et al., 2017) showing the importance of working with those cells in 
vivo, in intact systems. 
Nowadays, it is clear that microglia are highly dynamic and plastic cells, continuously in contact 
with their local environment, able to exchange information with it and within each other and 
to react to different signals. 
1.5.2 MICROGLIA ONTOLOGY 
In his third publication, Río-Hortega addressed the origin of microglia and he presented 
arguments in support of their mesodermal origin. Once again, he was right, and after much 
unnecessary discussion, today it is clear that microglia are, in fact, of mesodermal origin and 
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derive from early yolk sac macrophages that colonize the brain during embryogenesis. Also, 
the hematopoietic embryonic origin of microglial cells is conserved across vertebrate species 
(Ginhoux et al., 2013). For example, it has been shown that absence of pU.1, the myeloid 
transcription factor, leads to complete depletion of microglia both in mouse and fish (Beers et 
al., 2006; Peri and Nüsslein-Volhard, 2008). As a further prove for the hematopoietic origin of 
microglia, deletion of the macrophage specific receptor CSF-1R leads to the complete absence 
of microglia in mouse (Erblich et al., 2011; Ginhoux et al., 2010). Ginhoux and colleagues 
showed that microglia start appearing in the brain at E9.0-9.5 and that specific depletion of YS 
macrophages, but not circulating monocytes, dramatically reduces their number in the brain 
(Ginhoux et al., 2010). These data are confirmed also in zebrafish, where loss-of-function 
mutation in fms (the zebrafish orthologue of CSF-1R) impairs macrophages migration from the 
YS throughout the embryo, resulting in defective microglia brain colonization. However, 
normal numbers of microglia are restored at larval stages (Herbomel et al., 2001). Recently, 
our group identified Slc7a7, a Leucine/Arginine amino acid transporter, as a marker for 
microglia precursors; interestingly, at 22 hours post fertilization (hpf), only a restricted subset 
of YS macrophages expresses this gene and mutants lacking Slc7a7 have no microglia in the 
brain, but a normal number and distribution of other tissue macrophages (Rossi et al., 2015). 
Furthermore, in zebrafish, it has been shown that the establishment of the microglial 
population is linked to the rate and distribution of developmental apoptosis in the brain. 
Neuronal apoptosis promotes the entry and positioning of microglia by nucleotide signalling 
and Lysophosphatidylcholine (Casano et al., 2016; Xu et al., 2016). 
1.5.3 MICROGLIA FUNCTIONS 
It is clear that microglia are extremely versatile cells: the heterogeneity of their transcriptional 
profile, their different morphologies, their migratory capacity and their high motility are 
suggestive of the importance of microglia in brain development and homeostasis. Indeed, 
these macrophages are involved in many regulatory processes necessary for development, 
homeostasis, response to injury, infection and subsequent repair. Microglia are responsible for 
the rapid and efficient clearance of unwanted cells and debris and they react to damage signals 
(Ransohoff and Khoury, 2016) by migrating over long distances and by producing chemokines, 
cytokines and other pro- and anti- inflammatory signals to promote repair and homeostatic 
maintenance (Lenz and Nelson, 2018). In support of the important role of microglia, there is 
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the fact that deletion of microglia-related genes severely compromises proper brain 
functionality leading to altered brain wiring and producing behavioural deficits associated with 
neurodevelopmental and neuropsychiatric disorders (Chen et al., 2010a; Frost and Schafer, 
2016; Holstege et al., 2008; Parkhurst et al., 2013). 
Thanks to their phagocytic activity, microglia are involved in refinement of neuronal 
connectivity and spatial patterning. It has been shown that brain macrophages sculpt synaptic 
connectivity by engulfing the neuronal terminal that form synapses, a process known as 
synaptic pruning (Hong et al., 2016b; Paolicelli et al., 2011; Schafer et al., 2012; Stevens et al., 
2007; Tremblay et al., 2010). More recent studies confirmed this hypothesis by suggesting a 
model by which microglia would remodel synapsis through a process of trogocytosis (or 
nibbling) of synaptic structures rather than the engulfment of entire synapses (Weinhard et 
al., 2018). On the other hand, the role of microglial phagocytosis in sculpting the brain tissue 
is doubtless. As the local phagocyte of the brain, microglia engulf apoptotic neurons during the 
embryonic development (Casano et al., 2016; Sierra et al., 2010) and also in adult neurogenesis 
(Ekdahl et al., 2003; Monje et al., 2003). Furthermore, microglia are thought to actively take 
part in the shaping of organs by promoting apoptosis directly. This process is known as 
“phagoptosis” and it has been demonstrated for Purkinje cells (Marin-Teva et al., 2004), 
granular cells in the hippocampus (Dalmau et al., 1997), and ganglionic cells in the avian retina 
(Navascués et al., 1995).  
1.5.3.1 Phagocytic microglia  
A driving force behind many microglial activities is phagocytosis. This is a key function of 
immune cells in health and disease and microglial cells are a great model for studying this 
process. Indeed, programmed cell death in the CNS is central in establishing the brain 
cytoarchitecture, and microglia play a key role in removing apoptotic neurons preventing the 
leakage of harmful contents and suppressing unwanted immune responses. Microglial 
involvement in the physiologic removal of apoptotic cells has been first suggested by Perry and 
Ashwell, who documented the round and ameboid shape of microglia and their distribution 
preferentially in pyknotic areas of the developing mouse brain (Ashwell, 1990; Perry et al., 
1985). Similarly, also in avians, embryonic brain macrophages accumulate in areas 
characterized by high levels of cell death and show dense phagosome inclusions containing 
fragments of dead cells at different stages of digestion (Cuadros et al., 1993). Although the 
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importance of microglial phagocytosis is broadly recognized, factors involved in this process 
remain largely unknown. The engulfment of apoptotic neurons by microglia follows the multi-
step process described for all phagocytes and involves a well conserved molecular machinery 
across different species such as mouse and zebrafish (Davalos et al., 2005; Haynes et al., 2006; 
Mazaheri et al., 2014; Ravichandran, 2011; Sieger and Peri, 2012; Sieger et al., 2012). Other 
than being essential for proper tissue homeostasis, the ingestion and degradation of cells have 
several indirect consequences for both the phagocyte and the surrounding tissue. Indeed, 
phagocytosis triggers the activation of several pathways and microglia receive an incredible 
metabolic load leading to changes in the lipid, cholesterol and glucose metabolism (Han and 
Ravichandran, 2011). 
Overall, microglial phagocytosis is considered a beneficial phenomenon and defects have been 
linked to autoimmune and neurodegenerative diseases (Nagata et al., 2010; Neumann, 2013). 
Already Río-Hortega in his fourth paper of 1919 described the high migratory and phagocytic 
activity of microglia under pathological conditions (Sierra et al., 2016). Neurodegeneration by 
apoptosis is a major part of several brain diseases such as epilepsy, stroke, Alzheimer’s disease 
(AD) and Parkinson’s disease (PD) and the role of microglial phagocytosis in these conditions 
still remain controversial. For example, in AD microglia are thought to play a detrimental role 
by removing healthy neurons and synapses (Hong et al., 2016a; Sanagi et al., 2010). Conversely, 
microglia are thought to play a beneficial role after traumatic brain injuries where they support 
subsequent recovery by removing cell corpses and debris (Donat et al., 2017; Loane and 
Kumar, 2016).  
Thus, understanding the mechanisms by which microglia migrate, engulf and digest their prays 
is of great importance and interest in biology and also for developing novel therapeutical 
approaches to modulate microglia phagocytosis in different contexts. 
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1.6 ZEBRAFISH AS A MODEL SYSTEM TO STUDY MICROGLIA 
Since the work of Streisinger and colleagues in 1980s, zebrafish, Danio rerio, has emerged as 
an excellent model organism for biological studies (Streisinger et al., 1981). Today, zebrafish is 
widely used to study, for example, embryonic development, neurobiology and for mechanistic 
in vivo investigations in vertebrates (Amatruda et al., 2002; Dooley and Zon, 2000; Lele and 
Krone, 1996). This small tropical fish is relatively cheap to raise and maintain, it is easy to handle 
and breeds rapidly, laying per clutch around 100 embryos which develop rapidly and 
synchronously outside the mother.  
A great advantage of this model system, is its genetic accessibility. Originally, the zebrafish has 
been extensively used as a tool for large-scale forward genetic approaches. These screens 
typically are based on adding N-ethyl-N-nitrosourea (ENU) to the water of male zebrafish to 
induce in premeiotic spermatogonia random point mutations, which are then transmitted to 
the progeny. In this way stable mutant lines can be generated and used for the unbiased 
identification of new genes and genetic functions (Driever et al., 1996; Haffter et al., 1996; 
Meireles et al., 2014; Mullins et al., 1994; Patton and Zon, 2001; Rossi, 2013).  
Complementary to forward genetic approaches, with sequencing of the zebrafish genome, a 
collection of reverse genetics tools has been developed for studying the function of specific 
genes. Widely used are morpholinos (MOs), antisense oligonucleotides that knock down gene 
expression by affecting splicing or translation of mRNA. While in mouse antisense 
oligonucleotides are rapidly diluted during development, in zebrafish the effect of morpholinos 
can persist up to 5 days post fertilization (dpf), allowing the functional characterization of gene 
activity in vivo (Bedell et al., 2011). To overcome the transient nature of MOs and allow the 
generation of stable zebrafish mutant lines, engineered endonucleases including ZFNs (zinc 
finger nucleases), and TALENs (transcription activator-like effector nucleases) have been 
generated starting in 2008 (Doyon et al., 2008; Huang et al., 2011; Meng et al., 2008; Sander 
et al., 2011). Those methods allowed to achieve directly site-specific genome modification 
based on the induction of double strand breaks (DSB) in target genes. These induce non-
homologous end joining (NHEJ), an endogenous DSB repair response that results in small 
insertions and/or deletions. Alternatively, homology-directed repair (HDR) can occur if a 
template is supplied resulting in the generation of engineered alleles at the break site. 
However, those systems even though innovative and promising require time and skill. More 
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recently, the CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) system 
has been introduced and this has been immediately recognized as a game-changing advance 
in directed mutagenesis experiments since it is faster, easier and inexpensive compared to 
ZFNs and TALENs (Hwang et al., 2013a; 2013b; Sander and Joung, 2014). CRISPR-Cas are RNA-
directed endonucleases systems which evolved in bacteria and archaea as a mechanism of 
defence to silence foreign nucleic acids. These have been engineered to create single guide 
RNAs (sgRNAs) capable of directing site specific DNA cleavage by the Cas9 nuclease which has 
been modified by the addition of nuclear localization sequences (NLSs) to target the 
endonuclease activity to the nucleus in eukaryotes. The endonuclease-generated DSB repair 
can be manipulated so that the gene function is lost (targeted gene knock-out) or to add a new 
function (targeted knock-in) by taking advantage of NHEJ or HDR respectively.  
There is no doubt that one of the most remarkable advantages of the zebrafish model system 
is its transparency during embryonic stages. The use of vital dyes and the generation of 
transgenic lines that label different cell types combined with recent advances in light 
microscopy allows the monitoring and characterization of complex biological and 
developmental processes at an unprecedented spatial and temporal resolution in vivo (Casano 
et al., 2016; Huang et al., 2012; Mazaheri et al., 2014; Meireles et al., 2014; Morsch et al., 2015; 
Peri and Nüsslein-Volhard, 2008).  
A great innovation in zebrafish research has been introduced in 2010 thanks to the use of the 
site-specific recombinases (SSRs) PhiC31 (Hu et al., 2011; Lister, 2010; 2011; Lu et al., 2010; 
Mosimann et al., 2013). This recombinase mediates an integration reaction between 
heterotypic binding sites termed attB (attachment site Bacterium) and attP (attachment site 
Phage) without requirement for any accessory factors (Groth, 2004). The completed attP/attB 
recombination results in hybrid attL and attR (Left and Right) sites that are incompatible with 
the phiC31 integrase, thus rendering the recombination irreversible (Groth, 2000). The use of 
SSRs for generation of proteins’ live reporters allows to overcome some limitations such as 
possible overexpression phenotypes or the variable expression intensity and patterns among 
different transgenic lines allowing quantitative and qualitative evaluation of transgene 
expression. 
Another recent development that is perfectly suited for zebrafish is optogenetics, an approach 
that has revolutionized the toolbox arsenal that biologist possess to investigate basic 
fundamental processes in vivo. In fact, the genetic encoding of light-sensitive proteins that 
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activate or deactivate signalling pathways in response to light allows to monitor, control and 
perturb tissue and cellular dynamics. Its first application was the use of light-gated ion channels 
to manipulate the excitability of neuronal cells (Boyden et al., 2005), today the molecular 
engineering has also enabled optogenetic control of well-defined biochemical events (Airan et 
al., 2009; Toettcher et al., 2010; Wu et al., 2009). For example, early in 2009 Airan and 
colleagues described optical control of distinct G protein-coupled receptors (GPCR) 
biochemical pathways using vertebrate rhodopsin-GPCR chimeras (optoXRs), which recruit 
pathways that are governed by distinct heterotrimeric G-proteins (Gq and Gs) (Airan et al., 
2009). 
Relevant for this thesis is the fact that the immune system of the zebrafish closely resembles 
that of higher vertebrates or mammals, qualifying it as a valid model organism for comparative 
studies of macrophages, microglia and their interactions with the surrounding environment in 
the developing living organism (Ellett et al., 2011; Niethammer et al., 2009; Peri and Nüsslein-
Volhard, 2008; Renshaw and Trede, 2011; Sieger et al., 2012).  
Thus, in the last decade the zebrafish has emerged as a powerful and well-established model 
system for in vivo studies.
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2 AIM OF THE PROJECT 
The aim of this thesis was to take advantage of the optical transparency of the zebrafish larva 
and to combine genetical and chemical perturbations to investigate how microglia and 
macrophages process the ingested cargo. In particular, we aimed to determine the fate of 
mature phagosomes and understand how their processing impacts back on the phagocytic 
activity. The starting point of this work has been the identification during a previous genetic 
screen of a mutant in which microglia are round and bloated.  
 
Former PhD students in the lab contributed to this project. Specifically, Katrin Henke identified 
the blb mutant and mapped the mutations and Christian Moritz performed initial investigative 
experiments. This work has been conducted in collaboration with my colleague Jørgen 
Benjaminsen, who in particular focused on the ultrastructural characterizations of 
macrophages and microglia.
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3 RESULTS 
3.1 IDENTIFICATION OF A ZEBRAFISH MUTANT WITH AN ABERRANT MICROGLIA PHENOTYPE 
Previous work has shown that aberrant morphology of microglia or their phagocytic 
compartments can be indicative of defects in phagocytosis, such as the fusion between 
phagosomes and lysosomes (Peri and Nüsslein-Volhard, 2008) or proper lysosomes 
functionality (Shen et al., 2016). Thus, in order to investigate the mechanisms behind 
intracellular processing of the material engulfed and phagosomal resolution in brain 
macrophages, we revisited a large ENU mutagenesis screen that was carried out in 2005-2006 
at the MPI in Tubingen, looking for altered microglia morphologies. This was the first screen 
addressing specifically microglial phenotypes in a vertebrate system. By the use of Neutral Red 
(NR), a pH indicator staining in the brain microglia, we isolated a class of mutants characterised 
by an altered morphology (Henke, 2011). This mutant was named bubblebrain (blb), because 
of the enlarged, bloated morphology of microglia.  
The mutant cells were swollen and had a bubble-like morphology, visible already with low 
magnification at the stereomicroscope (Figure 3.1 A-D). In order to investigate this phenotype, 
stable transgenic lines expressing different fluorescent markers were used. In particular, viable 
blb homozygous mutants where crossed with lines labelling all macrophages 
(Tg(spi1b:Gal4,UAS:eGFP); Tg(spi1b:Gal4,UAS:TagRFP) and Tg(mpeg1:eGFP-caax)) (Ellett et 
al., 2011; Peri and Nüsslein-Volhard, 2008; Sieger et al., 2012), or specific for microglia 
(Tg(ApoE:lyn-eGFP)) (Peri and Nüsslein-Volhard, 2008). Then, crosses of these animals with 
Tg(NBT:dsRed) (Peri and Nüsslein-Volhard, 2008) and Tg(NBT:secA5-BFP) (Mazaheri et al., 
2014) allowed labelling at the same time of macrophages/microglia and neurons or apoptotic 
neurons respectively. These crosses allowed live imaging of mutant microglia, and confocal 
microscopy of 4 dpf blb embryos revealed that the aberrant morphology observed from the 
bright field and NR staining was caused by the presence of a single, large vesicle that could 
reach up to 40 µm in diameter (Figure 3.1 F, H and J). Most of the cell body, indeed, was 
occupied by this large vesicle (blb “vacuole”) and it was left with very little cytoplasm. 
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Moreover, the bubble morphology was accompanied by an important loss of ramifications 
(Figure 3.1 compare J to I).  
 
Figure 3.1. Characterization of bubblebrain (blb), a mutant with bloated microglia. 
(A and B) Bright field view of the dorsal side of a 4 dpf wild type (A) and blbNY007 (B) embryo. 
(C and D) Neutral Red staining in a 4 dpf wild type (C) and blbNY007 (D) embryo. 
(E-J) Microglia cells labelled with Tg(mpeg1:eGFP-caax) in 4 dpf wild type (E, G and I) and blbNY007 (F, H and 
J) embryos. (E and F) Maximum intensity projections of the optic tectum of wild type (E) and blbNY007 (F) 
embryo, scale bar 30 µm. (G and H) Single plans of an optic tectum region of wild type (G) and blbNY007 (H) 
embryo, scale bar 30 µm. (I and J) Microglia cell of wild type (I) and blbNY007 (J) embryo, scale bar 30 µm. 
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3.2 MUTANT MICROGLIA ARE PHAGOCYTIC AND THE PHENOTYPE INCREASES OVER TIME  
During brain development, the main function of microglia is the clearance of apoptotic 
neurons. To determine whether these cells are also phagocytically active in blb we took 
advantage of the Tg(NBT:secA5-BFP) line, which labels apoptotic neurons with BFP. In 
particular, by using this PS reporter (Mazaheri et al., 2014) it was possible to progressively 
localize apoptotic neurons in 4 dpf mutant embryos. Interestingly, this approach showed that 
the blb vacuole is filled up with apoptotic neuronal material (Figure 3.2 A), suggesting that 
mutant microglia are phagocytically active. 
 
 
Figure 3.2. Mutant microglia are phagocytic and the blb vacuole grows over time. 
(A) Microglia cell labelled with Tg(mpeg1:eGFP-caax) and Tg(NBT:secA5-BFP) to visualize apoptotic neurons 
in a 4 dpf blbNY007 embryo. 
(B) Quantification of the “bubble” size in blbNY007 embryos from 2.5 to 4.5 dpf in optic tectum (OT, red plots) 
and in the hindbrain (HB, orange plots). P value < 0.0001. N reported in Table 3.1. 
 
 
The characterization of blb microglia in terms of morphology and content was performed at 4 
dpf, when the brain is fully populated by microglia (Casano et al., 2016). The presence of 
apoptotic neuronal material inside the blb vacuole suggests that the bubble-morphology could 
be acquired by phagocytosis over time. Thus, to investigate the progression of the blb 
phenotype, we followed those cells during development. In particular, we imaged at the 
confocal microscope blb embryos at different time points, starting at 2.5 dpf when microglia 
just started entering the brain, through 3, 3.5, 4 dpf till 4.5 dpf when the entire microglia 
population is established. For each time point, we imaged several embryos (Table 3.1) and we 
acquired full brain stacks. The analysis was performed by measuring the diameter of the blb 
vacuole in the different brain regions imaged, such as optic tectum (OT) and hind brain (HB). 
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Indeed, this revealed that the blb phenotype progresses over time. At 2.5 dpf few cells were 
identified with a bubble morphology and the diameter of the vacuole was 3 times smaller than 
the one observed at the latest time point. From the earliest time point, the size of the bubble 
increased progressively in all brain regions (Figure 3.2 B). Previous work in the lab showed that 
different areas in the brain are characterised by different levels of apoptosis (Casano et al., 
2016), in particular cell death is significantly less in the HB than in the OT. Our data showed 
that even though in both regions the bubble diameter increased over time, the growth of the 
blb vacuole was significantly higher in the OT than in the HB (Figure 3.2 B compare red to 
orange), suggesting a correlation between apoptosis/phagocytosis and progression of the 
phenotype in blb. 
Together these results show that the mutant microglia are phagocytically active, as they 
contain apoptotic neurons, and that the blb vacuole grows progressively, in particular in brain 
regions characterised by high level of neuronal PCD. 
 
 
 
  
Localization OT OT OT OT OT HB HB HB HB HB 
dpf (approx.) 2.5 3 3.5 4 4.5 2.5 3 3.5 4 4.5 
N (fish) 11 54 48 44 44 11 54 48 44 44 
n (cells) 92 333 372 391 389 48 253 208 198 158 
Table 3.1. N and n quantification in Figure 3.2 B 
Number of embryos and cells analysed at each time point for the quantification of the bubble growth. 
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3.3 THE BLB PHENOTYPE RESULTS FROM DEFECTS IN PROCESSING OF THE ENGULFED MATERIAL 
The bloated phenotype observed in blb microglia and the accumulation of apoptotic material 
in those cells could be the consequence of increased phagocytic activity. This might be induced 
by higher levels of neuronal apoptosis, therefore we investigated whether programmed cell 
death was altered in blb mutants. The number of apoptotic cells was quantified in living 
samples by staining with Acridine Orange (AO). This is an intercalating agent that binds to the 
fragmented DNA of apoptotic cells and has been widely used for fast labelling and analysis of 
cell apoptosis in vivo (Abrams et al., 1993; Casano et al., 2016; Mazaheri et al., 2014; Paquet 
et al., 2009). In particular, for a proper estimation of the absolute amounts of dead cells 
accumulated in the brain, phagocytic microglia were genetically depleted in blb and wild type 
controls. This was achieved via a morpholino approach, by knocking down the myeloid 
transcription factor pU.1, which impairs the production of macrophages and microglia (Peri 
and Nüsslein-Volhard, 2008; Rhodes et al., 2005). This approach revealed that apoptosis occurs 
at a normal rate in mutant embryos as numbers of apoptotic nuclei in embryos lacking 
microglia are comparable between wild type and blb (Figure 3.3 A-C).  
Then, we asked if the phagocytic activity was affected in blb mutants, and to achieve this we 
used two different approaches. First, we performed AO staining in wild type and blb embryos 
in the presence of phagocytic microglia and we quantified the number of uncollected apoptotic 
neurons. Contrary to what expected, this showed that the amount of un-engulfed apoptotic 
cells is significantly higher in blb when compared to wild type embryos (Figure 3.3 D). These 
data suggest that in blb while neuronal cell death is normal, the clearance of apoptotic neurons 
is defective. To test this, we took an in vivo approach by using live reporters labelling microglia 
and apoptotic neurons. Time lapse imaging in wild type and blb embryos were quantified by 
counting the number of phagocytic events over time. This showed that blb microglia engulf 
fewer neurons per hour when compared to wild type cells (Figure 3.3 E). 
Collectively, these findings excluded that the blb-bloated morphology was caused by increased 
apoptosis or engulfment. Therefore, we asked if the blb defect would occur downstream of 
these events, in the processing of dead neurons. To test this, different approaches were used 
to manipulate brain apoptosis or microglia engulfment and monitor the effects on blb microglia 
morphology.  
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Figure 3.3. Bubblebrain functions downstream of cell death and engulfment. 
(A-C) Microglia depletion in wild type and blbNY007 embryos and Acridine Orange (AO) staining for apoptosis 
quantification. (A and B) Dorsal view of a 3.5 dpf wild type (A) and blbNY007 (B) embryo injected with the pU1 
morpholino to deplete microglia and stained with AO to visualize apoptotic neurons. (C) Quantification of 
apoptotic neurons visualized by AO in wild type (n=18) and blbNY007 (n=19) injected with the pU1 morpholino 
to deplete microglia in 3.5 dpf embryos; representative images in (A) and (B).  
   RESULTS 
 35 
(D and E) Analysis of the phagocytic rate of wild type and blbNY007 embryos. (D) Quantification of uncollected 
apoptotic neurons visualized by AO in wild type (n=20) and blbNY007 (n=17) embryos. P value < 0.0001. (E) 
Quantifications of phagocytic events per cell per hour in wild type (n=50;47) and blbNY007 (n=61;77) embryos 
at 3.5 dpf and 4dpf, respectively.  P value <0.0001. 
(F-H) Analysis of blb microglial morphology upon apoptosis inhibition. Dorsal view of blbNY007; 
Tg(spi1b:Gal4,UAS:GFP); Tg(NBT:DsRed) (F) and blbNY007; Tg(spi1b:Gal4,UAS:GFP); Tg(NBT:DsRed) injected 
with a Caspase 3 morpholino and treated with Z-VAD to reduce apoptosis (G), representative images 
quantified in (H). (H) Quantification of (F) and (G). Number of microglia with bubble morphology in blbNY007 
(n=61) and blbNY007 with reduced apoptosis (n=61). P value < 0.0001. 
(I-K) Analysis of blb microglial morphology upon engulfment inhibition. (I and J) Microglial cells labelled with 
Tg(spi1:Gal4,UAS:GFP) in 4 dpf blbNY007 (I) and in blbNY007 injected with morpholinos against BAI1 and TIM4 
to reduce engulfment (J), representative images quantified in (K). (K) Quantification of (I) and (J). Number of 
microglia with bubble morphology in blbNY007 (n=50) and blbNY007 injected with BAI1+TIM4 morpholino to 
reduce engulfment (n=50) P value < 0.0001. 
 
First, we decreased cell death. The pathway of apoptosis is incredibly conserved between 
mammals and fish, and many of its core components can be compared between the two 
groups of vertebrates (Eimon and Ashkenazi, 2010). Thus, cell death reduction was achieved 
by targeting the effector caspase-3, a critical executioner of apoptosis, using a morpholino-
mediated knock down and the irreversible caspase inhibitor Z-VAD-fmk (Williams and Holder, 
2000; Yamashita et al., 2008). Previous work in the lab showed that those treatments 
combined were efficient in reducing of 50% apoptosis levels (Casano et al., 2016). Here, 
quantification of the number of microglia with a bubble morphology, showed a significantly 
lower number of bloated microglia in blb embryos in which we reduced apoptosis as described 
above (Figure 3.3 F-H). 
Next, we inhibited microglial engulfment. In particular, we targeted simultaneously two PS 
receptors, BAI1 and TIM4, which are highly expressed on microglia and are involved in 
phagocytic cup formation and phagosome stabilization respectively (Mazaheri et al., 2014). 
Previous work in the lab demonstrated that morpholino knock down of both PS receptors leads 
to a significant decrease in engulfment (Mazaheri et al., 2014). Here, similarly to the result 
obtained for apoptosis inhibition, also the down regulation of engulfment receptors decreased 
significantly the number of visible bubble-like microglia in the brain of blb (Figure 3.3 I-K). 
Therefore, apoptosis inhibition and engulfment down regulation prevented the formation of 
the typical bubble-like morphology in blb.  
The data presented above identify blb as a factor required in microglia for intracellular 
processing downstream of apoptotic cell engulfment. 
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3.4 THE BLB PHENOTYPE IS NOT RESTRICTED TO MICROGLIA BUT AFFECTS ALL MACROPHAGES 
To determine whether the blb phenotype was restricted to microglia or if other professional 
phagocytes display a similar bloated morphology, we examined other tissue resident 
macrophages. The use of the transgenic line Tg(mpeg1:eGFP-caax) labelling all macrophages 
allowed live imaging of trunk macrophages which exhibited a normal morphology at 
physiological conditions (Figure 3.4 A). It has been previously shown that in the trunk apoptotic 
levels are low (Cole and Ross, 2001; Yamashita, 2003), therefore the normal macrophages’ 
phenotype could be due to their lower phagocytic activity compared to microglia. To test this, 
we induced all macrophages to engulf more by elevating cell death. In particular, we induced 
ectopic apoptosis by treating the zebrafish embryos (blb and wild type controls) with the drug 
Camptothecin (CPT) (Li et al., 2017). CPT is an alkaloid which reversibly binds DNA-
topoisomerase-I complexes, but not the enzyme or DNA alone, inducing apoptosis in dividing 
cells. This treatment resulted in blb trunk macrophages developing a bubble-like morphology 
similar to that of microglia (Figure 3.4 B). Similarly, trunk macrophages developed the 
characteristic blb microglia phenotype when induced to phagocyte more in response to a 
tissue damage induced with either laser ablation or mechanical injury by forceps (data not 
shown).  
These data indicate that the blb phenotype is not restricted to the brain, but it can affect all 
phagocytically active macrophages in the body. 
 
 
Figure 3.4. The mutant phenotype affects all macrophages. 
(A and B) Representative examples of trunk 4dpf macrophages in blbNY007 (A) and blbNY007 treated with 
Camptothecin to increase apoptosis (B). Scale bar 10µm.   
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3.5 THE BLB VACUOLE IS CHARACTERIZED BY A DISTINCT ULTRA-STRUCTURE 
The most striking feature of the blb mutant was the presence of a single large vesicle per cell. 
As described earlier, at 4 dpf, the identification of mutant microglia is straightforward even 
without any fluorescent labelling observing the zebrafish head at low magnification at the 
stereomicroscope. Thus, we aimed to describe the ultrastructure of this vesicle which grows 
over time upon phagocytic activity. Electron microscopy (EM) is a major analytical method, 
with significant higher resolution compared to confocal microscopy, and commonly used in 
biology to investigate the structure and content of a wide range of biological samples and 
compartments. Thus, by taking an EM approach we described the morphology and content of 
the blb vacuole and the general ultrastructure of mutant microglia. As observed by live 
imaging, this approach confirmed that blb microglia have a very limited cytoplasm as most of 
the cell volume is occupied by one large vesicle. In addition, this approach revealed that this 
big vesicle is surrounded by a single lipid bilayer and has a strikingly electron lucent, clear 
lumen that contains sparse membrane debris (Figure 3.5). Interestingly, we couldn’t find any 
description in the literature of such a compartment in microglia or macrophages. 
 
 
Figure 3.5. The blb vacuole has a distinct ultrastructure. 
Electron micrograph of a representative blbNY007 microglia at 3.5 dpf. Scale bar 5µm. 
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3.6 GENETIC MAPPING OF BLB REVEALS THAT THE UNDERLYING GENE ENCODES FOR SOLUTE 
CARRIER FAMILY 37 MEMBER 2 (SLC37A2) 
Previous work in the lab has mapped the blb mutation on chromosome 5, in an interval that 
includes the gene Slc37a2 (Figure 3.6 A). This is a solute carrier transporter predicted to 
harbour 12 transmembrane a helixes and responsible for glucose-6-phosphate (G6P) 
transport. In particular, two non-complementing mutant alleles - NY007 (blbt30301) and NI150 
(blbt30913) - characterized by a C to T transition at bp +442 and a T to A transition at bp +1016 
respectively have been identified. In both cases, the point mutations lead to the formation of 
premature stop-codons and the consequential production of a truncated, potentially non-
functional protein (Figure 3.6 A) (Henke, 2011).  
 
 
Figure 3.6. Cloning and characterization of Slc37a2, the gene underlying the blb phenotype. 
(A) Schematic of the slc37a2 locus. Sequences of the NY007/t30301allele (C/T mutation) and NI150/t30913 allele 
(T/A mutation). 
(B) Western blot analysis of Slc37a2 (55kDa) and gTubulin (48kDa) in wild type, blbNY007 and blbNI150 total 
lysates. 
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(C) Sequence with annotations of the STOP-cassette injected in wild type Tg(mpeg1:eGFP-caax) labelled 
embryos to generate the Slc37a2-CRISPR knock-out via CRISPR-Cas9. 
(D and E) Dorsal view of 4 dpf Slc37a2 CRISPR knock-out embryo generated as shown in (A and C) labelled 
with Tg(mpeg1:eGFP-caax). Red dots indicate microglia with bubble morphology, green dots indicate 
microglia with normal morphology. Scale bar 30 µm. (D) Embryo injected with CRISPR-Cas9 targeting Slc37a2 
in combination with the STOP-cassette. F0 generation. (E) F1 generation of (D) obtained by incross. 
 
To investigate the expression and localization of Slc37a2 protein, a mouse monoclonal 
antibody was raised against the fish epitope. In particular, we selected 32 aa (aa 236-267) in 
the loop between transmembrane domain 6 and 7, as the stretch of this protein is predicted 
to be exposed, enabling binding of the antibody. First, we used this monoclonal antibody for 
western blot (WB) analysis to determine the Slc37a2 protein expression in wild types, NY007 
and NI150 embryos. To this aim, 4 dpf embryos were homogenised and proteins were obtained 
by using a lysis buffer optimized for extraction of transmembrane proteins (Fiorotto et al., 
2016). The samples were run on a gel and transferred on a membrane for immunoblot with 
Slc37a2 and g-tubulin antibodies. The Slc37a2 protein is post-translationally modified with the 
addition of N-linked glycans and migrates as a heterogeneous species of 50-75 kDa, while g-
tubulin is a 50 kDa protein commonly used as housekeeping protein for the positive control. 
As expected, wild type lysates showed both bands at the proper molecular weights, while 
NY007 and NI150 extracts had a comparable g-tubulin band, but absence of the Slc37a2 one. 
This showed that protein extraction and immunoblot were successful in all samples, but both 
blb mutants lacked Slc37a2 protein (Figure 3.6 B). These data supported the conclusion that 
both blb mutations are null alleles for Slc37a2. 
Commonly, to confirm the phenotype of interest is actually caused by the lack of the identified 
protein, cloning is used to test whether gene overexpression does rescue the observed 
phenotype. Unfortunately, we were never able to clone the fish Slc37a2 gene as this turned 
out to be highly toxic to several different bacteria strains, regardless the method of cloning 
and/or culturing. To overcome this problem, we adopted an opposite approach and, by taking 
advantage of reverse genetics, we knocked out Slc37a2 gene in wild type embryos and 
characterized microglial cells. In particular, we used CRISPR-Cas9 technology to introduce a 
DSB at the beginning of the gene and induce HDR to introduce stop codons. By using the 
software CHOPCHOP we designed a sgRNA targeting the first exon of the gene (bp +108); this, 
co-injected in one cell stage wild type embryos together with Cas9 protein, introduced DSB at 
the desired position (Figure 3.6 A). To generate a knock out gene, we co-injected a short 
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nucleotides sequence containing STOP codons in every reading frame and homology arms to 
mediate HDR (Figure 3.6 C). Already F0 injected embryos displayed a mosaic expression of the 
blb phenotype clearly visible both at the stereomicroscope and confocal microscope (Figure 
3.6 D). Embryos from F1 generation obtained by incross of injected F0, had all microglia showing 
the typical bubble-like morphology and were indistinguishable from blbt30301 and blbt30913 
mutants (Figure 3.6 E, compare with Figure 3.1 F). 
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3.7 LACK OF SLC37A2 CAUSES SUGAR BUILD-UP AND OSMOTIC STRESS IN MACROPHAGES 
Slc37a2 belongs to the Slc37 family which consists of four members, a1, a2, a3 and a4. The 
latter, also known as glucose-6-phosphate (G6P) transporter (G6PT), is the best characterized. 
It has been shown that G6PT coupled with G6Pase-a or G6Pase-b maintains blood glucose 
homeostasis or neutrophils energy homeostasis and functionality, respectively (Chou et al., 
2010a; 2010b; Jun et al., 2010). Deficiency in sugar transport or processing can severely affect 
homeostasis, leading to pathological conditions. Mutations in Slc37a4 have been associated 
with various forms of glycogen storage disease. Indeed, Chou and colleagues showed that lack 
of G6PT causes glycogen storage disease 1b, a metabolic and immune disorder (Chou et al., 
2010a; 2010b). 
While the role of Slc37a4 is clear, very little is known about Slc37a2. It was first identified by 
Takahashi and colleagues in RAW 264.7 macrophages as a cAMP-inducible gene (Takahashi et 
al., 2000). This, together with the finding by Kim and colleagues that Slc37a2 is highly expressed 
in macrophages in white adipose tissue of obese mice (Kim et al., 2007), suggests a 
macrophage specific function for the gene. Subsequent studies in vitro identified Slc37a2 as a 
protein anchored to the endoplasmic reticulum and functioning as a phosphate-link G6P 
antiporter catalysing G6P:Pi and Pi:Pi exchanges (Bartoloni and Antonarakis, 2004; Chou et al., 
2013; Pan et al., 2011). Thus, lack of G6P:Pi transport might lead to G6P accumulation followed 
by an influx of water. 
 
 
Figure 3.7. Heads of blb embryos show an accumulation of D-gluconate-6-phsphate. 
(A and B) Mass-spectrometry data showing normalised intensities of glucose 6-phosphate (A) not significant, 
and D-gluconate-6-phosphate (B) significant in wild type and blbNY007. P value < 0.0001. 
 
To investigate the substrate of Slc37a2 transporter in vivo, we took a mass spectrometry 
approach. To this aim, we compared levels of sugars in the heads of wild type and blb embryos. 
   RESULTS 
 42 
Interestingly, while we couldn’t detect any significant difference in the levels of G6P (Figure 
3.7 A), this approach revealed in mutant heads a significant enrichment in D-gluconate-6-
phosphate, a well-known by product of G6P in the pentose phosphate pathway (Figure 3.7 B). 
Thus, lack of Slc37a2 is likely to cause a build-up of D-gluconate-6-phosphate that cannot be 
extracted from the phagocyte. This sugar accumulation might induce an osmotic stress which 
induce microglia to swallow. In line with this, injection of a saturated glucose solution locally 
in the brain of mutant embryos led to the complete collapse of blb microglia, indicating that 
those cells are indeed subjected to osmotic stress (Moritz, 2014). 
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3.8 SLC37A2 LOCALIZES TO PHAGOSOMES IN MICROGLIA AND MACROPHAGES 
As previously shown, the blb phenotype is not restricted to microglia, but affects all 
phagocytically active macrophages in the body (Figure 3.4 B). The expression of Slc37a2 in 
macrophages is in line with its first identification in RAW 264.7, one of the most commonly 
used lines of mouse macrophages (Takahashi et al., 2000) and the identification of this protein 
highly expressed in the macrophages of obese mice (Kim et al., 2007). In order to determine 
the subcellular localization of Slc37a2, we performed whole mount immunohistochemistry in 
3 and 4 dpf wild type embryos. In particular, we used the monoclonal antibody directed against 
the fish epitope and performed double labelling experiments in wild type Tg(mpeg1:eGFP-
caax) transgenic embryos to visualize at the same time Slc37a2 and macrophages. This showed 
that, in the brain, Slc37a2 localizes specifically on microglia (Figure 3.8 A). Higher magnification 
of the stained tissue showed that in particular Slc37a2 localizes around phagosomes (Figure 
3.8 B). 
 
Figure 3.8. Subcellular localization of Slc37a2 in fish microglia and mouse macrophages. 
(A and B) Dorsal view of a representative immunostaining of a 4 dpf wild type embryo where microglia are 
in green Tg(mpeg:GFP-caax) and Slc37a2 in red. Scale bar 30µm. (B) Magnification of (A). Scale bar 15µm. 
The yellow arrow points to a phagosome positive for Slc32a2.  
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(C and D) Immunostaining in RAW 264.7 cells. The yellow arrows point to phagosomes positive for Slc37a2. 
Scale bar 5 µm. (C) Immunostaining of Slc37a2 (cyan) and Lamp1 (red). (D) Immunostaining of Slc37a2 (cyan) 
and Lamp2 (red). 
 
Slc37a2 localization around phagosomes suggested a role for this protein in the phagocytic 
pathway. However, a limitation of the zebrafish model system is the poor availability of 
antibodies. For this reason, to better characterize Slc37a2 and its relation with other 
phagocytic markers, we investigated the localization of this protein in RAW 264.7. 
Immunofluorescence staining on RAW 264.7 by using a commercial antibody against the 
mouse protein (see material and methods), showed that -similarly to what observed in fish 
microglia- Slc37a2 localizes to vesicles inside the phagocyte (Figure 3.8 C and D, cyan). 
Interestingly, the Slc37a2-positive vesicles were negative for Lamp1 and Lamp2, two classical 
lysosomal markers (Figure 3.8 C and D, red). 
The data reported here showed that Slc37a2, a sugar transporter, is localized on the 
membrane of phagosomes in microglia and macrophages. Here, it is likely to mediate the 
export of sugar(s) deriving from engulfed material (such as apoptotic neurons), participating 
at the phagosomal maturation.  
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3.9 IN VIVO TRACKING OF PHAGOSOMES SHOWS THAT PROCESSING OF APOPTOTIC NEURONS 
REQUIRES SLC37A2-MEDIATED COMPACTION  
Previous work in the lab has shown that in the developing zebrafish embryo, the higher level 
of apoptosis in the brain are observed at 3 dpf (Casano et al., 2016), which therefore is the 
stage when microglia are most phagocytically active. The data presented above identified 
Slc37a2 as a protein localized on phagosomes in microglia, however its lack induces the 
enlargement of a single vesicle in the cell. To understand the consequences of lack of Slc37a2 
on phagosomes within microglia, we took a quantitative approach. To this aim, we imaged by 
confocal microscopy several wild type and blb embryos at 3 dpf taking full brain stacks. In line 
with the previously quantified phagocytic activity (Figure 3.3 D), blb showed less phagosomes 
per cell when compared to wild type (Figure 3.9 A). Moreover, measurement of phagosomal 
diameter revealed a significant difference in vesicles size between wild type and blb, with the 
latter having, on average, bigger phagosomes (around 5 µm, Figure 3.9 B). However, the 
distribution of phagosomes diameter in both genotypes revealed that while in blb all 
phagosomes are around the same size (approximately 5 µm), in wild type the range of size was 
much broader, varying from 1 to 6 µm, with two high-density-areas around 2 µm and 4-5 µm 
respectively (Figure 3.9 B).  
To understand the dynamics behind the difference in phagosomal size distribution we took a 
live imaging approach. In particular, we aimed to image wild type and blb brains at high 
temporal and spatial resolution in order to describe the process of microglial phagocytosis in 
great detail. Noteworthy, the light excitation during live imaging is associated with 
phototoxicity which increases with higher thickness of the sample and faster temporal 
resolution. At 3 dpf, the transparent larval tectum is 300-400 µm and populated by 20-30 cells 
(Peri and Nüsslein-Volhard, 2008). Here, to minimize phototoxicity and photobleaching 
without compromising on the imaging resolution, we took advantage of Single Plane 
Illumination Microscopy (SPIM). This approach allowed us to acquire the entire brain volume 
of 3 dpf living embryos in thin sections (0.5 µm) and at fast temporal resolution (15-30 seconds) 
for several hours. Interestingly, SPIM imaging in wild type and blb embryos showed that 
neuronal engulfment results in the formation of phagosomes of similar size (around 5µm, 
Figure 3.9 C), further supporting the conclusion that defects lie downstream of engulfment. 
Moreover, we tracked newly formed phagosomes and measured their diameter over time. This 
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revealed that wild type phagosomes are highly dynamic compartments that undergo a 
progressive shrinkage corresponding to a reduction of 34% of their initial volume, on average 
(Figure 3.9 D, green line). By contrast, blb phagosomes maintain their initial size (Figure 3.9 D, 
red line). These results explain the different distribution in phagosomal size and suggest the 
requirement of Slc37a2 in wild type phagosomal size reduction. 
 
 
Figure 3.9. Tracking of phagosomes reveals that these shrink in a Slc37a2-dependent manner. 
(A) Box plot showing the number of phagosomes per cell in wild type (N=9; n=72) and blbNY007 (N=9; n=40) 
at 3 dpf. P value < 0.0001. 
(B) V-plot showing size distribution of phagosomes in wild type (N=27; n=141) and blbNY007 (N= 27; n=47) at 
3 dpf. P value < 0.0001.  
(C) Quantification of the size of newly formed phagosomes in 3 dpf wild type (n=13) and in blbNY007 (n=16).   
(D) Quantification of relative vesicle diameter over time in 3 dpf wild type (n=13) and blbNY007 (n=16). T0 
corresponds to first fusion event. Data are normalized against the initial size. 
(E and F) Representative time-lapse of phagosomal tracking in 3 dpf wild type (E) and blbNY007 (F). Microglia 
are labelled with Tg(mpeg1:eGFP-caax). Scale bar 5µm. 
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3.10 PHAGOSOMES CONVERGE INTO A UNIQUE CELLULAR COMPARTMENT 
Continuous imaging of newly formed phagosomes in wild type revealed two important 
phagosomal behaviours. First, as described before, that those vesicles significantly reduce their 
size along maturation; second, that tracks of phagosomes terminate with fusion events with 
other vesicles (Figure 3.10 A). In blb, quantification of the bubble growth along development, 
showed that the typical mutant morphology is an acquired phenotype that progresses over 
time rather than being intrinsic of blb microglia (Figure 3.2 B). In line with this, laser depletion 
of all microglia in blb zebrafish embryos at 3 dpf led to the repopulation by new macrophages 
that at first were small and highly branched, and progressively enlarged acquiring the round 
phenotype with a single, big vesicle (Moritz, 2014). To investigate the genesis of this 
compartment, we imaged the brains of blb embryos at early developmental stages (2.5 dpf) 
when microglia just entered the brain. Previous work in the lab has shown that brain 
macrophages derive from a sub-population in the YS that invade the CNS entering from the 
frontal part of the head and then differentiate into microglia (Rossi et al., 2015). Thus, we once 
again took advantage of SPIM microscopy, which allows to acquire large volumes of sample 
with very limited phototoxicity and high temporal resolution. In this way, we were able to 
image the entire zebrafish head which gradually, during imaging, got populated by microglia. 
This approach revealed that, at early stages, mutant microglia are indistinguishable from wild 
type as they are highly branched and dynamic, actively involved in the clearance of apoptotic 
cells. Tracking of un-compacted 5 µm phagosomes at early time points (2.5 dpf) showed that 
phagosomes converge into a receiving compartment that expands progressively, taking over 
gradually most of the cell volume (Figure 3.10 B and C). 
These data showed that the blb phenotype develops as a consequence of phagosomal fusion 
with a receiving compartment, which as a consequence keeps expanding. Previously, it has 
been shown that vesicular fusion in microglia is mediated by the v0-ATPase a1 subunit, a 
function that is independent of its proton pump activity (Peri and Nüsslein-Volhard, 2008). To 
further prove that vesicular fusion is at the basis of blb morphology, we blocked this process 
by knocking down the a1 subunit of the vATPase via morpholino injection in blb (Peri and 
Nüsslein-Volhard, 2008). This, indeed, prevented the bubble formation in blb and resulted 
instead in mutant microglia with many individual vesicles (Figure 3.10 D and E). 
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Noteworthy, newly formed phagosomes along their maturation process fuse with lysosomes. 
This event allows phagosomal acidification and therefore degradation of the engulfed material. 
Different live pH indicators, such as lysotracker and lysosensor, can be used to track fusion 
events between phagosomes and lysosomes and in general to label acidic compartments (Peri 
and Nüsslein-Volhard, 2008). Here, we showed that the blb phenotype develops as a 
consequence of fusion events between phagosomes and a receiving compartment. To 
investigate the involvement of lysosomes and acidification in this process, we combined SPIM 
imaging with lysotracker staining in blb. Interestingly, this live staining showed that in blb, un-
shrunk 5 µm phagosomes fuse with the collecting compartment after acidification (Figure 3.10 
F). Fusion with lysosomes and acidification are commonly considered the last steps of the 
pathway, indeed phagolysosomes are referred to as terminal phagocytic compartments. 
Hence, this result opens the possibility to a scenario where the existence of specialized post-
lysosomal compartments might play important roles in phagocytosis resolution. 
 
 
Figure 3.10. Tracking of phagosomes in vivo reveal that these converge into one cellular compartment. 
(A) SPIM time-lapse of wild type microglia labelled in Tg(mpeg1:eGFP-caax). Tracking highlights fusion 
events, in yellow phagosomes segmentation. Time in minutes. Scale bar 5µm.  
(B and C) SPIM time-lapse of blbNY007 microglia labelled with Tg(mpeg1:eGFP-caax) at different time points. 
The red dot marks the growing vesicle, the cyan dot marks incoming phagosomes. (B) 2.5 dpf blbNY007 
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microglia. Time indicated in minutes. Scale bar 10µm. (C) A representative fusion event in a 3 dpf blbNY007 
microglia. Scale bar 5µm. 
(D and E) Representative examples of microglia labelled with Tg(mpeg1:eGFP-caax) in blbNY007 (D, top panel) 
and in blbNY007 injected  with a morpholino against the a1-vATPase (D, bottom panel) to prevent vesicular 
fusion. (E) Quantification of experiment in (D). Percentage of microglia with more than 1 vesicle per cell, in 
blbNY007 (n=15) and blbNY007 injected with a morpholino against the a1-vATPase (n=21). P value < 0.0001.  
(F) Time-lapse of a representative fusion event in blbNY007 microglia labelled with Tg(mpeg1:eGFP-caax) and 
Lysotracker (in red) to visualize acidification. Scale bar 5µm. 
 
The currently accepted view of phagocytosis proposes that mature phagolysosomes act 
autonomously, with each vesicle processing and recycling its own cargo independently. Here, 
however, imaging and genetic data suggest an alternative model where these vesicles fuse into 
a single post-lysosomal compartment. To further investigate this, we developed an in vitro 
assay to track the fate of wild type phagosomes and their cargos (Figure 3.11 E). Specifically, 
we used mammalian RAW 264.7 macrophages which we showed have Slc37a2 positive 
phagosomes (Figure 3.8 C and D). In particular, we co-cultured on glass coverslips RAW 
macrophages together with nuclear-labelled red and green HeLa cells (1:1 ratio). 
Approximately 12 hours after seeding, when cells reached 60-80% confluence, HeLa cells were 
selectively killed via apoptosis using the anti-tumoral drug TRAIL (Steven R Wiley et al., 1995). 
This triggered the engulfment of the dying HeLa labelled with green or red nucleus. The 
coverslips were fixed at different time points (3, 6 and 9 hours after apoptosis induction), and 
at every time point it was possible to identify in RAW macrophages vesicles containing the 
HeLa apoptotic fluorescent material engulfed. This showed that RAW macrophages which 
engulfed both red and green HeLa cells, at early time points (3 hours after apoptosis induction) 
contained several distinct red and green fluorescent vesicles (Figure 3.11 A). At the next time 
point (6 hours after apoptosis induction) there was the appearance of a single yellow vesicle 
per cell, together with red and green fluorescent phagosomes (Figure 3.11 B). However, at the 
latest time point (9 hours after apoptosis induction), this yellow vesicle was the only 
fluorescent compartment visible in RAW cells which engulfed both red and green labelled 
apoptotic HeLa (Figure 3.11 C).  
The existence of a single yellow vesicle supports a model where wild type phagosomes fuse 
and converge into a collecting compartment (Figure 3.11 E). This was fluorescent only when 
RAW macrophages were fed with labelled apoptotic HeLa (Figure 3.11 D). Interestingly, this 
compartment always appeared to be highly light scattering and easily visible from the bright 
field, a feature that might be related with the content of the compartment itself. 
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Figure 3.11. In vitro phagocytic assay on mammalian macrophages show that phagosomes converge into 
one cellular compartment. 
(A-C) Fixed RAW264.7 macrophages, co-cultured with HK H2B-mCherry (red) and HeLa H2B-GFP (green), 
3hrs (A), 6hrs (B) and 9hrs (C) after induction of apoptosis in HeLa and HK. The yellow arrow indicates the 
collection compartment. 
(D) RAW264.7 macrophages fixed 9 hours after apoptosis induction. The image shows two adjacent cells 
with a collection compartment each. One is fluorescently labelled (yellow arrow) while the other is not 
(white arrow). Scale bars 5µm. 
(E) Schematic representation of the experiment in (A-C). 
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3.11 THE COLLECTING COMPARTMENT IS IDENTIFIED IN MOUSE MACROPHAGES AND ZEBRAFISH 
MICROGLIA AND HAS A DISTINCT ULTRA-STRUCTURE  
The ability to fluorescently label this compartment specifically allowed the investigation of its 
ultrastructure by using Correlative Light Electron Microscopy approach (CLEM). To this aim, 
the experiment was conducted on glass bottom gridded dishes as described above, and cells 
were fixed 9 hours after apoptosis induction for CLEM. Cells of interest, namely macrophages 
containing a yellow vesicle, were identified by confocal microscopy. Then, we performed EM 
to study their ultrastructure. This revealed that the yellow compartment identified in 
phagocytic RAW macrophages was a large, single membrane vesicle with an electron-lucent 
lumen containing what appears to be cellular debris (Figure 3.12 A-C). As mentioned earlier, 
the collecting compartment always appeared to be easily visible in fixed samples without the 
use of fluorescence. In this context, we also investigated this compartment for its morphology 
and characteristics visible from the bright field. Interestingly, also EM directed on this resulted 
in the identification of the same ultra-structure. Therefore, after several verifications, this 
feature has been used in later experiments to identify the compartment of interest from the 
bright field. 
This experiment allowed us to identify in mouse macrophages fed with apoptotic cells a 
compartment highly resembling the collecting compartment identified in zebrafish blb 
microglia. Hence, both in mutant zebrafish and wild type mouse macrophages, we identified a 
compartment that receives the cargo of all incoming phagosomes and is characterised by a 
distinct ultrastructure. 
This prompted us to investigate the ultrastructure of wild type zebrafish microglia. To this aim, 
we developed a CLEM pipeline for the zebrafish brain, using near infrared branding (NIRB) to 
introduce fiducial markers in fixed samples and precisely map fluorescently labelled microglia 
in EM preparations (Figure 3.12 D). Scanning at high resolution by SBF-SEM (Figure 3.12 E and 
F) allowed the unbiased exploration of entire wild type microglia volume in zebrafish embryos 
at 3 dpf. Thanks to this method that we developed, we were able to reconstruct wild type 
phagocytic microglia from an in vivo unperturbed context, describing the ultrastructure of the 
cell and its subcellular compartments. This revealed the identification of several phagosomes 
per cell, which appeared highly electron-dense and packed with digested material (Figure 3.12, 
yellow vesicles in E and structure marked as “P” in F). Contrary to those, in each microglia we 
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identified a single electron-lucent compartment containing debris of membranes and digested 
material and clearly distinguishable from the surrounding more electron-opaque cytoplasm 
(Figure 3.12 F). Interestingly, we could always identify one vesicle with such characteristics per 
cell and the high conservation of features suggests this is the same compartment identified in 
fed mouse macrophages (compare Figure 3.12 F and C) and that expands so dramatically in blb 
microglia (compare Figure 3.12 F and Figure 3.5).  
 
 
Figure 3.12. Structural characterization of the gastrosome. 
(A-C) CLEM of RAW264.7 macrophages fixed 9 hours after induction of apoptosis in HK H2B-mCherry (red) 
and HeLa H2B-GFP (green). (A) Confocal microscopy data. Scale bar 5µm. (B) Low magnification EM data. 
White arrowhead points to the compartment of interest. Scale bar 5µm. (C) High magnification of the 
compartment of interest in TEM data. Scale bar 2µm. 
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(D-F) CLEM on wild type zebrafish. (D) Segmentation of µCT data. 4dpf zebrafish embryo outline is in blue. 
Yellow and red mark near-infra-red-branding as detected by 2-photon microscopy and µCT, respectively. 
Outline of the microglial cell of interest is in green. (E) Segmentation of the cell of interest. Green outlines 
the cell body. Blue marks the nucleus. Phagosomes are in yellow. The receiving compartment (gastrosome) 
is in red, white arrowhead points towards it. (F) High magnification of the gastrosome in SBF-SEM data. P 
indicates a phagosome. Scale bar 2µm. 
(G) SPIM time-lapse of a representative 3dpf wild type Tg(mpeg1:eGFP-caax) microglia in an embryo treated 
with Camptothecin to increase apoptosis. Scale bar 5µm.  
 
Thus, phagocytosis in microglia and macrophages relies on the existence of a collecting 
compartment where phagosomes fuse and converge, which we termed “gastrosome” as, 
similar to a stomach, it receives ingested material. In microglia, the existence of the 
gastrosome, only became apparent through a genetic approach where the absence of a solute 
carrier transporter normally expressed on phagosomes caused its massive and obvious 
expansion (Figure 3.1 and Figure 3.6). Our data showed that there is a correlation between 
phagocytosis and gastrosomal expansion, in particular, we showed that the blb phenotype is 
the result of defects in the intracellular processing of the engulfed material (Figure 3.3). Thus, 
we asked if gastrosomal expansion could also be triggered via non-genetic routes, for example 
by elevating cell death by using CPT, which -as shown earlier - results in macrophages engulfing 
more apoptotic cells (Figure 3.4). Indeed, increased engulfment led to the rapid expansion of 
a single vesicle which enlarged as a consequence of phagosomal income (Figure 3.12 G). CPT 
treated wild type embryos developed a microglia phenotype which, at the cellular level, highly 
resembles the one of blb (compare Figure 3.12 G with Figure 3.1 J). 
Together this data revealed a new step in the phagocytic pathway, namely the existence of a 
new post-lysosomal compartment, which collect all phagosomes and is characterised by a 
distinct ultrastructure. This appeared to be conserved across vertebrates and represents a 
critical bottleneck in the processing of engulfed material. 
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3.12 THE GASTROSOME IS CHARACTERIZED BY A DISTINCT MOLECULAR SIGNATURE 
To better characterize the identity of the gastrosome and establish its molecular signature we 
stained RAW 264.7 macrophages fed with apoptotic HeLa with a variety of endocytic, 
phagosomal and lysosomal markers. This revealed that the collecting compartment has a 
hybrid nature that differs from that of classical phagolysosomes. Indeed, the gastrosome 
proved to be positive for Rab7, Lamp1, Lamp2 and LBPA, which are all well-known late 
endosomal or lysosomal markers (Figure 3.13 A-D). On the contrary, the gastrosome was 
negative for Cathepsin D (Figure 3.13 E), a proteolytic enzyme normally expressed in lysosome 
and as a consequence traceable in phagolysosomes, and classically used as a marker of 
proteolytic-lysosomal activity and late marker of phagocytosis (Garin et al., 2001; Yeung et al., 
2006). Interestingly, Slc37a2 is not localised on the gastrosome (Figure 3.13 F).  
 
 
Figure 3.13. Molecular characterization of the gastrosome. 
(A) RAW264.7 macrophages fixed 9 hours after apoptosis induction of unlabelled HeLa cells. Immunostaining 
against Rab7 (red). The white arrow indicates the collection compartment (gastrosome). Scale bars 10µm. 
(B) RAW264.7 macrophages fixed 9 hours after apoptosis induction of unlabelled HeLa cells. Immunostaining 
against Lamp1 (red). The white arrow indicates the collection compartment (gastrosome). Scale bars 5µm. 
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(C) Fixed RAW264.7 macrophages, 9hrs after apoptosis of unlabelled HeLa cells. Immunostaining against 
LBPA (red) and Rab7 (cyan). The white arrow indicates the collection compartment (gastrosome). Scale bars 
5µm.  
(D) RAW264.7 macrophages fixed 9 hours after apoptosis induction of unlabelled HeLa cells. 
Immunostaining against Lamp2 (red). The white arrow indicates the collection compartment (gastrosome). 
Scale bars 5µm. 
(E) RAW264.7 macrophages fixed 9 hours after apoptosis induction of unlabelled HeLa cells. Immunostaining 
against Cathepsin D (red). The white arrow indicates the collection compartment (gastrosome). Scale bars 
5µm.  
(F) RAW264.7 macrophages fixed 9 hours after apoptosis induction of unlabelled HeLa cells. Immunostaining 
of Lamp1 (red) and Slc37a2 (cyan). The white arrow points to a collection compartment (gastrosome) that 
is Lamp1 positive and Slc37a2 negative. Scale bar 5µm. 
 
The distinct ultrastructure and the hybrid molecular signature identify the gastrosome as a 
new compartment. The existence of an additional step following the phagolysosome 
formation, namely the fusion of phagosomes with the gastrosome, suggests a possible need 
for further degradation or disposal of the digested target.  
The EM analysis in fish (both wild type and blb) and in the fed mammalian macrophages 
indicated that the gastrosome contains sparse membranous debris. This prompt us to screen 
a panel of lipid dyes differentially staining different kind of lipids, with the aim of describing 
the gastrosomal content and therefore speculate on its possible function. In particular, we 
stained both fed RAW 264.7 and zebrafish blb microglia with wheat germ agglutin (WGA) that 
is classically used for labelling plasma membrane by detecting glycoconjugates residues on it, 
the lipophilic dye Nile Red and Bodipy 493/503 to detect neutral lipids and lipid droplets and 
finally with Nile Blue Chloride which is a pH sensitive dye detecting DNA and lipids. All probes 
labelled the gastrosome in both models, indicating its content is indeed lipidic (Figure 3.14 A-
H). Interestingly, these dyes do not give a uniform labelling of the gastrosomal lumen in blb, 
but rather highlight discrete structures within this compartment. We next asked if a similar 
staining could be observed also in wild type microglia, and to this aim we repeated the CPT 
experiment to induce gastrosomal expansion without perturbing the expression of Slc37a2. 
Upon increase of apoptosis by CPT treatment, the wild type enlarged gastrosome was labelled 
with Nile Blue which, once again, reveals the presence of circular structures within the lumen 
(Figure 3.14 I and J). We conclude that the gastrosome is a previously un-described phagocytic 
compartment that contains lipids and membrane structures and that responds dynamically to 
changes in microglial phagocytosis.  
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Figure 3.14. In macrophages and microglia the gastrosome contains lipids and membranes. 
(A-D) RAW264.7 macrophages fixed 9 hours after apoptosis induction of unlabelled HeLa cells. Stained with 
BODIPY (A), Nile red (B), WGA (C) and Nile Blue (D). The white arrow points to the gastrosome. Scale bar 5 
µm. 
(E-H) 4pf blb microglia stained with BODIPY (E), Nile red (F), WGA (G) and Nile Blue (H).  Scale bar 10 µm.  
(I and J) 3 dpf wild type Tg(mpeg1:eGFP-caax) microglia (red) (I and J) stained with Nile Blue (cyan) (J) in an 
embryo treated with Camptothecin to increase apoptosis. Scale bar 5µm. The asterisk marks the 
gastrosome. 
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3.13 GASTROSOMAL EXPANSION AFFECTS MICROGLIAL MORPHOLOGY AND FUNCTIONALITY  
In highly phagocytic microglia the gastrosome constitutes a critical bottleneck in the phagocytic 
pathway that, by altering the cellular morphology, could also affect microglial functionality. 
One of the strengths of our in vivo system is that we can directly address the impact of 
gastrosomal expansion on higher order microglial functions, such as their ability to migrate and 
engulf apoptotic neurons. It is clear that blb microglia are less efficient in phagocytosis when 
compared to wild type. Indeed, as previously shown, mutant microglia remove fewer neurons 
per hour (Figure 3.3 E) and have less phagosomes per cell (Figure 3.9 A). Moreover, we 
quantified the length of each phagocytic event in wild type and blb by measuring the time 
intercurrent between phagosome formation and retraction of the branch to the cell body. This 
analysis showed that not only blb engulf fewer targets over time, but also that each phagocytic 
event lasts significantly longer than in wild type embryos (Figure 3.15 A).  
 
 
Figure 3.15. Gastrosomal defects affect microglial functionality. 
(A) Quantification of engulfment duration in wild type (n=20) and blbNY007 microglia (n=11). P value < 0.001. 
(B) Quantification of microglia responding to an injury in wild type and blbNY007 microglia at different 
developmental stages; n(wt, 3.5 dpf)=20; n(blbNY007, 3.5 dpf)=20; n(wt, 4 dpf)=20; n(blbNY007, 4 dpf)=16. P 
value < 0.0001.  
 
 
Finally, we asked to which extent the enlarged gastrosome affects microglia functionality. To 
test this, we measured the ability of blb microglia to react to injuries. In particular, a pulsed 
532 nm cutting laser attached to a commercial Olympus FluoView 1200 was used to generate 
spatiotemporally controlled cell death in the brain. The ablation protocol was set up to kill 
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around 200 neurons without perturbing the blood brain barrier and influencing the larval 
development (Sieger et al., 2012). We induced laser ablation at the brain midline, a protocol 
which was previously shown to induce microglia of both hemispheres to migrate towards the 
site of injury at a speed of around 3.3 µm/min in wild type (Sieger et al., 2012). Here, while in 
wild type microglia reacted and migrated by 30 minutes from injury induction, in blb these cells 
were unable to migrate (Figure 3.15 B). The migration defect correlated with the progression 
of the phenotype. At earlier developmental time points (such as 3 dpf), when mutant microglia 
have a smaller gastrosome (Figure 3.2 B), they were still partially able to respond to injuries 
(Figure 3.15 B) even though with reduced efficiency. However, upon further gastrosomal 
expansion (4 dpf, Figure 3.2 B) mutant microglia were completely unable to migrate to the site 
of injury (Figure 3.15 B). This is consistent with a scenario where the expansion of the newly 
identified gastrosome has a dramatic impact on microglia functionality. Thus, the discovery of 
this new cellular compartment constitutes a new potential entry point for microglia 
manipulation, as interfering with its morphology directly impacts on microglia activity and 
functionality. 
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4 DISCUSSION 
Although much is known about the complex mechanisms that control phagosome maturation 
and fusion with lysosomes (Kinchen and Ravichandran, 2008; Levin et al., 2016), we know very 
little about the final stages of cargo degradation, including export of resulting macromolecules 
and the processing of membranes.  
In this study we have described bubblebrain (blb) a zebrafish mutant in the solute carrier 
transporter Slc37a2 that is characterized by microglia with a dramatically enlarged 
morphology. In Slc37a2 knock outs the cell body of microglia is occupied by a single large 
compartment which keeps expanding upon phagocytosis due to a defect in the processing of 
the engulfed material. In vivo imaging of mutant microglia at high temporal and spatial 
resolution allowed the discovery of several novel and important aspects of phagocytosis 
(Figure 4.1). These results were also validated in vitro using mouse RAW 264.7 macrophages. 
First, we discovered a process by which phagosomes shrink progressively. This is mediated by 
Slc37a2, a putative glucose-6-phosphate transporter that we showed is localized on 
phagosomes both in fish microglia and mouse macrophages. Second, we identified a novel step 
in the phagocytic pathway, namely the existence of a post lysosomal compartment which we 
termed gastrosome. Indeed, we showed that in zebrafish and mammalian macrophages 
phagosomes do not act autonomously, but they rather converge into a collecting compartment 
which is characterized by a distinct ultrastructure and by a hybrid distinct molecular signature. 
Third, we investigated the impact of gastrosomal disfunction on microglial activities, such as 
migration or phagocytosis. Finally, our in vivo data showed that increased levels of 
phagocytosis result in a dramatic gastrosomal expansion that affects microglial cell 
morphology to an unprecedented level.   
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Figure 4.1. Results summary: schematic comparison between wild type and blb microglia. 
(A) During phagosomal maturation, D-gluconate-6-phosphate is exported from the phagosomes through the 
solute carrier transporter Slc37a2, a process responsible for phagosomal shrinkage. Moreover, phagosomes 
fuse and converge in the gastrosome, a unique cellular compartment rich in lipids and membranes.  
(B) Lack of Slc37a2 prevents export of D-gluconate-6-phosphate and therefore phagosomal shrinkage. The 
fusion of un-shrunk phagosomes with the gastrosome mediates its expansion caused by osmotic stress. 
Gastrosomal expansion drastically affect microglia morphology and phagocytic activity. 
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4.1 PHAGOSOMAL MATURATION INVOLVES SLC37A2-MEDIATED SHRINKAGE  
The removal of apoptotic cells by phagocytosis is an essential cell biological process involved 
in development, homeostasis and disease. Since the first description of phagocytosis in 1883 
by Elie Metchnikoff, our knowledge about this process grew exponentially, however many 
aspects remain unknown or are still highly debated. In particular, our understanding of 
phagosomal resolution is fragmented and incomplete and very often what we know comes 
from studying other endocytic processes (Levin et al., 2016). 
Today, it is well accepted that the lumen of a nascent phagosome lacks degradation capacity. 
Shortly after its formation, the young phagosome undergoes maturation, a process that leads 
to the degradation of its cargo. Indeed, fusion events between the phagosome and organelles 
of the endocytic pathway, such as early endosomes, late endosomes and eventually lysosomes, 
allow the acquisition of digestive enzymes necessary for the degradation (Kinchen and 
Ravichandran, 2008; Vieira et al., 2002). Interestingly, data presented here show that 
phagosomes, during their maturation, undergo a dramatic size reduction and that this 
shrinkage depends on the activity of the solute carrier transporter Slc37a2. Growing evidence 
shows that solute carrier transporters are essential cellular components, in particular for 
supporting lysosomal functions, by localizing on these vesicles (Bissa et al., 2016). Here, we 
show that both in zebrafish microglia and mouse macrophages Slc37a2, a putative Glucose-6-
phosphate-transporter, is localized on phagosomes. The size of these vesicles (~5µm) and lack 
of Lamp1 suggest that these vesicles are phagosomes and not lysosomes. Lack of Slc37a2 leads 
to accumulation of D-gluconate 6 phosphate in the zebrafish head, and it affects phagosomal 
maturation. Indeed, while wild type phagosomes reduce their size significantly, lack of Slc37a2 
prevent this shrinkage. The molecular mechanisms that pair Slc37a2-mediated transport with 
vesicular contraction are of course of great interest, also because recent reports have shown 
that phagosomal size can influence the transport and the behaviour of these vesicles inside 
the cell (Keller et al., 2017). A mechanism reported to be involved in phagosome remodelling 
and size maintenance is the formation of intraluminal vesicles (ILVs). By delivering vesicles to 
the lumen of the phagolysosome, this process allows the degradation of integral membrane 
components. However, some ILVs seem to undergo back-fusion with the phagosomal 
membrane. (Fairn and Grinstein, 2012). Work in bacteria and plants show that formation of 
micro-lumina and finger-like protrusions reduces membrane length, allowing the resizing of 
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vesicles and cells. Those vesicular size adjustments are observed downstream of osmotic 
variations and solute trafficking and could represent a possible mechanism for phagosomal 
shrinkage (Claessens et al., 2008). Similar size reduction is observed during the maturation of 
the entotic vacuole by the Overholtzer group (Krajcovic et al., 2013). Here the authors show 
that entotic vacuoles undergo a late maturation step characterized by mTOR-mediated fission, 
which redistributes vacuolar contents in the lysosomal network. More recently the same group 
identified the lipid kinase PIKfyve as a regulator of an alternative pathway that distributes 
engulfed contents in support of intracellular macromolecule synthesis during different 
endocytic pathways (Krishna et al., 2016). Our in vivo data clearly identify Slc37a2 as a key 
molecule mediating phagosomal shrinkage during apoptotic cells digestion in microglia. 
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4.2 THE DISCOVERY OF THE GASTROSOME, A POST-LYSOSOMAL COMPARTMENT 
During phagosomal maturation the engulfed cargo get degraded thanks to the activity of 
enzymes which typically activate at acidic pH. The phagocytic target is typically complex and 
rich in different macromolecules. It is clear that the phagolysosome can catabolize its content 
thanks to the presence of a diverse arsenal of hydrolytic enzymes acquired by fusing with the 
lysosomes. However, the products of this digestion have to be processed for the phagocyte to 
return to homeostasis, and it is unclear how phagolysosomes get reabsorbed and resolved. 
More than 20 years ago, in vitro experiments based on engulfment of latex beads and sucrose 
indicated the possibility of retrograde fusion events between “terminal lysosomes” and the 
late endosomal compartment via the microtubule network (Jahraus et al., 1994). Similarly, 
retrograde transport of undigested cargo through phosphatidylinositol 3-phosphate 
(PtdIns(3)P) has been observed from early endosomes to the trans-Golgi network (TGN) (Cullen 
and Korswagen, 2012). More recently, Krajcovic and colleagues predicted continual 
fusion/fission between lysosomes and the shrinking entotic vacuole (Krajcovic et al., 2013). 
Finally, the Desjardins group observed that small endosomes fuse with each other. In 
particular, they fed small latex beads (LBs) to cultured J774 macrophages and showed that 
while LBs are initially internalized individually in small vesicles, within 15 minutes from 
internalization bigger endosomes are containing a larger number of LBs, suggesting the 
coalescence of multiple small vesicles containing single beads (Duclos et al., 2011). However, 
a clear evidence of how the phagolysosomes are resolved is still missing.  
In this work, we identified a previously undescribed step in the phagocytic pathway subsequent 
the formation of phagolysosomes. Combining in vivo studies in zebrafish microglia with an in 
vitro approach using mammalian macrophages we uncovered a new compartment, the 
gastrosome, to whom phagosomes fuse and deliver their content. Given the huge biological 
and medical importance of phagocytosis, it is surprising that today it is still possible to discover 
un-described steps in this pathway. One possible explanation for why this has gone unnoticed 
so far, could come from the fact that previous studies have been conducted mostly in cultured 
phagocytes fed with either bacteria or undigestible beads. The first have been extremely useful 
in uncovering the immune relevance of phagocytosis during infection, however many 
microorganisms developed mechanisms to escape the phagocytic system making impossible 
to follow their degradation over time. On the other hand, gold or latex beads are artificial prays 
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that by definition are indigestible, and therefore can “clog” the system. While these 
approaches have been fundamental for the identification of key molecular players and early 
steps in phagosomal maturation, they are perhaps not perfectly suited for addressing how 
these vesicles are resolved. Here, we investigated the fate of apoptotic cell components in vivo 
in an unperturbed, physiological context namely the developing brain. The identification of the 
gastrosome was first possible thanks to the study of a zebrafish mutant where this 
compartment enlarges upon phagocytic activity. Here, in vivo tracking of newly formed 
phagosomes at high temporal resolution showed that those vesicles, after acidification, merge 
with one compartment which keeps enlarging upon fusion. Acidification was visualized by Lyso-
Tracker, a vital dye which becomes fluorescent at acidic pH, a feature acquired by phagosomes 
after fusion with lysosomes. This observation shed light on the existence of an undescribed 
post lysosomal compartment, the gastrosome. This was confirmed also by the development of 
an in vitro phagocytic assay that we developed to monitor the fate of apoptotic cells engulfed 
by mammalian wild type macrophages. This confirmed that phagosomes converge into a single 
compartment in the cell.  
The discovery of the gastrosome is in partial contrast with the current view that phagosomes 
and phagolysosomes are autonomous terminal organelles. Indeed, we show that they have a 
“collective” behaviour and that they all converge into the same vesicle. This vesicle is 
characterized by a unique combinatorial molecular signature and by a distinct ultrastructure 
that we determined via an unbiased exploration and reconstruction of wild type microglia. 
Both phagocytic microglia and macrophages have a single gastrosome, this has a peri-nuclear 
localization and it is delimited by a single membrane surrounding an electron-lucent lumen 
containing lipids and membranous structures.  
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4.3 CHARACTERIZATION OF PHAGOCYTIC COMPARTMENTS 
The discovery of a new step during phagocytosis more than a century after the first description 
of this process, is certainly surprising and of a certain significance. While we can clearly 
demonstrate the importance of the gastrosome for phagocytosis and for microglia 
functionality (see below), today we failed to identify a specific marker for this compartment 
and we still do not know its exact function. In this section, I would like to discuss these two 
aspects in the light of what is currently known about the phagocytic pathway. 
4.3.1 THE CLASSICAL VIEW: ENDOCYTIC MARKERS RUNNING IN ORDER  
During maturation, phagosomes actively remodel the membrane-associated proteins and 
lipids. Great advances in this field have been obtained thanks to proteomic studies of isolated 
phagosomes which revealed the identities of hundreds of proteins associated with phagocytic 
compartments (Boulais et al., 2010; Campbell-Valois et al., 2012; Garin et al., 2001; Griffiths 
and Mayorga, 2007; Shui et al., 2008). The continuous alteration of phagosomal-associating 
molecules is believed to enable the phagosomes to preferentially interact with distinct 
endocytic organelles driving phagosome maturation in a stepwise manner. Among several 
molecules identified, some are considered classical markers of specific stages of maturation. 
For example, the lipid second messenger PtdIns(3)P and the small GTPase Rab5 are considered 
early markers of phagosomal maturation. In particular Rab5, localized on early phagosomes 
and early endosomes, has been shown to be essential for endosome-phagosome fusion (Fairn 
and Grinstein, 2012; Kinchen and Ravichandran, 2008). Recycling events are primarily 
mediated by Rab GTPases, specifically Rab11 and Rab4 have been shown to be involved in slow 
and fast recycling respectively (Garin et al., 2001; Levin et al., 2016). Additionally, Rab10 has 
also been implicated in phagosomal recycling and maturation upstream of Rab5 (Cardoso et 
al., 2010). A key event in phagosome maturation is the rapid removal of Rab5 from the 
phagosomal membrane and its exchange with the later marker Rab7. This protein is typically 
localized on late endosomes and late phagosomes and mediates the recruitment of lysosomes. 
Fusion between late phagosomes and lysosomes leads to the formation of phagolysosomes 
which are enriched in lysosomal markers Lamp1 and Lamp2. The phagosomal lumen is 
continuously acidified owing to the activity of the vATPase which is acquired already at early 
stages, until reaching below 5.0 at the phago-lysosomal stage. Here, thanks to the oxidation 
   DISCUSSION 
 66 
and acidification, the hydrolases carried by the lysosomes are fully activated and result in the 
degradation of the phagocytic cargos (Levin et al., 2016). 
4.3.2 THE ALTERNATIVE VIEW: PHAGOCYTOSIS AS A DYNAMIC PROCESS RELYING ON CONSTANT 
INTERACTION BETWEEN DIFFERENT COMPARTMENTS 
The identification of protein markers for early and late phagocytic compartments surely 
allowed the description of phagosomal maturation and its key players. However, in the last 30 
years it became clear that phagocytosis and its compartments are much more dynamic than 
previously expected. Already the intrinsic nature of an early phagosome, late phagosome or 
phagolysosome is per se a clear example of the impossibility to assign exclusive markers to 
each of this compartment. Indeed, during phagosome maturation the nascent phagosomes 
acquire properties from the donor organelles including distinct membrane markers and acidity. 
Another interesting aspect to consider is the localization pattern of distinct Rab proteins: while 
some markers (such as Rab5, Rab2 and Rab14) are relatively transient and identified exclusively 
in early phagosomes and endosomes (Bin He et al., 2010; Guo et al., 2010; Mangahas et al., 
2008), Rab7, once recruited, maintains its association with the phagosome until the cargo is 
completely degraded (Yu et al., 2008). Consequently, Rab7 is not an exclusive marker for late 
phagosomes and endosomes. Moreover, also the terminology used for lysosomes is highly 
confusing (Griffiths, 1996). Since the late 1980s lysosomes have been defined as the terminal 
compartment of the endocytic and phagocytic pathways devoid of recycling receptor 
molecules (Griffiths, 1996; Jahraus et al., 1994; Kornfeld and Mellman, 1989). They are 
enriched in specific molecules such as Lamps and hydrolases, which are, however, also found 
in late endosomes. A recent work from Cheng and colleagues also comments on the use of so-
called lysosomal markers (such as Lamp1/2) and they suggest that labelling a set of lysosomal 
hydrolases combined with various endosomal markers would be more accurate than simply 
relying on a single “classical” staining to assess the nature of a compartment and its functions. 
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Figure 4.2. Phagosomal maturation and resolution: multi-step processes defined by fusion events and hybrid 
molecular signatures. 
Phagosomal maturation relies on a series of fusion and fission events between the phagocytic and endocytic 
pathways. Those give rise to new hybrid compartments at every step of maturation, which are characterized 
by overlapping molecular signatures. While molecular markers can be divided into “early” and “late” (see 
red dotted line), it is not possible to identify exclusive markers for each stage of maturation (see grey dotted 
lines). Here we encourage a description of the phagocytic compartments based on a combinatorial 
molecular signature (i.e. the gastrosome is Rab7, Lamp1/2 and LBPA positive but Cathepsin D and Slc37a2 
negative), and their ultrastructure which describe the content of each compartment, a valuable readout of 
cargo degradation. 
 
Thus, all these aspects support a view where the different phagocytic compartments are in 
close relation with each other and therefore give rise, after every interaction, to hybrid 
compartments that acquire new functions along the pathway (Figure 4.2) (Lu and Zhou, 2012; 
Vieira et al., 2002). In our work we identify a new compartment, the gastrosome, which fuses 
with other phagocytic organelles. Thus, to identify the gastrosomal molecular signature, we 
stained macrophages fed with apoptotic cells with a panel of known phagocytic markers. This 
   DISCUSSION 
 68 
showed that the gastrosome is a late compartment that is positive for Rab7, Lamp1/2 and 
LBPA. On the other hand, the gastrosome is different from a classical phagosome or 
phagolysosome as it lacks Slc37a2 and Cathepsin D, molecules that localize on phagosomes 
and lysosomes, respectively (Figure 3.13 and Figure 4.2). 
4.3.3 A POSSIBLE ROLE FOR THE GASTROSOME IN LIPID DIGESTION AND MEMBRANE RECYCLING 
As mentioned earlier, a second important aspect is to determine the function of the newly 
identified gastrosome. What is clear already from this first study is that the gastrosome 
contains membrane debris and lipids as revealed by electron microscopy and fluorescent lipid 
dyes, indicating a possible role in membrane recycling or metabolism. In support of this 
hypothesis there is also the gastrosomal localization of LBPA. This lipid has been shown to be 
enriched in late endosomes and phagosomes where it mediates cholesterol efflux (Kobayashi 
et al., 1999) and it may play a similar role in phagosomes. Finally, LBPA has been described as 
involved in lipid digestion and ILV formation (Matsuo et al., 2004). The Gruenberg group 
showed that LBPA can be visualized in late endosomes and phagosomes and it is highly 
enriched in ILVs, suggesting its involvement in their formation. 
Previous studies have shown that degrading enzymes in the lumen of lysosomes and 
phagolysosomes are responsible for digestion and recycling of lipids (Kolter and Sandhoff, 
2010; Linke et al., 2001). Membranes are essentially composed of amphiphilic acids and 
proteins, and obviously complex lipids have to be degraded within the phagocytosis process so 
that the final degradation products can leave the compartment, either as waste or for 
recycling. It has been shown that lysosomal digestion of membranes allows break-down of 
glycosphingolipids which are continuously recycled and reutilized in salvage process 
(Tettamanti et al., 2003). Proteins such as NPC1 and NPC2 have been proposed as possible 
exporters of sphingosine from lysosome and phagolysosomes, however the observed 
endosomal accumulation associated with lack of this transporters (Niemann-Pick type C 
disease) may be an indirect consequence of excessive cholesterol accumulation (Lloyd-Evans 
et al., 2008). ABC transporters similar to those that transport cholesterol at the plasma 
membrane have been identified in lysosomal compartments, but whether they play a role in 
the export of cholesterol from the phagosome is unclear (van der Kant et al., 2013). There are 
enzymes which has been reported to be highly expressed in macrophages and found in 
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phagosomes able to catabolize lipids, however, the mechanisms whereby lipids are processed 
after traversing the phagolysosomal membrane are virtually unknown (Levin et al., 2016).  
Careful delineation of gastrosomal functions will require extensive further investigation. 
However, the existence of an additional compartment containing membrane debris suggests 
that lysosomes and phagolysosomes are not the sole organelles responsible for (lipid) 
housekeeping functions in the cell. Located at the end of the phagocytic pathway, the 
gastrosome may constitute a centre for lipid degradation, sorting and/or recycling. 
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4.4 PHAGOCYTOSIS AS A SOURCE OF NUTRIENTS AND ITS METABOLIC IMPACT 
Billions of cells die via apoptosis daily and are efficiently removed. Moreover, it appears that 
there are fewer phagocytes than apoptotic cells in a tissue, meaning that phagocytes have to 
engulf multiple targets. During this process, the phagocyte essentially doubles its content of 
protein, carbohydrates, nucleotides, lipids and other cellular materials. An interesting but 
largely unanswered question is how does the phagocyte handle this excess. It is noteworthy 
that culturing phagocytes in a uncomplete nutrient environment, such as low glucose, tends 
to promote apoptotic clearance, while a high glucose environment reduces uptake (Park et al., 
2011). Glycolysis is the major catabolic pathway that supplies cellular energy, therefore it is 
possible that the products of corpses digestion could modify the levels of glucose in the 
phagocyte and affect cellular glucose transport and synthesis.  One pathway that might be of 
interest, in particular, is the pentose phosphate pathway, in which the products NADPH and 
pentoses are used for the synthesis of nucleic acids and amino acids. Slc37a2, localized on the 
phagosomal membrane, could play an important role in the extraction of sugars from the 
engulfed target and in the maintenance of glucose homeostasis. Notably, the majority of sugar 
in a cell is converted to glucose 6 phosphate by phosphorylation, and this sugar, transported 
by Slc37a2, lays at the start of the two major metabolic pathways: glycolysis and the pentose 
phosphate pathway. In addition, this sugar can also be converted to glycogen for cellular 
storage.  
Solute carrier membrane transporters control essential physiological functions, including 
nutrients uptake, ion transport and waste removal. Expressed in different cell types, SLCs 
regulate the chemical exchange with the environment and the transport of small molecules 
keeping the internal physiology. It is surprising how, despite its clear relevance to health and 
disease, the SLC protein family is comparatively less well studied than other gene families. 
Indeed, 76% of SLCs with an already identified disease have no associated compound yet 
(César-Razquin et al., 2015) and this may be due to a number of technical barriers. Specifically, 
acquiring competent biological reagents for SLC study can be highly challenging as those are 
integral membrane proteins difficult to express and purify and very often poorly detected by 
typical mass spectrometry protocols (César-Razquin et al., 2015). Loss or gain of function 
studies can be confounded by endogenous SLC with overlapping specificities and high-quality 
antibodies are available only for few SLCs. In phagocytic cells, different SLCs have been 
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reported to localize to lysosomes and endosomes where they mediate the transport of 
essential molecules deriving from the ingested cargo. For example, Slc38a9 has been identified 
as an arginine sensor at the lysosomal membrane (Wang et al., 2015) and its modulation has 
been proposed as a new therapeutic intervention in neurodegenerative and aging disorders. 
Phagocytosis was not always used for immunity, but rather to intake nutrients from the 
environment. Therefore, is not surprising how this complex intracellular machinery is suited 
for nutrients extraction from the cargo digestion and homeostasis maintenance.  
Proteomic studies recently described in macrophages and dendritic cells (DC) a high 
enrichment of transporters, in particular from the SLC family (Duclos et al., 2011). Interestingly, 
while pumps of the vATPase family have been shown to only localize to late endosomes and 
lysosomes, SLC transporters are differentially distributed between early, late endosomes and 
lysosomes (Duclos et al., 2011). There, the authors suggest that those transporters might 
participate in distinct functions performed by macrophages and DC and they define these 
molecules as potential differentiation or activation markers in those immune cells. Here, we 
identify Slc37a2 as a sugar transporter localized on phagosomes and essential for their 
maturation, as its absence prevents phagosomal size reduction. Finally, the gastrosome could 
also play an important role in lipids and membranes recycling and in the phagocyte 
homeostasis as defects strongly affect cellular behaviour and functionality.  
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4.5 INSIGHTS INTO A NEW WAY OF CLASSIFYING MICROGLIA 
An interesting aspect of the Slc37a2 phenotype is that blb microglia display an aberrant bloated 
morphology that we show is associated with a migratory defect and low rate of engulfment. 
By contrast, in the microglial field, round morphologies are often used as a measure of cellular 
“activation” with round microglia being considered highly active and phagocytic. On the 
contrary, even though it is clear that ramified microglia are not inactive, they are usually 
associated with a surveillance rather than a phagocytic state. A careful delineation of microglial 
morphology, regional heterogeneity, transcriptome and turnover is emerging greatly. For 
example, in the adult human cortex, microglia acquire a ramified morphology when surveying 
the environment and an amoeboid morphology with retracted processes when they are 
removing the debris of dying neurons or reacting to a foreign body (Gomez-Nicola and Perry, 
2015). 
 
 
Figure 4.3. Highly phagocytic wild type microglia are rounded and can develop bubble-like morphology. 
(A and B) SPIM time-lapse of a representative wild type embryo labelled with Tg(mpeg1:eGFP-caax) at 
different developmental stages. Microglia at 3 dpf are highly dynamic, assume rounded morphology (see 
white arrows) and dynamically recover a more ramified shape (compare 3 dpf t1 and 3 dpf t2). Microglia at 
4 dpf are ramified. (B) Segmentation of the cells in (A), magenta line indicates round microglia, the blue line 
indicates ramified microglia. Scale bar 30 µm. 
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Our work, without being in contrast with the current classification of microglia morphology, 
adds a new level of complexity to it. Indeed, the Slc37a2 knockout phenotype reveals that 
defects in intracellular processing also lead to enlarged microglia. Our data show that the 
bubble morphology in blb is acquired over time and that it depends on the phagocytic activity. 
In line with this, inhibition of phagocytosis prevents the development of the characteristic blb 
phenotype. In addition, when wild type microglia are exposed to higher level of apoptosis, they 
also develop the same rounded phenotype. Most importantly, we showed that once microglia 
become so enlarged, they are less efficient phagocytes and unable to migrate and to engulf 
new targets.  
Untreated zebrafish wild type microglia at 3 dpf when level of apoptosis in the brain are high 
(Casano et al., 2016), are on average rounded and some can develop a bubble morphology 
(Figure 4.3). This phenotype is transient, and wild type microglia can actively and dynamically 
revert this morphology. In physiologic conditions, a dynamic equilibrium is maintained, 
however, defects in the intracellular processing of the engulfed material, such as in blb, can 
lead to an irreversible bubble morphology which is associated with low microglia functionality. 
This calls for a new way of classifying these cells and their activity (Figure 4.4).  
 
 
Figure 4.4. Microglia morphology model. 
Microglia are highly dynamic cells. Highly ramified microglia are considered in a surveillance state. Upon 
increase of phagocytic activity, microglia assume an amoeboid shape. Those morphologies exist in a dynamic 
equilibrium. When microglia are highly phagocytic can transiently assume a bubble-like morphology, which 
can also occur when the intracellular processing of the ingested material is defective. A bubble-like shape is 
indicative of an inefficient cell, characterized by low phagocytic activity. 
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4.6 GASTROSOMAL ENLARGEMENT AFFECTS MICROGLIA MIGRATION AND ENGULFMENT AND 
COULD CONTRIBUTE TO THE PATHOGENESIS OF LYSOSOMAL STORAGE DISORDERS 
Defects in either engulfment or degradation of apoptotic cells contribute to different 
conditions such as autoimmune diseases, suggesting that both eating and digesting apoptotic 
cells are essential for proper immune responses (Elliott and Ravichandran, 2010; Nagata et al., 
2010). Kawane and colleagues showed the importance of apoptotic cell degradation by 
studying the DNase II knockout mice which lack the lysosomal enzyme responsible for the 
degradation of nuclear DNA of the engulfed cells (Kawane et al., 2001). Those mice suffer of 
improper activation of innate immunity and die at birth because of severe anaemia (Yoshida 
et al., 2005a; 2005b). Phagocytes such as professional macrophages are interested by a specific 
family of disorders known as Lysosomal Storage Diseases (LSDs). LSDs represent a group of 
about 50 genetic disorders caused by deficiencies of lysosomal and non-lysosomal proteins. 
Here, enzymes required for the degradation of specific compounds are lacking, leading to their 
accumulation in lysosomal and non-lysosomal compartments. LSDs have been shown to 
reduce macrophages endocytic recycling capabilities and migration to the target (Berg et al., 
2016). 
In our study, by characterizing blb, a zebrafish mutant lacking a sugar transporter where 
phagosome do not reduce their size during maturation, we identify the gastrosome as a new 
phagocytic compartment which dynamically respond to the phagocyte’s activity and feeds 
back to it. In this mutant, the gastrosome keeps enlarging upon phagocytosis transforming 
microglia into large, poor phagocytes. It is surprising however how no diseases related with 
Slc37a2 transporter or gastrosomal expansion have been reported yet. Surprisingly, zebrafish 
homozygous knockouts for Slc37a2 are viable and their lifespan is comparable to those of wild 
type. As in the mutant, the bubble-like phenotype is visible only in the brain while trunk 
macrophage can develop this morphology only by increasing the level of apoptosis in the 
embryo, we hypothesize that the immune system can cope and handle the phagocytic 
requirements. Mutant microglia grow over time reading a peak at 4 dpf. At later time points 
levels of apoptosis in the brain are significantly reduced. Moreover, in other tissues the number 
of macrophages is much higher than in the brain while levels of apoptosis are significantly 
lower (Casano et al., 2016) preventing the development of the blb phenotype in the other 
tissue resident macrophages. Finally, Slc37a2 has been shown to localize specifically on 
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macrophages (Kim et al., 2007), meaning that other phagocytic cells should not be affected. 
Thus, we would assume that, at least in absence of further external challenges (such as injuries, 
infections etc.), the immune system of Slc37a2 knock out organisms could be able to handle 
the physiological levels of apoptotic cell clearance, explaining why mutations in this gene might 
have gone unnoticed so far. 
In our work, the injury experiments and quantifications of the phagocytic activity in blb clearly 
highlight the importance of the gastrosome in phagocytosis as interfering with its function 
affects microglia morphology and behaviour. Moreover, the finding that this compartment 
expands dynamically in response to elevated apoptosis in wild type embryos raises the 
possibility of an entry-point for manipulating microglial cellular morphology and modulating 
the impact that these cells have in the context of many neurodegenerative disorders. 
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5 MATERIAL AND METHODS 
5.1 FISH REARING AND HANDLING 
5.1.1 ZEBRAFISH STRAINS AND TRANSGENIC LINES 
For this study, Golden, Tübingen and TLF fish were used as wild types. Macrophages and 
microglia were visualized by using either a Tg(spi1b:GAL4,UAS:EGFP), a 
Tg(spi1b:GAL4,UAS:TagRFP) line (Peri and Nüsslein-Volhard, 2008; Sieger et al., 2012) or a 
Tg(mpeg1:eGFP-caax). In the first two lines, the yeast-derived transcription activation factor 
Gal4 is expressed under the control of the pU.1 promoter and specifically binds UAS (Upstream 
Activation Sequence). This allows a stable labelling of all myeloid cells and their progeny even 
when the activity of the original promoter is weak or active for a restricted period of time. In 
the Tg(mpeg1:eGFP-caax) line, the eGFP-caax fusion protein was cloned downstream of the 
macrophage mpeg1 promoter (Ellett et al., 2011) using the Gateway cloning kit from Thermo 
Fisher Scientific to label the plasma membrane of all macrophages. 
Microglia were as well specifically labelled using the Tg(apoeb:lyn-eGFP) line (Peri and 
Nüsslein-Volhard, 2008). Here the membrane bound fluorescent marker was cloned in the 
Apolipoprotein-E locus and a BAC line was generated.  
To visualize neurons a Tg(NBT:DsRed) line was used, where DsRed expression is under the 
control of the Xenopus neural beta-tubulin (nbt) promoter (Peri and Nüsslein-Volhard, 2008). 
To monitor neuronal apoptosis in vivo a Tg(nbt:DLexPR:SecA5-TagBFP) line was used (Mazaheri 
et al., 2014). Here the fluorescent protein TagBFP was cloned downstream of Secreted 
Annexin-V. The expression of this construct was driven by the NBT promoter and DLexPR (a 
constitutively active form of the inducible LexPR system). 
5.1.2 FISH HUSBANDRY 
Zebrafish were raised and maintained as indicated in “Zebrafish – A practical approach” 
(Nüsslein-Volhard and Dahm, 2002). Adult zebrafish were kept in aquaria from Aquaschwarz 
Aquarienbau (Gottingen, Germany) and Muller & Pfleger (Rockenhause, Germany), at 27-28°C 
in a 14 hours light and 10 hours dark cycle. System water was desalted and adjusted to pH ~7 
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and conductivity of 400 ± 50 μS. Embryos were obtained by pairs of males and females 
naturally mating and after collection they were kept in E3 medium 1x (pH 7.2) at 28°C. Embryos 
were either analysed at the desired stage or bleached for rising. Staging was done according 
to Kimmel at al., 1995 (Kimmel et al., 1995).  
 
Medium Composition Concentration 
E3 60x NaCl 3 mM 
 KCl 0.17 mM 
 CaCl2×2H2O 0.33 mM 
 MgSO4×6H2O 0.33 mM 
PBS 1x pH 7.4 NaCl 137 mM 
 KCl 2.7 mM 
 Na2×HPO4 10 mM 
 KH2PO4 2 mM 
 
5.1.3 BLEACHING PROCEDURE 
To reduce the risk of pathogen contamination, embryos to be raised were disinfected by 
bleaching using sodium hypochlorite 10-15% according to Nüsslein-Volhard and Dahm, 2002 
(Nüsslein-Volhard and Dahm, 2002). Briefly, embryos were incubated in bleaching solution for 
5min and then rinsed in E3 + dH2O for additional 5min. This procedure was repeated twice, 
finally followed by a last rinsing step. After bleaching, the eggs were placed in a new Petri dish 
and 10 μg/ml pronase was added to help the embryos hatching from the bleached egg. As 
recommended, bleaching was performed only on embryos up to 28hpf. 
 
Reagent Stock Solution Supplier (cat.no.) 
Sodium hypochlorite solution 10-15% NaOCl, store at 4°C Sigma (425044) 
Pronase 30 mg/ml, store 1 ml aliquots at -20°C Roche (11459643001) 
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5.1.4 PTU TREATMENT 
To avoid pigmentation of the larvae which starts from 24-28 hpf, embryos were kept in E3 
medium containing 1% v/v of N-Phenylthiourea (PTU). Since PTU blocks the process of 
melanogenesis only transiently, it had to be applied at a constant rate with every exchange of 
medium, but only after 6 hpf, as if applied before it could lead to heart oedema and 
developmental delays. PTU stock solution was prepared as following.  
 
 
5.1.5 ANAESTHESIA OF ZEBRAFISH EMBRYOS 
Prior manipulation, embryos were anesthetized by adding Ethyl 3-aminobenzoate 
methanesulfonate salt (Tricaine) to the E3 medium. Tricaine stock solution was prepared as 
following and kept at 4°C.  
 
Reagent Stock Solution Supplier (cat.no.) 
Tricaine 100x solution: dissolve 2g Tricaine in 489.5 ml autoclaved 
water + 10.5 ml Tris 1M pH 9.5. Adjust pH to ~7 
Sigma (A5040) 
 
5.1.6 MOUNTING EMBRYOS FOR LIVE IMAGING 
Embryos to be imaged under the confocal or light sheet microscope were anaesthetized and 
screened based on the expression of the desired fluorescent labelling, using the stereoscope 
Olympus SZX16. Selected embryos were then embedded in 1.3% low-melting agarose, 
dissolved in E3 medium and tricaine and mounted on a glass bottom dish. The dish was then 
filled with E3 medium containing PTU and tricaine for imaging.  
 
Material Supplier (cat.no.) 
peqGOLD Low Melt Agarose peqLab Biotechnologie GmbH (35-2030) 
Glass bottom Microwell Dishes MatTek Corporation (P35G-1.5-10-C) 
Reagent Stock Solution Supplier (cat.no.) 
PTU 100x solution: dissolve 750 g in 250 ml of PBS medium. 
Warm up to 60°C and stir to dissolve. Store at 28°C. 
Sigma (P7629) 
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5.2 CELL CULTURE 
RAW 264.7 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) High Glucose 
wilt L-glutamine plus 10% Heat Inactivated Fetal Bovine Serum (FBS). HeLa Kyoto H2B-EGFP 
and HeLa Kyoto H2B-mCherry were cultured in DMEM-1g/L D-Glucose, Pyruvate plus 10% FBS, 
1% Penicillin/Streptomycin and 1% GlutMAX-l 100x. Cells were cultured in a cell culture 
incubator (5% CO2, 37°C) and handled in a sterile cell culture hood. Cells were grown to 70-
80% confluency, rinsed with 1x PBS, trypsinized with 0.05% Trypsin-EDTA 1x, washed with 
complete culture medium and introduced into a culture flask (10-30% confluency) or seeded 
for co-culture experiments. 
 
Reagent/Material Supplier (cat.no) 
RAW 264.7 ATCC (TIB-71) 
HeLa Kyoto H2B-EGFP Gift from Lars Velten and Lars Steinmetz, EMBL 
HeLa Kyoto H2B-mCherry Gift from the Mitocheck consortium, EMBL 
DMEM High Glucose, L-Glutamine ATCC (30-2002) 
DMEM 1g/L D-Glucose, Pyruvate Gibco (11880-028) 
Heat Inactivated FBS Gibco (10500-064) 
Penicillin/Streptomycin Gibco (15140-122) 
GlutMAX-l (100x) Gibco (35050-061) 
0.05% Trypsin-EDTA (1x) Gibco (25300-054) 
 
5.2.1 PHAGOCYTOSIS ASSAY 
For phagocytosis experiments, cells were co-cultured in RAW 264.7 medium on glass coverslips 
(22 mm) in a 1:1 (RAW264.7:HeLa) ratio until 50% confluence. To induce HeLa-specific 
apoptosis, we used a medium containing Recombinant Human TRAIL/TNFSF10 (80 ng/ml, 
(Steven R Wiley et al., 1995)), a homologous of Fas ligand able to induce rapid apoptosis in 
cancer cells. After 1 hour, the drug was removed and fresh medium was added. Cells were kept 
in the incubator, then rinsed with PBS 1x and fixed with 4% Paraformaldehyde (PFA) after 3, 6 
or 9 hours from treatment. Coverslips were incubated overnight at 4°C before antibody or dyes 
staining.  
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Reagent Stock Solution Supplier (cat.no.) 
TRAIL/TNFSF10 10 µg /ml stock solution: resuspend 20 µg in 1 ml 
of filtered PBS 0.5% BSA. Store 20 µl aliquots at -
20°C, up to 1 month. 
R&D Systems (375-TEC-010) 
PFA, prills, 95% 4% Solution: Dissolve 1g PFA powder in 15 ml PBS 
1x pre-heated at 60°C. Add NaOH dropwise until 
the solution clears. Adjust pH to ~7 and bring to a 
final volume of 25 ml with PBS 1x. 
Sigma (441244) 
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5.3 MOLECULAR BIOLOGY TECHNIQUES 
5.3.1 CRISPR/CAS9 GENOME EDITING 
5.3.1.1 Target design 
CRISPR-Cas9 has been used to genetically modify the genes of interest. CRISPR-Cas9 is a 
technology based on a bacterial system of programmable DNA endonucleases. By the use of a 
sgRNA complementary to a specific sequence on the genome, Cas9 endonuclease is able to 
induce very efficiently and quickly a cleavage of the double strand DNA, 4 base pairs upstream 
of the so-called PAM sequence (NGG). The cell will repair the double strand brake in the DNA 
by either non-homologous end joining (NHEJ) or by homology directed repair (HDR) when 
homology sequences are present. NEHJ is an error-prone repair mechanism that result in 
insertions and deletions that often disrupt the gene, reason why it is often used to generate 
knock outs. On the other hand, HDR uses homology recombination leading to a precise repair 
on the cut double strand and this repair mechanism can be used to insert small pieces of DNA 
into the cleavage. Here, HDR has been used to introduce specific sequences (cassettes) in the 
loci of interest. In particular, the first exon of Slc37a2 has been targeted to introduce a short 
sequence which, whatever the reading frame, will lead to the introduction of a STOP codon 
(STOP cassette). On the other hand, P2Y6, P2Y12 and P2Y13 loci have been targeted at 50-100 
bp from the ATG to introduce a STOP cassette plus the landing site for PhiC31 integrase 
recombination (attB/STOP cassette) which will allow the generation of knock ins. 
The sgRNAs were designed using the CRISPR-Cas9 target online predictor CHOPCHOP 
(http://chopchop.cbu.uib.no) based on the ENSEMBL Transcript ID. Only coding regions were 
considered as targets, and the sgRNA were designed 20 nucleotides long + full PAM sequence 
(NGG) at the 3’. The sgRNA targets were selected based on their position in the gene (by 100 
bp from ATG), GC percentage (ideally between 60-70%) and the target score which takes into 
consideration self-complementary, efficiency and absence of predicted off-targets.  
 
Gene Transcript ID sgRNA (5’-3’) Cutting site position 
Slc37a2 ENSDART00000038602.6 TGATAGGCTTTCGAGAGAGA 108 nucleotides after ATG 
P2Y6 XM_689367.6  GAAGGCCGAAGATGAAGACC 93 nucleotides after ATG 
P2Y12 ENSDART00000154780 AGTTCATCCTGTTCTCGAGA 61 nucleotides after ATG 
P2Y13 ENSDART00000155392 GAAGTGTGAGCGGGACACTC 42 nucleotides after ATG 
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The cassettes were ordered as oligos purified by HPLC through Sigma. Those were designed by 
flanking the STOP or attB/STOP cassette by 30 nucleotides specific for the target. In particular, 
from the Cas9 cutting site (4 nucleotides before the PAM sequence), 5 nucleotides were left 
to each side and then 30 bp left and right were taken as homology arms flanking the cassette 
of interest. 5.4 µM stocks of cassettes were prepared for each gene. 
5.3.1.2 sgRNA synthesis 
A PCR was used to generate the DNA template for the sgRNA which will be generated by retro-
transcription. This PCR take advantage of the use of three common (66F, 66R and 67R) and 
one specific primers which partially overlap (Figure 5.1). All oligos are ordered as highly purified 
primers (purified by high performance liquid chromatography, HPLC).  The specific oligo, 
always 81 nucleotides long, mediates the overlap among the 4 primers working as a template 
for the PCR. In particular, it contains the T7 promoter sequence (21 nucleotides) followed by 
the target sequence (5’-3’, 20 nucleotides) and a 40 nucleotides long tail common in every 
sgRNA.  
 
Primer 
name 
length Primer sequence / structure (5’-3’) 
Specific 
oligo  
81 nt GCGTAATACGACTCACTATAGNNNNNNNNNNNNNNNNNNNNGTTTTAGAGCT
AGAAATAGCAAGTTAAAATAAGGCTAGTC 
66F  20 nt GCGTAATACGACTCACTATA 
66R 20 nt GCACCGAGTCGGTGCGGATC 
67R 81 nt GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTT
AACTTGCTATTTCTAGCTCTAAAAC 
 
 
Figure 5.1. Schematic representation of the oligos for the synthesis of sgRNAs. 
Cassette 
name 
Cassette sequence 
STOP  GGCTAATTAATTAAGCTGTTGTAG 
attB/STOP  GGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGGGCTAATTAATTAAGCTGTTGTAG 
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Three partially overlapping primers (66F, 66R and 67R) are used for the synthesis of every sgRNA. A specific 
oligo is designed for the target of interest. This include the T7 promoter sequence (yellow) where 66F binds 
and used for the RNA synthesis, the specific sequence of the target (green) and the sgRNA tail shared by all 
sgRNA for Cas9 recognition (orange) where 66R and 67R primers bind. 
 
50 µl of PCR mix for the synthesis of the sgRNA template was done as following. 
Reagent Volume (x1)  Supplier (cat.no.) 
Buffer 10x 5 µl Genaxxon Bioscience (M3454) 
X7 Pfu polymerase 0.5 µl Protein Expression and Purification Facility, EMBL, 
Heidelberg, Germany 
10 mM dNTPs 1 µl Thermo Fisher Scientific (R0192) 
100 µM specific oligo 0.4 µl Sigma 
100 µM 67R 0.4 µl Sigma 
100 µM 66F 2.5 µl Sigma 
100 µM 66R 2.5 µl Sigma 
H2O 37.7 µl  
 
PCR Conditions   
94°C 3 min  
94°C 15 sec  
50°C 15 sec 40x 
72°C 15 sec  
72°C 5 min  
4°C hold  
Storage at 4°C   
 
The successful amplification of the template was tested by electrophoresis. 3 µl of PCR (plus 
6x dye) were run on a 1.5% agarose gel in TAE 1x. Nucleotides were visualized by SYBR safe 
and a DNA ladder was used as a molecular weight reference. After the 122 bp fragment was 
visualized by gel, the PCR product was purified by column using QIAquick PCR Purification Kit 
according to the manufacturer’s instructions.  
The concentration of the purified PCR product was then measured by Nanodrop (NanoDrop 
8000 Spectrophotometer, Thermo Fisher Scientific), and the RNA was synthetized in vitro 
taking advantage of the T7 promoter by using the MEGAshortscript T7 kit according to the 
manufacturer’s instructions. The freshly synthetized sgRNA was then purified by column using 
the miRNeasy Mini Kit following instruction from step 6 of the manufacturer’s protocol and 
the purified sgRNA was eluted in 60 µl of RNAse free water. 
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After purification, 1 µl of sgRNA plus 1 µl 6x dye and 10 µl water was heated up at 70°C for 5 
min, then kept 2 minutes on ice and immediately loaded on a 2% agarose gel and run for 10 
min at 140V to check for integrity. Finally, the concentration was measured by Nanodrop and 
a stock of 600 ng/µl was prepared for each sgRNA. 
 
Reagent/Material Stock Solution Supplier (cat.no.) 
TAE 50x stock solution: 121g 
TRIZMA base + 50 ml EDTA 
0.5M (pH 8.0) + 28.55 ml 
glacial acetic acid. Bring to 
500 ml with Millipore H2O 
and autoclave before use. 
Store at room temperature. 
Stock solution prepared by EMBL 
laboratory kitchen 
Agarose - Sigma (A9539) 
SYBR Safe DNA gel stain 10000x Thermo Fisher Scientific (S33102) 
GeneRuler 100 bp DNA ladder - Thermo Fisher Scientific (SM0241) 
6x DNA loading Dye 6x Thermo Fisher Scientific (R0611) 
QIAquick PCR Purification Kit  - Qiagen (28104) 
MEGAshortscript T7 - Thermo Fisher Scientific (AM1354) 
miRNeasy Mini Kit - Qiagen (217004) 
 
5.3.2 MICROINJECTIONS OF ZEBRAFISH EMBRYOS 
Injection plates were prepared as indicated in Nüsslein-Volhard and Dahm, 2002 (Nüsslein-
Volhard and Dahm, 2002) with 2% Agarose in E3, and freshly laid zebrafish eggs were placed 
and aligned in the groves. 1-cell stage embryos were injected with a Pneumatic PicoPump 
microinjector (WPI, SYS-PV820). The capillaries (Harvard Apparatus No. 30-0035) were pulled 
using a Sutter P9 Micropipette Puller (Sutter) (pulling conditions: heat 630, pull 80, velocity 75, 
time 90). After the injection the embryos were transferred into a fresh petri dish with E3 and 
placed in 28°C incubator. About 7 hours later, unfertilized eggs were sorted out.  
5.3.2.1 Morpholino knock-downs 
For morpholino-mediated knockdown, 1-cell stage embryos were injected into the yolk. 
Morpholinos (Gene Tools, LLC. Oregon, USA) were diluted in dH2O as stock solutions and co-
injected with 0.1M KCl and 0.2% Phenol red (Sigma) at the desired concentration. 
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Gene Sequence (5’-3’) 
Working 
Concentration 
Reference 
pU.1 GATATACTGATACTCCATTGGTGGT 0.5 mM (Rhodes et al., 2005) 
Caspase 3 TTGCGTCCACACAGTCTCCGTTCAT 0.1 mM (Yamashita, 2003) 
BAI-1 CTAGAACTCTAACACACTTACTCAT 1 mM (Mazaheri et al., 2014) 
TIM4 CATAGTTTATCAACACTTACCATCA 0.7 mM (Mazaheri et al., 2014) 
a1vATPase CCTCGCTACGAAACAGCTCCCCCAT 0.4 mM (Peri and Nüsslein-Volhard, 2008) 
 
5.3.2.2 sgRNA and Cas9 injection 
To induce Cas9-double strand break and the insertion of the cassette by homologous 
recombination, an injection mix was prepared as follow and incubated for 20 minutes at 37°C 
to allow Cas9 protein (Protein Expression and Purification Core Facility, EMBL Heidelberg) re-
folding before injection into the single cell of freshly laid zebrafish embryos. 
 
Composition [Stock] [Use] Volume (x1) 
sgRNA  600 ng/µl 200 ng/µl 1.36 µl 
Cassette 5.4 µM 1 µM 0.74 µl 
KCl 1M 300 mM 0.9 µl 
Cas9 4000 ng/µl 1000 ng/µl 1 µl 
 
5.3.3 GENOTYPING 
5.3.3.1 Fin Clip 
To collect tissue from adult fish for genotyping, fish were transferred in 250 ml fish water 
containing 6 ml of Tricaine 100x. As soon as the righting reflex was lost, a small piece of fish 
tail was cut and collected in a PCR tube. The sedated fish was immediately moved to fresh 
water in a screening tank numbered in the same way as the PCR tube containing the fish tissue.  
5.3.3.2 DNA extraction 
To identify F0 founders carrying the cassette in the germline, offspring of the outcross between 
adult F0 injected fish and with wild types were genotyped (single embryos). From F1 onwards, 
fish were genotyped by fin clipping (as described above). The total genomic DNA was extracted 
by adding 25 µl to single embryos or 40 µl to fin-tissue from adult fish (fin clip) of Quick Extract 
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Solution. The samples were incubated for 15 minutes at room temperature, vortexed for 10 
seconds and transferred for 5 minutes at 65°C. After mixing 10 seconds by vortex, samples 
were incubated at 95°C for 2 minutes and transferred at 4°C or -20°C for long storage. Before 
use, the genomic DNA was spin down by centrifuge. 
 
Reagent Supplier 
QuickExtract DNA Extraction Solution Epicentre (QE09050) 
 
5.3.3.3 Polymerase chain reaction (PCR) 
To determine the genotype of the samples, the sequence of interest was amplified from the 
total genomic extract. In particular, two different PCRs were performed per gene: one having 
the forward primer binding on the cassette inserted by HDR and the reverse primer on the 
gene, the second having both primers binding on the gene, outside the inserted cassette. The 
first PCR was used to determine whether the cassette of interest was inserted by the presence 
(or absence) of the proper length band. The second PCR product was used to verify proper 
insertion by evaluating the size of the fragment amplified but especially by analysing the 
amplified product by sequencing. The following PCR mix, cycles and primers pairs were used. 
 
PCR Mix Volume (x1) 
Buffer 10x 2 µl 
Taq Polymerase 0.4 µl 
10 µM Frw primer 0.4 µl 
10 µM Rev Primer 0.4 µl 
10 mM dNTPs 0.4 µl 
Genomic DNA 2 µl 
H2O 14.4 µl 
 
5.3.3.4 Sequencing 
PCR Conditions   
95°C 2 min  
95°C 30 sec  
Tm 30 sec 40x 
72°C 30 sec  
72°C 2 min  
4°C hold  
Storage at 4°C   
Primer pair; Tm Target Amplificate size 
20F/7R; 60°C attB/STOP cassette P2Y12 538 bp (if with cassette) 
20F/9R; 60°C attB/STOP cassette P2Y13 231 bp (if with cassette) 
20F/19R; 60°C attB/STOP cassette P2Y6 385 bp (if with cassette) 
7F/7R; 65°C P2Y12, for sequencing 643 bp 
9-10F/9R; 64.1°C P2Y13, for sequencing 338 bp 
19F/19R; 65°C P2Y6, for sequencing 519 bp 
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To analyse the sequence of the fish on genotyping, the PCR product of interest was first tested 
on 1% agarose gel (2 µl to verify the length of the amplificated), then purified by column using 
the QIAquick PCR Purification Kit according to manufacturer’s instructions. Sequencing on 
purified PCR products was outsourced to GATC Biotech (Konstanz, Germany) by providing an 
aliquot of 10 µM forward primer. Sequencing results were analysed using Geneious Software 
(Biomatters, New Zealand).  
5.3.4 PROTEIN EXTRACTION 
To obtain whole-embryo protein lysate, 50 wild type or blb (NY007 and NI150) embryos at 4 
dpf were anesthetized in 0.01% tricaine and resuspended in 200 µl of lysis buffer (Fiorotto et 
al., 2016) supplemented with protease inhibitor cocktail tablets (1 tablet/10 ml; Roche). 
Embryos were homogenized with a microfuge pestle until uniform consistency and lysates 
were incubated for 30 min at 4°C under rotation. The samples were centrifuged at 10000g for 
30 min at 4°C, then the supernatant was transferred to a new tube and the total protein extract 
was measured by Coomassie Protein Assay Reagent (Thermo Fisher Scientific, 1856209) using 
a spectrophotometer (Eppendorf BioPhotometer plus). 
 
Lysis Buffer composition Concentration Supplier (cat.no.) 
Tris-HCl [1M, pH 7.5] 50 mM  
EDTA [10mM] 1 mM  
Octyl b-D-glucopyranoside 2% Sigma (O8001) 
2-Mercaptoethanol 5 mM Sigma (M6250) 
NaCl [3M] 0.25 M Merck (1.06404.1000) 
Na3VO4 1 mM Sigma (S6508) 
NaF 20 mM Sigma (201154) 
Glycerol 5% Merck (1.04093.1000) 
Triton X-100 100 µL Sigma (T9284) 
 
5.3.5 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS (-PAGE) 
Discontinuous gel electrophoresis under denaturing conditions was used for protein 
separation of zebrafish lysates. Therefore, 800 µg of sample protein were solubilized in 20 µl 
of 1x Laemmli buffer-10% 2-Mercaptoethanol and warmed up for 10 min and 37°C. Proteins 
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were separated electrophoretically based on their molecular size using precast polyacrylamide 
gels for 1.5 hours at 200V and MOPS or MES buffers for big or small proteins respectively. 
 
Reagent Supplier (cat.no.) 
Laemmli Buffer 4x Biorad (161-0747) 
2-Mercaptoethanol Sigma (M6250) 
NuPAGE 4-12% Bis-Tris Protein Gels Novex (NP0321BOX) 
NuPAGE MOPS SDS Running Buffer (20x) Novex (NP0001) 
NuPAGE MES SDS Running Buffer (20x) Novex (NP0002) 
5.3.6 IMMUNOBLOTTING 
Immunoblotting was used to identify specific proteins recognized by antibodies. To this aim, 
proteins separated by SDS-PAGE were transferred electrophoretically onto nitrocellulose 
membranes. Prior to blotting membranes, filter paper, fiber pads and gels were equilibrated 
in transfer buffer 1x prepared according to the manufacturer’s instructions and the gel-
membrane transfer sandwich was assembled. Proteins were transferred at room temperature 
for 1 hour at 170 mA. Membranes were first rinsed with TBS-T (0.1% Tween-20), then free 
binding sites were blocked by immersing the membrane in 5% fat-free milk powder in TBS-T 
for 1 hour at room temperature. Primary antibodies (Table 5.1) were diluted in blocking buffer 
and incubated overnight at 4°C with constant gentle agitation. Membranes were washed 
thoroughly at least 3 times in TBS-T buffer for at least 10 minutes each. Washing was followed 
by incubation with the appropriate fluorescent secondary antibody, diluted 1:2500 in blocking 
buffer for 1 hour at RT. Membranes were again washed for at least 30 min with several times 
changed TBS-T buffer before HRP detection systems and autoradiography films according to 
the manufacturer’s instructions. 
 
Reagent/Materials Supplier (cat.no.) 
Nitrocellulose membranes, 0.2 µm pore size Novex (LC2000) 
NuPAGE transfer buffer 20x Novex (NP0006) 
Tween-20 Sigma (P9416) 
Immobilion Western Millipore (WBKLS0500) 
Super signal West Pico PLUS  Thermo Fisher Scientific (34579) 
Amersham Hyperfilm MP GE Healthcare (28906845) 
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PRIMARY ANTIBODY SPECIES SUPPLIER (CAT.NO.) APPLICATION/DILUTIO
N 
Anti-fish Slc37a2* Mouse, 
monoclonal 
EMBL Rome WB (1:100); IF (1:20) 
Anti-mouse Slc37a2 Rabbit, 
polyclonal 
Invitrogen (PA5-20916) IF (1:100) 
Anti-mouse Rab7 Rabbit, 
monoclonal 
Abcam (Ab137029) IF (1:100) 
Anti-mouse LBPA Hamster, 
monoclonal 
Millipore (MABT837) IF (1:100) 
Anti-mouse Lamp1 Rat, 
monoclonal 
Abcam (Ab25245) IF (1:100) 
Anti-mouse Lamp2 Rat, 
monoclonal 
Abcam (Ab25339) IF (1:100) 
Anti-mouse g-Tubulin Mouse, 
monoclonal 
Sigma (T6557) WB (1:2000) 
Anti-rat Cathepsin D Rabbit Gift from Bernard 
Hoflack 
IF (1:100) 
Table 5.1. List of Primary Antibodies used in this Thesis. 
Antibodies with their characteristics including supplier and specific information about their application are 
listed in this table. 
 
* Generation of the monoclonal antibody for Slc37a2 
A monoclonal antibody against Slc37a2 was raised in mouse at the Monoclonal Antibodies Core 
Facility (MACF) at the EMBL outstation in Rome, Italy. The following epitope was selected: 
CTAPQHHERVEEEPLLRNSSTNEEIFNSHTST (236-267). This is located in the loop between 
transmembrane domains 6 and 7 of the protein. 
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5.4 HISTOLOGICAL METHODS 
5.4.1 ACRIDINE ORANGE  
Acridine Orange (AO) is an organic compound used as a nucleic acid-selective fluorescent dye. 
AO selectively penetrate cells undergoing programmed cell death, therefore it was used to 
visualize apoptotic cells in vivo. Embryos were incubated with 10μg/ml AO in E3/PTU for 1h 
and extensively washed with fresh E3 prior live imaging microscopy. Since AO is light sensitive, 
embryos were kept in the dark during the procedure. 
 
Reagent Stock Solution Supplier (cat.no.) 
Acridine Orange hemi(zinc 
chloride) salt 
Dissolve 10 mg/ml in double distilled water. 
Store at 4°C 
Sigma (A6014) 
 
5.4.2 NEUTRAL RED STAINING 
Neutral Red (NR) is a dye used to stain acidic compartments (such as lysosomes). NR staining 
was used to visualize microglia in the living zebrafish embryo, since during development those 
are the cells containing acidic compartments. For the staining, Neutral Red was added to a final 
concentration of 5 μg/ml to the larvae in E3/PTU. After 2 h in the staining solution at 28 °C, the 
larvae were transferred to new E3, washed several times with E3, anesthetized and analysed 
under a stereomicroscope (Olympus SZX16, Olympus) and/or mounted and imaged at a 
confocal microscope (Olympus FV 1200).  
 
Reagent Stock Solution Supplier (cat.no.) 
Neutral Red 
Dissolve 500 μg/ml in autoclaved water. 
Store at 4°C 
Sigma (N4638) 
 
5.4.3 LYSO-TRACKER STAINING 
LysoTracker Red DND-99 is a weakly basic amine that selectively accumulates in cellular 
compartments with low internal pH. It can be used as a vital stain to label lysosomes and 
phago-lysosomes. For staining, 12 µl were added to 30 ml E3/PTU 1% DMSO and the embryos 
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were stained for 1 hour, in the dark at 28 °C. Before mounting for confocal microscopy fish 
were washed several times with fresh E3.  
 
Reagent Supplier (cat.no.) 
LysoTracker Red DND-99 Thermo Fisher Scientific (L7528) 
 
5.4.4 LIPID STAINING 
To stain membranes and lipids, a panel of different lipidic dyes was used on both cell culture 
and zebrafish embryos. In particular, BODIPY 493/503 and Nile Red were used for neutral lipid 
staining, Wheat germ agglutinin (WGA) was used to stain lectins and Nile Blue Chloride to 
visualize lipids and DNA. 
 
Reagent Stock Use Supplier (cat.no.) 
BODIPY 493/503 1 mg/ml in DMSO 1µg/ml Thermo Fisher (D3922) 
Nile red 1 mg/ml in DMSO 5µg/ml Thermo Fisher (N-1142) 
Nile Blue Chloride 1 mg/ml in H2O 5-10µg/ml Sigma (222550) 
WGA, AF 488 1 mg/ml in PBS 5µg/ml Thermo Fisher (W11261) 
 
On cell culture, stainings were performed after phagocytosis experiments on samples fixed 9 
hours after apoptosis induction. The fixed co-culture was first washed with PBS 1x, then 
directly incubated with the dyes dissolved in PBS 1x for 30 minutes at room temperature. 
Stained co-cultures were washed 3 times for 5 minutes with PBS 1x and mounted using a 
Vectashield Kit (Vector Laboratories, Inc., Burlingame, CA) for confocal imaging. 
For staining on zebrafish embryos, the live dyes (BODIPY 493/503, Nile Red and Nile Blue) were 
added to the medium of 4 dpf Zebrafish embryos for 30 minutes at 28°C. After incubation with 
the dye, the embryos were rinsed extensively with E3 medium, anesthetized with 0.01% 
Tricaine and mounted in 1.3% low-melting agar for confocal imaging.  
For staining on fixed samples, Zebrafish embryos at 4 dpf were anesthetized with 0.01% 
tricaine and fixed overnight at 4°C in freshly prepared 4% PFA. Fixed embryos were extensively 
permeabilized by washing 5x30 minutes with PBS-Tx100 0.8%. Embryos were incubated with 
WGA for 30 min at room temperature after permeabilization. Subsequently they were rinsed 
with PBS and mounted in 1.3% low-melting agar for confocal imaging. 
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5.4.5 IMMUNOHISTOCHEMISTRY ON ZEBRAFISH EMBRYOS 
For whole mount antibody staining, Tg(mpeg1:eGFP-caax) Zebrafish embryos at the desired 
stage of development were anesthetized with 0.01% tricaine and fixed overnight at 4°C in 
freshly prepared 4% PFA. Embryos were then extensively permeabilized by washing 5x30 
minutes with permeabilizing solution. Subsequently they were rinsed with 10x blocking buffer 
and incubated with blocking solution 10x for 1 hour at room temperature. The primary 
antibody was added (Table 5.1) in blocking buffer 1x overnight at 4°C with gentle rocking. On 
the next day, embryos were washed extensively in PBS-Tx100 rinsed with 10x blocking buffer 
and then blocked for 1 hour at room temperature. The secondary antibody (1:500) and GFP 
booster (1:200, Chromotek GBA488-100) to enhance the green fluorescence of the microglia 
were added in blocking buffer 1x and incubated overnight at 4°C with gentle rocking. Embryos 
were washed extensively (3x30 minutes) in PBS-Tx100 and mounted in 1.3% low-melting agar 
for confocal imaging. To avoid bleaching it is advised to protect the sample from light during 
the whole procedure. 
 
Reagent Composition 
Permeabilizing Solution PBS-Tx100 0.8% (800 µl in 100ml) 
Blocking Solution 10x 10% NGS in permeabilizing solution (600 µl in 6 ml) 
Blocking solution 1x Dilute 1:10 the blocking solution 10x 
 
5.4.6 IMMUNOHISTOCHEMISTRY ON CELL CULTURE 
Antibody stainings were performed on glass coverslips with co-cultures of HeLa and RAW 264.7 
cells prior and after apoptosis induction fixed at different time points depending on the 
experiment set up. Cells were fixed overnight with freshly prepared 4% PFA, washed with 3 
times for 5 minutes with PBS 1x and permeabilized for 7 minutes. After 1 hour blocking at room 
temperature with gentle rocking, cells were incubated overnight at 4°C with primary antibody 
(Table 5.1) in blocking buffer. The next day, cells were washed 3 times for 5 minutes with PBS 
1x and incubated at room temperature with the appropriate secondary antibody. After 1 hour, 
unbound antibody was removed by washing in PBS 1x and coverslips were mounted using a 
Vectashield Kit (Vector Laboratories, Inc., Burlingame, CA).  
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Reagents/Materials Supplier (cat.no.) 
Triton X-100 Sigma (T9284) 
Bovine Serum Albumine Sigma (A2153) 
Normal Goat Serum (NGS) Merck (S26) 
 
  
Reagent Composition 
Permeabilizing Solution PBS-TritonX-100 0.2% (200 µl in 100 ml) 
Blocking Solution PBS-0.2%TritonX-100-3%BSA (3g BSA in 100 ml permeabilizing solution) 
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5.5 CHEMICAL TREATMENTS 
5.5.1 Z-VAD-FMK TREATMENT 
The drug Z-VAD-fmk (Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone) was 
used to reduce the levels of apoptosis in the zebrafish embryo. To facilitate uptake, it was 
dissolved to its final concentration (300 µM) in E3 medium containing 1% DMSO 
 
5.5.2 CAMPTOTHECIN TREATMENT 
The drug Camptothecin (CPT) was used to increase apoptosis level in the embryos and 
therefore further enhance microglia and macrophages phagocytosis. CPT was dissolved in E3 
with 1% DMSO at a final concentration of 1 µM. 
 
 
  
Reagent Stock Solution Supplier 
Z-VAD-fmk 
20 mM stock solution: Dissolve 5 mg of Z-VAD-fmk in 535 
µl of sterile DMSO. Store at -20°C. 
Bachem 
(4027403) 
Reagent Stock Solution Supplier 
(S)-(+)-Camptothecin 
25 mM stock solution: Dissolve 100 mg of CPT powder in 
11.5 ml of sterile DMSO in sterile conditions. A second 
dilution in DMSO was done to prepare 1 mM stock 
aliquots. Store at -20°C. 
Sigma (C9911) 
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5.6 MICROSCOPY AND IMAGE ANALYSIS 
5.6.1 LIVE IMAGING 
For live imaging, zebrafish embryos were anesthetized in 0.01% tricaine and embedded in 1.3% 
low-melting-point agarose. Imaging was performed using the Olympus FV1200, the Leica SP8 
and the Andor Spinning disk with 40x/NA1.15 and 20x/NA0.7 objectives. For full brain imaging 
an average of 30-40 stacks were captured, with a z-step of 1.5 µm. Live imaging at high 
temporal resolution to track phagosomes was performed using the Zeiss Lightsheet Z.1 with a 
20x detection objective, the Leica SP8 DLS and the Luxendo MuVi SPIM with a 25x detection 
objective, at a temporal resolution between 15 and 30 seconds. All images and videos were 
analysed in Fiji and Imaris.  
5.6.2 LASER INDUCED INJURY 
Injuries were performed using the 532 nm cutting laser attached to the FV1000 or the 355 nm 
cutting laser attached to the Andor Spinning Disk confocal microscope. Using the FV1000, the 
tornado tool was used with 40-45 % laser intensity in a ROI of 30x30 pixels. On the Spinning 
Disk microscope, injuries were induced using a frequency of 2500 Hz, 100 % laser intensity and 
1000 pulses/point. To induce smaller injuries, the laser intensity was decreased.  
5.6.3 MICROSCOPY FOR FIXED MATERIAL 
Confocal analysis of fixed cells was performed using the Olympus FV1200 and Leica SP8 with a 
40x/NA1.15 water objective. 0.5µm serial optical sections were collected for analysis. All 
images were analysed in Fiji. 
5.6.4 CORRELATIVE LIGHT ELECTRON MICROSCOPY (CLEM) 
My colleague Jørgen Benjaminsen performed EM and CLEM to describe the ultrastructure of 
the gastrosome. Here I report the methods he used both for cell culture and zebrafish 
embryos. 
5.6.4.1 Cell culture 
Cells were cultured in dishes marked with a coordinate system (MatTek, P35G-1.5-14-CGRD). 
At the respective time points they were chemically fixed with freshly prepared 4% 
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formaldehyde (FA) (Electron Microscopy Sciences, 15710) and 0.1% glutaraldehyde (GA) 
(Electron Microscopy Sciences, 16020) in 0.1M PHEM buffer (60mM PIPES; 25mM HEPES; 
10mM EGTA: 2mM Magnesium chloride: pH 6.9). 2X fixative was added directly to the dish in 
a 1:1 ratio with culture medium and replaced after 5 minutes with 1x fixative. Prior to light 
microscopy, quenching of excess fixative was performed with 0.15 M glycine in 0.1M PHEM. 
Light microscopy was carried out with cells covered with 0.1M PHEM using a FV 1200 confocal 
microscope (Olympus) or Axio Observer.Z1 widefield microscope with a side mounted Axio 
MRm camera (Zeiss). Care was taken that the MatTek dish coordinates were clearly visible in 
images of interest.  
After imaging, samples were fixed with 2.5% GA and 4% FA in 0.1 M cacodylate buffer, followed 
by rinsing with 0.1 M cacodylate and post-fixation with 1% osmium tetroxide (OsO4) and 0.8% 
potassium ferrocyanide (K3Fe(CN)6) in water. Samples were then further rinsed with 0.1 M 
cacodylate buffer and stained with 1% tannic acid for 20 min on ice. The tannic acid was 
removed and samples rinsed with water, before staining with 1% uranyl acetate (UA) (in 
water), and rinsed with water. Samples were then taken through a series of dehydration steps 
with ethanol (EtOH) (25%, 50%, 75%, 90%, 95% and 2x100%). Finally, they were infiltrated with 
EPON (Serva) resin and polymerized in a 60°C oven for 48 h. All processing steps were 
performed using a microwave as described below, except for tannic acid incubation. 
Polymerized samples were removed from the MatTek dish and the coordinate system was 
used to trim the resin block around the region of interest (ROI). For this an EM UC7 
ultramicrotome (Leica) with an ultra 45° diamond knife (Diatome) was used to cut 70 nm 
sections that were placed on slot grids (Plano, G2500C). Post section contrasting was 
performed with 2% UA in water for 5 min and Reynolds lead citrate for 30 sec. Electron 
microscopy was carried out on a Biotwin CM120 electron microscope (FEI) and images 
acquired with a bottom mounted 1K CCD Camera (Keen View, SIS). 
5.6.4.2 Zebrafish embryo 
4dpf zebrafish embryos Tg(spi1b:Gal4,UAS:RFP) were anesthetized (0.01% tricaine) and 
immersed in fixative (2.5% GA and 4% FA in 0.1M PHEM buffer). Heads were immediately 
removed and processed in the microwave as detailed below. 
Light microscopy was carried out with a FEI Corrsight prototype or 780 NLO two photon 
microscope (Zeiss). In both cases, a near-infrared laser was used to create artificial landmarks 
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(circles 20-30 µm in diameter) in the brain surrounding the cell of interest, after which a z-
stack of the entire area was recorded. 
Serial block-face scanning electron microscopy (SBF-SEM) sample preparation was adapted 
from Hua and colleagues (Hua et al., 2015). Incubation steps were performed in a microwave 
as detailed below. Excessive resin was removed and samples polymerized. Samples were 
mounted on microtome stubs (Agar Scientific, G1092450) using an EPO-TEK adhesive (Electron 
Microscopy Sciences, #12670-EE) and polymerized for 48 h at 60 °C. X-ray microtomography 
(µCT) scanning was performed in a Phoenix Nanotom m (GE Sensing & Inspection 
Technologies, Fairfield, CT) operating under xs control and Phoenix datos|x acquisition 
software (both GE Sensing & Inspection Technologies).  
SBF-SEM was performed with the FEI Teneo VolumeScope (VS) and the VS plugin of the Maps 
software (FEI). The microscope was operated at 1.78 kV and 0.1 nA, imaging parameters used 
were 2.5 nanometer pixel size, with a dwell time of 100 nanoseconds and 4 times averaging, 
and the microtome was set to section 30 nanometer slices. Post-acquisition processing of 
Teneo images was performed using Fiji. A Gaussian blur, sigma 2.0 was applied for de-noising 
before xy scaling of 0.5 and the grayscale was inverted. 
For electron microscopy on the blb mutant no CLEM was required as vacuoles could be 
detected readily by µCT or at low magnification in the electron microscope. 
5.6.4.3 Biowave processing 
A PELCO Biowave equipped with a ColdSpot (Ted Pella) was used for all processing steps except 
where stated otherwise. For the GA/FA fixation and OsO4 post-fixation the microwave was 
operated at 100W cycling intervals of 2 min under vacuum at room temperature. For 
Thiocarbohydrazide ((NH2NH)2CS) the same settings were used at 40 °C and for UA and lead 
aspartate (C4H5NO4Pb) at 50 °C. Quenching, rinses and dehydration were 40 sec long at 250W 
with no vacuum at room temperature. The resin infiltration was a 5-step-graded series of 
EtOH/resin followed by 2 changes of 100% resin; these steps were 3 min long at 250W under 
vacuum at room temperature. 
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5.7 LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (LC-MS) 
To investigate which compounds get accumulated in the blb zebrafish head, we performed LC-
MS. To this aim, 4 dpf zebrafish embryos were anesthetized with 0.01% tricaine and 
decapitated with a scalpel. Heads were processed with 500 µL cold methanol and vortexed 5 
min vigorously followed by sonication in ice for 10 min. Extracts were centrifuged at 3,500 rpm 
for 10min at 4°C and supernatant was transferred in a 2ml tube. All samples were centrifuge 
again at 14,000 rpm for 5 min to remove particulate matter. LC-MS was performed and 
analysed by the metabolomic core facility at EMBL Heidelberg (Germany).  
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5.8 STATISTICAL ANALYSIS 
Statistical analysis was performed using the scipy.stats library (version 0.19.0) for python 
2.7.11 or using Prism 7. All hypothesis tests were performed without parametric assumptions. 
Unless otherwise specified, conditions were compared using two-tailed Mann-Whitney U tests 
(scipy.stats.mannwhitneyu). The python scripts were written by Jonas Hartmann. 
 
P Value Wording Summary 
< 0.0001 Very highly significant **** 
0.0001 to 0.001 Highly significant *** 
0.001 to 0.01 Very significant ** 
0.01 to 0.05 Significant * 
³ 0.05 Not significant ns 
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5.9 SOFTWARE USED  
In the course of my PhD I have taken advantage of the following software: 
Software Developer 
Fiji  
ImageJ 1.46r NIH 
Imaris 7.6.4 Bitplane 
FV-ASW-2.1c Olympus 
ZEN 2012 Zeiss 
Photoshop CC 2018 Adobe 
Illustrator CC 2017 Adobe 
Keynote Apple 
Microsoft Word Microsoft 
Microsoft Excel Microsoft 
Microsoft PowerPoint Microsoft 
Pubmed NCBI 
Ensembl Genome Browser EMBL-EBI, Wellcome Trust Sanger Institute 
Geneious Biomatters 
Papers3 for Mac MIT 
Prism 7 Graphpad 
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6 APPENDIX: 
TOWARDS UNDERSTANDING NEURONAL-MICROGLIAL INTERACTION 
VIA PURINERGIC SIGNALLING 
6.1 INTRODUCTION 
Cell signalling is a topic of great interest for both cell and developmental biology. The ability of 
cells to communicate relies on an exchange of “messages” with the surrounding environment 
and is key for the proper functioning of tissues and organs. Importantly, individual cells can 
receive several distinct signals simultaneously and integrate this information into a unified 
action plan. Often, the same receptor can be activated by multiple ligands and these in turn 
can stimulate several receptors, adding extra layers of complexity to the system. As an 
example, in many biological contexts diffusible molecules are employed to provide 
directionality by forming gradients that guide motile cells towards a given location within 
tissues.  
6.1.1 SOLUBLE CUES AND DIRECTED MIGRATION 
Directed migration occurs on multiple scales, from the movement of bacteria towards a source 
of nutrients to the migration of microglia in the developing brain. A common base in all these 
mechanisms, is that the cell interprets and responds to an environmental cue to guide its 
migratory route. Migration of individual cells can be stimulated by a wide variety of different 
cues including chemicals, light, stiffness, temperature, electric fields and even gravity (Thomas 
et al., 2018). Most importantly, cells display tactic reaction only in response to temporal or 
spatial gradients.  
Nearly all cells exhibit gradient senses capabilities, however prokaryotes and eukaryotes sense 
external gradients through different mechanisms. The firsts mainly rely on random tumbling 
to stochastically reach a region of higher stimulus concentration, at which point they decrease 
the tumbling rate (Sourjik and Wingreen, 2012). In contrast, eukaryotic cells integrate spatial 
and temporal information to actively sense gradients, exploiting cell surface receptors and 
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complex intracellular signalling pathways to measure the stimulant ligand (Devreotes and 
Janetopoulos, 2003; Swaney et al., 2010). In particular, the directed migration of cells in 
response to a chemical stimulus is known as chemotaxis, a crucial mechanism in several 
biological processes such as immune-cell migration, angiogenesis, haematopoiesis, neuronal 
development and migration of germ cells. 
To date, several molecules have been shown to have chemotactic properties for eukaryotic 
cells, including lipids (e.g. platelet-activating factor (PAF) (Carolan and Casale, 1990)), protein 
fragments (e.g. C5a (Ehrengruber et al., 1994)), peptides (e.g. fMLP (Dorward et al., 2015)) and 
proteins (e.g. chemokines (de Oliveira et al., 2016; McDonald and Kubes, 2011)). Interestingly, 
chemoattractant messages are primarily transmitted through G-protein coupled receptors 
(GPCRs) (Murphy et al., 2000). The members of this superfamily share a seven transmembrane 
(7TM) architecture with an extracellular N-terminal and an intracellular C-terminus (Tuteja, 
2009). The TM and extracellular protein domains are involved in ligand binding and activation 
of the receptor, while the intracellular loops and the C-terminus domain are involved in 
receptor trafficking, subcellular localization and selective coupling to heterotrimeric G-proteins 
(Erb and Weisman, 2012). Binding of GPCR agonists classically results in the activation of the 
G-protein, which consists of 3 subunits, Ga, Gb and Gg . Upon activation, exchange of GDP to 
GTP is mediated by Ga and the heterotrimer dissociates into Ga-GTP and Gbg which will 
subsequentially activate a number of distinct intracellular pathways. On top of this, three main 
GPCR-coupled pathways can be distinguished, i.e. Gi/o, Gq and Gs. In particular, the Gi/o 
modulates ion channel conductances, the Gq mediates Ca2+ release from intracellular stores 
and activates ion conductances, while the Gs pathway uses cAMP as its second messenger 
(Tuteja, 2009). 
Among the different soluble cues identified, the class of protein-chemoattractant is surely the 
best characterized. One such examples, are chemokines, small vertebrate-specific proteins 
(~8-10 kDa), usually secreted in the extracellular space and able to trigger cellular response 
upon binding with a receptor. Chemokines are divided in four classes (C, CC, CXC and CX3C), 
based on the position of the cysteine residue within their amino acidic sequence (Zlotnik and 
Yoshie, 2000). Those proteins are among the most studied chemoattractant and can function 
both as gradients leading to directed cell migration or in a non-graded manner, as for example 
during the extravasation of leukocytes from the blood vessels (Girard et al., 2012).  
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In addition to chemokines, more recently, nucleotides have been identified as signalling 
molecules with very potent chemotactic properties. These molecules, behind their mostly 
known role for nucleic acids building blocks and energy carriers, also cover a variety of 
additional functions ranging from extracellular messengers to regulators of cell behaviours. In 
the following section, I will summarize the main aspects of nucleotides signalling, with 
particular attention to their receptors. 
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6.1.2 NUCLEOTIDE SIGNALLING AND PURINERGIC RECEPTORS 
Nucleotides, in particular ATP, are well known for their function as intracellular energy source. 
Interestingly, those have a completely different role in the extracellular compartment, where 
they function as highly potent signalling molecules. The first evidence for nucleotides working 
as extracellular transmitters, dates back to the late ‘50s when sensory nerves were observed 
to release ATP upon stimulation (Holton, 1959). Since then, extracellular ATP has been 
described in several processes such as activation of ion channels (Kolb and Wakelam, 1983), 
neuron depolarization (Krishtal et al., 1983) and synaptic transmission (Edwards et al., 1992; 
Evans et al., 1992). To date, it is well known that besides serving as energy carriers for virtually 
all cell functions, nucleotides are also very powerful chemoattractant. Although some studies 
claim that ATP is not directly involved in inflammatory cell chemotaxis, but rather mediates the 
release of additional chemoattractants (Kronlage et al., 2010; McDonald et al., 2010), other 
show clear evidence for ATP and ADP functioning as true chemotactic signals (Davalos et al., 
2005; Haynes et al., 2006; Honda et al., 2001). In this context, pannexins might be involved in 
the release of ATP from apoptotic cells (Chekeni et al., 2010). Moreover, Idzko and colleagues 
showed that neutrophils and mast cells migrate in response to UTP (Idzko et al., 2001). 
To date, many reports showed in particular that in immune cells extracellular nucleotides signal 
via the activation of nucleotide receptors, referred to as purinergic P2 receptors. In contrast to 
the purinergic P1 receptors, which are activated by the ATP metabolite adenosine, the P2 
receptors are activated by ATP and/or other nucleotides (such as UTP). P2 are further divided 
in two subfamilies: the metabotropic P2Y (GPCRs) and the ionotropic P2X (cation channels) 
receptors, which are described in the following sub-sections.  
6.1.2.1 Metabotropic P2Y receptors 
Among the P2R, the group of metabotropic receptors (P2YRs) consists of eight subtypes, a 
family of P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14. The missing numbers 
represent either non-mammalian receptors (P2Y3 is the chicken orthologue of human P2Y6) 
or other GPCRs that share some sequence homology with P2YRs, but cannot be activated by 
nucleotides. Moreover, depending on the sequence and phylogenic divergence, two distinct 
subgroups have been proposed for P2Ys. The first group includes P2Y1/2/4/11 receptors which 
are characterized by a 35-52% of amino acids sequence homology and the presence of a 
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specific motif in the TM alpha helix 7, thus affecting ligand-binding characteristics. The second 
group includes P2Y12/13/14 receptors, with members sharing a sequence homology of 47-
48% and, once again, the presence of a conserved motif in the TM alpha helix 7. The two groups 
also differ in their primary coupling to G proteins; while the first group is paired to Gq/G11 
(leading to Ca2+ release), the second group binds to Gi/o proteins (which inhibit adenylate 
cyclase and modulate flow through channels) (Burnstock, 2009; King and Burnstock, 2002). 
The most abundant and best characterized endogenous ligand for P2YRs is ATP, which binds 
to all P2YRs except P2Y6 and P2Y14. At low concentrations, ATP is the only native agonist for 
P2Y11, but at higher concentrations it functions as partial agonist for P2Y1 and P2Y13. Other 
nucleotides such as ADP, UTP, UDP and UDP-sugars are more specific for individual P2Ys. For 
example, ADP activates P2Y1, P2Y12 and P2Y13, while UTP primarily binds P2Y2 and P2Y4 and 
to a lower extent to P2Y6, for which UDP is the preferred endogenous ligand. Only P2Y14 is 
predominantly activated by UTP-glucose (or other UTP-sugars). Thus, the ability of different 
nucleotides to bind specifically to individual P2YRs (Table 6.1) highlights the complexity of 
P2YRs signalling and suggests non-redundant signalling pathways. 
On the other hand, studies on mice carrying large P2YRs deletions indicate the likelihood for 
some partial redundancy in the signalling system, or at least the existence of compensatory 
mechanisms among the different P2YRs. In fact, despite the widespread expression of these 
receptors, mice lacking individual P2YRs only display mild phenotypes (when maintained 
unchallenged in a germ-free environment). 
 
RECEPTOR AGONIST G PROTEIN MAIN EFFECTOR MOLECULES 
P2Y1 ADP Gq/11 PLC (+), Ca2+ release 
P2Y2 ATP, UTP Gq/11 PLC (+), Ca2+ release 
 ATP, UTP Go PLC (+), Ca2+ release, Rac (+) 
 ATP, UTP G12 RhoA (+) 
P2Y4 UTP Gq/11 PLC (+), Ca2+ release 
 UTP Go PLC (+), Ca2+ release 
P2Y6 UDP Gq/11 PLC (+), Ca2+ release 
P2Y11 ATP Gq/11 PLC (+), Ca2+ release 
 ATP Gs AC (+), increased cAMP 
 UTP Go PLC-independent Ca2+ release 
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P2Y12 ADP Gi AC (-), decreased cAMP 
 ADP G12/13? RhoA (+) 
P2Y13 ADP Gi/o AC (-), decreased cAMP PLC(+),Ca2+ release 
P2Y14 UDP-glucose Gi/o PLC(+),Ca2+ release 
Table 6.1. P2Y receptor subtypes and G-protein coupling. 
List of P2Y receptors and their ligand(s), associated G protein and downstream pathway. Modified from 
(Erb et al., 2006). 
 
6.1.2.2 Ionotropic P2X receptors 
P2XR are plasma membrane channels selective for monovalent and divalent cations (Na+, Ca2+ 
and K+) which are directly activated by extracellular ATP. P2XR have seven subunits that may 
form six homomeric (P2X1-P2X5Rs and P2X7R), and at least seven heterotrimeric (P2X1/2, 
P2X1/4, P2X1/5, P2X2/3, P2X2/5, P2X2/6 and P2X4/6Rs) receptors (Burnstock, 2009; King and 
Burnstock, 2002). Contrary to the P2YRs, the primary sequence of P2XRs has no important 
sequence homology with any other proteins, and among the family they share a common 
topology with two TM domains (TM1 and TM2), a large extracellular loop responsible for ligand 
binding and an intracellular N and a longer C terminus. 
In contrast to P2YRs signalling, all human P2XRs have ATP as their main endogenous agonist. 
However, despite the shared agonist and the significant sequence homology they have little 
redundancy due to the fact that they come together forming homomeric and heterotrimeric 
receptors (Idzko et al., 2014). 
In line with this, although single P2XRs knockout mice are viable and survive to adulthood, 
some of them reveal unexpected phenotypes, suggesting that functional roles of individual 
receptors subunits that can’t be compensated by others. Several evidences implicate P2XRs in 
particular during inflammation and immune response against microbes (Coutinho-Silva and 
Ojcius, 2012; North and Jarvis, 2013). 
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6.1.3 NUCLEOTIDES AND PURINERGIC SIGNALLING IN APOPTOTIC CELL CLEARANCE: A LESSON 
FROM MICROGLIA 
Of particular interest for this thesis, is the role of purinergic signalling in the clearance of 
apoptotic cells. Apoptotic engulfment is characterized by the migration of the phagocyte 
toward the dying cell, followed by recognition and degradation. During this process, signalling 
exchange between the dying cell and the phagocyte is key to ensure efficient clearance 
(Medina and Ravichandran, 2016). In particular, it has been shown that apoptotic cells are 
likely to release “long-range attraction” and “short-range interaction-protrusion” signals that 
allow the phagocyte to sense the damage and selectively recognize and remove the dying cells 
from the living-healthy tissue. Many key molecules and several pathways have been identified 
to orchestrate the safe disposal of apoptotic cells. Those are generally referred to as “find-me” 
and “eat-me” signals, and a detailed description of those, together with references, can be 
found in the main introduction of this thesis. Here, I would like to focus in particular on 
nucleotides and purinergic signalling in the context of apoptotic cell clearance (a process 
referred to as efferocytosis). 
The release of nucleotides from dying cells and subsequent purinergic signalling play a pivotal 
role in efferocytosis (Elliott et al., 2009; Ravichandran, 2010; Sieger et al., 2012). During the 
last decade, several studies showed the fundamental role for P2YRs in this process. ATP release 
and concomitant P2Y2 signalling has been identified as a “find-me” signal for leukocytes, 
promoting phagocytic clearance of apoptotic bodies or bacteria by macrophages (Elliott et al., 
2009) and neutrophils (Chen et al., 2006; 2010b), therefore contributing to the resolution of 
inflammation. The study from Elliot et al. showed that “small” amounts of ATP and UTP are 
released during early apoptosis to establish a gradient for macrophages attraction through 
binding with P2Y2 receptor (Elliott et al., 2009). Several other studies also confirm that binding 
of nucleotides to P2Y2R promotes monocyte migration by regulating adhesion 
molecule/chemokine expression in vascular endothelial cells (Goepfert et al., 2001; Seye et al., 
2003). It has also been proposed that macrophages navigate in a gradient of the 
chemoattractant C5a through the release of ATP and autocrine “purinergic feedback loops” 
involving P2Y2 and P2Y12 receptors (Kronlage et al., 2010). 
A great advance in our understanding of purinergic signalling in the removal of apoptotic cells 
comes from studies on microglia, the tissue resident macrophages of the brain (a detailed 
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description of these cell can be found in the main introduction of this thesis). Those studies 
showed that ATP induces chemotaxis as well as phagocytosis through P2Y12 and P2Y13 
receptors and P2Y6 receptor, respectively (Davalos et al., 2005; Haynes et al., 2006; Honda et 
al., 2001; Koizumi et al., 2007; Sieger et al., 2012). In particular, the first study linking 
extracellular ATP and ADP and microglia chemotaxis with P2YRs dates back to 2001. Here, 
Honda and colleagues showed that membrane ruffling induced by these extracellular 
nucleotides and the subsequent cell migration is most likely mediated by Gi/o-coupled P2YRs, 
such as P2Y12 and P2Y13. Interestingly, this first study showed that although UTP induced 
obvious morphological changes, ruffle formation was not significant. On the other hand, 
adenosine (the endogenous ligand for P1 receptors) induced neither morphological change 
nor ruffle formation (Honda et al., 2001). Only few years later, in vivo studies showed that 
within minutes of brain damage microglial processes rapidly extend toward the injured site 
(Davalos et al., 2005). In particular, the chemotactic response is triggered by ATP which is 
released at the site of injury and the consequent activation of P2Y12 receptor on microglia 
(Davalos et al., 2005; Haynes et al., 2006). More recently, work from our lab has shed light on 
the mechanism behind nucleotide release upon laser injury, illustrating how extracellular 
nucleotides sensed by P2Y12 receptors induce a redistribution of microglia. By using zebrafish 
as a model system (see main introduction for a detailed description), we showed that, upon 
tissue damage, glutamate released from injured neurons induces the formation of Ca2+ waves 
via activation of N-methyl-D-aspartate (NMDA) receptors on neighbouring cells. This in turn 
leads to ATP release which provides a guidance for microglia in their migration towards the 
injury site (Figure 6.1) (Sieger et al., 2012).  
 
 
Figure 6.1. Schematic overview of the microglial response to injury. 
The injured dying cells release glutamate. This, through binding to NMDA receptor on the neighbouring cells 
leads to an influx of Ca2+, which in turn leads to release of ATP that is sensed by microglia via their P2Y12 
receptor. Reproduced from (Sieger et al., 2012). 
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Interestingly, all these studies showed that lack of P2Y12 significantly delays but does not 
abolish the ability of microglia to respond to local tissue damage (Haynes et al., 2006; Koizumi 
et al., 2013; Sieger et al., 2012), without affecting the baseline motility (Madry and Attwell, 
2015). In line with this, in vitro studies have shown that P2Y13 receptors might fulfil similar 
functions as P2Y12, suggesting a possible redundancy between those two molecules (Idzko et 
al., 2014; Zeng et al., 2014).  
While ATP and ADP have been shown to be involved in microglia chemotaxis, work in vitro 
points to a role for UDP and its receptor P2Y6 in promoting the actual removal of dying cells. 
In an elegant study, Koizumi and colleagues showed that injured neurons release UTP and UDP, 
causing the upregulation of P2Y6R expression on microglia, and simultaneous enhancement of 
their phagocytic capacity for dying cells (Koizumi et al., 2007). 
Specifically, microglia are reported to express several P2 receptors; P2X4 and P2X7 receptors 
which form ion channels, and the GPCRs P2Y2, P2Y6, P2Y12 and P2Y13. A notable characteristic 
of microglial P2XRs is calcium entry through the channel which is often associated with 
cytokine and chemokine release in the context of inflammation and bacterial removal 
(Burnstock, 2016; Inoue et al., 1998; Lister et al., 2007). On the other hand, as described above, 
microglial P2YRs have been shown to mediate efferocytosis, making those cells an interesting 
model to study purinergic signalling in apoptotic cell clearance. Although many studies have 
already established a requirement for P2YRs in this context, not much is known about their 
regulation in both space and time and how they induce distinct cellular activities and 
behaviours in microglia. Interestingly, it has been suggested that the expression of purinergic 
receptors is temporally regulated, i.e. upon microglial binding to ATP/ADP, P2Y12 receptors 
are down-regulated, while P2Y6 expression is up- regulated (Koizumi et al., 2013). Thus, while 
P2Y12 is involved in sensing the “long range- attraction” signal, P2Y6 might be important for 
subsequent steps of phagocytosis. These data suggest that distinct P2Y receptors might have 
different roles in engulfment of dying cells. Importantly, the functional activity and specificity 
of these receptors have been mainly studied by using agonist/antagonist approaches -such as 
ATP, Suramin, Reactive Blue-2, etc.- and generating single knock out mice. These approaches 
allowed to study end point phenotypes, however to date we still lack a mechanistic 
understanding of how nucleotides can elicit distinct microglial functions (Kügelgen and 
Hoffmann, 2015; Madry and Attwell, 2015). The ultimate goal is to understand how these 
receptors are controlled with spatial and temporal precision to mediate and orchestrate 
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microglial activities. A proper understanding of P2Ys coordination could clarify how microglia 
are able to communicate with each other to coordinate their activities.  
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6.1.4 METHODS AND TOOLS FOR THE STUDY OF GPCRS 
Purinergic signalling has been shown to be involved in several pathways and therefore altered 
in different diseases, ranging from Cystic Fibrosis (Burnstock et al., 2012) to chronic obstructive 
pulmonary disease (COPD) (Lommatzsch et al., 2010) to neurodegenerative disorders, such 
Alzheimer’s disease (AD) (Kim et al., 2012). In general, P2YRs have crucial roles in regulating 
immune response, becoming an obvious pharmacological target for the treatment of 
infectious or inflammatory diseases. Owing to their diverse modulatory functions, in general 
GPCRs represent one of the major drug targets in the pharmaceutical industry.  
The first methods that have been developed for the control of GPCRs relied on chemical 
compounds, which either activate or inhibit GPCRs pathways, albeit with limited specificity. 
One such examples are RASSLs (Receptors Activated Solely by Synthetic Ligands), engineered 
receptors which lack the ability to respond to their endogenous ligand and are exclusively 
activated by synthetic compounds (Strader et al., 1991). Here, replacement of amino acids in 
the neuronal b adrenergic receptor (bAR) successfully modified its specificity. This system 
surely introduced a great innovation in the study of GPCRs, however still had some limitations. 
In particular, due to the much lower binding affinity of RASSLs compared to the native ligands, 
it is not clear whether the synthetic ligands might influence other proteins in the same 
neuronal circuit. The second generation of RASSLs has been termed DREADDS (Designer 
Receptors Exclusively Activated by Designer Drugs), which are GPCRs engineered to be 
activated exclusively by synthetic, biologically inert drugs (Armbruster et al., 2007). Those 
constitutes powerful tools in probing GPCRs signalling by triggering selectively individual GPCR 
subtypes without side effects. However, the spatiotemporal resolution in vivo is very low with 
these methods because of the slow application kinetics, washout and ligand degradation.  
More recently, new approaches have been developed for controlling signalling cascades. Those 
allow the targeting of specific receptors and cell types and the control of GPCRs with high 
spatio-temporal resolution. In particular, different tools have been developed to activate 
GPCRs via a light stimulus that is able to penetrate tissues and cells. This method is generally 
referred to as optogenetics.  
The first optogenetic approach to control GPCRs pathways was the chARGe system developed 
by Zemelman and colleagues in the early 2000 (Zemelman et al., 2002). This was based on the 
co-expression of three genes belonging to the Drosophila visual phototransduction cascade: 
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Arrestin-2, Rhodopsin and the a subunit of the cognate heterotrimeric G protein (hence the 
name chARGe).  Here the authors reported that illumination of a mixed population of neurons 
elicits a response selectively in the genetically chARGed members (Zemelman et al., 2002). 
Only few years later, vertebrate rhodopsin (vRh) and the green algae channelrhodopsin 2 
(ChR2) have successfully been used to control neuronal excitability and modulate synaptic 
transmission in vitro and in vivo (Li et al., 2005). vRh has been engineered also for the study of 
the serotonergic (5-HT) signalling by the generation of a light-activatable GPCR that targets 
into 5-HT receptor domains and substitutes for endogenous receptors (Oh et al., 2010). 
Moreover, the Khorana’s group has demonstrated that similar goals can be achieved by the 
generation of chimeric receptors (Kim et al., 2005). In this study, the authors replaced the 
cytoplasmic loops of rhodopsin with those of the b2-adrenergic receptor (b2-AR) to specifically 
activate the signalling mediated by b2-AR by light. Similarly, other GPCRs, such as the a1a-
adrenergic receptor, have been engineered to chimeric receptors with rhodopsin (Airan et al., 
2009). 
More recently, Karunarathne and colleagues developed a set of optical triggers based on non-
rhodopsin opsins capable of selectively modulating the activity of all three major 
heterotrimeric G proteins (Gi/o, Gq and Gs) in selected regions of the cell in a fast and reversible 
manner (Karunarathne et al., 2013).  
To date, there are no reports of opto-P2YRs. However, taking an optogenetic approach to 
investigate P2Ys would allow testing of several key unknowns, namely if the activation of these 
receptors is sufficient to trigger specific cellular events such as migration and phagocytosis, if 
these receptors work in concert or sequentially and if their behavioural outputs depend on 
signalling duration and strength. In particular, the use of zebrafish as a model system, thanks 
to its transparency, small size and genetic accessibility, would allow the investigation of these 
systems in vivo, in a physiological-unperturbed context.  
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6.2 AIM OF THE PROJECT 
There is no doubt that phagocytes, such as microglia, have the ability to recognize and remove 
apoptotic cells with great precision and that nucleotides and purinergic receptors are needed 
to mediate these interactions. The aim of this project is to understand how the activation of 
these receptors is controlled in space and time to mediate and orchestrate different microglial 
responses. The immediate goal is to create knock-outs for purinergic receptors such as P2Y6, 
P2Y12 and P2Y13 to determine their functional requirement in microglia. The second goal is to 
generate knock-ins for real-time visualization of receptor activity and light-mediated 
manipulation in vivo.  
 
During my PhD, in parallel to my main thesis project (described before), I worked on these aims 
and I followed a combined approach to simultaneously knock out these receptors in zebrafish 
and introduce “landing sites” for targeted site-specific insertion at endogenous loci. These 
acceptor lines will be used to define loss of function phenotypes, to express novel live reporters 
for signal activity and to perform optical perturbations in vivo.  
In the following sections I will describe the state of this project, including preliminary data.
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6.3 RESULTS 
The Peri lab has developed a system aimed at studying the removal of dying neurons by 
microglia in the transparent zebrafish larva. This involved the generation of transgenic lines to 
visualize microglia, macrophages, neurons, apoptotic neurons and the signalling systems that 
allow them to communicate (Casano et al., 2016; Mazaheri et al., 2014; Peri and Nüsslein-
Volhard, 2008; Sieger et al., 2012). With its small dimension (400 µm wide), the zebrafish brain 
is a powerful model system which allows unprecedented imaging of the entire microglia 
network. In this context, reverse genetics to remove specific receptors of the phagocytic 
pathway has been essential for establishing the role of these factors in apoptotic cell clearance. 
For example, a previous study from our lab revealed novel and distinct functions for the surface 
receptors TIM4 and BAI1, previously described as general dying cell “recognition receptors” 
(Miyanishi et al., 2007; Park et al., 2007a). Using live imaging and reverse genetic to knock-
down these two phagocytic receptors simultaneously or separately, Mazaheri and colleagues 
showed that while BAI1 is required for phagosome formation, TIM4 is involved in phagosome 
stabilization (Mazaheri et al., 2014). I intend to use a similar combination of live imaging and 
targeted perturbations to uncover the function of P2YRs in neuronal recognition and removal.  
The first aim of this project is to quantitatively define the morphology and behaviour of 
microglia in absence of P2YRs signalling, via the analysis and comparison of mutant phenotypes 
using live imaging approaches. To this aim, I followed a combined approach to simultaneously 
knock-out these receptors and to introduce “landing sites” for the targeted site-specific 
insertion at the endogenous genes. These acceptor lines will be used to determine loss of 
function phenotypes and to express novel live reporters of P2YRs signalling and optical 
perturbation tools under the endogenous transcriptional regulation. 
In the following paragraphs I will present the state of this project and the preliminary results 
obtained so far. 
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6.3.1 GENERATION OF P2Y6, P2Y12 AND P2Y13 ATTB/STOP LINES 
To investigate the role of purinergic receptors in the removal of dead neurons, I combined 
CRISPR-Cas9 genome editing and PhiC31 Integrase recombination to allow one-step 
generation of knock-outs and insertion of a landing site for subsequent integration in the 
endogenous loci. In particular, I used CRISPR-Cas9 technology to introduce a double strand 
break (DSB) at the beginning of the genes and to promote homology directed repair (HDR) to 
introduce a cassette containing STOP codons and an attB site (attB/STOP). By using the 
software CHOPCHOP I designed three different sgRNAs/gene directed to the sequences of 
interest. To test the efficiency of each sgRNA in vivo and select the best working one, I co-
injected those in one cell stage wild type embryos together with Cas9 protein. The efficiency 
of the sgRNAs in introducing DSB was tested by extracting the genomic DNA of 20 randomly 
selected injected embryos per condition and running on an agarose gel a 100 bp PCR 
amplificate of the targeted region next to the same amplificate from un-injected controls. DSBs 
are repaired by non-homologous end joining (NHEJ) which introduces insertion and/or 
deletions. Those can be visualized by gel as smeared bands due to the mosaic expression of 
different mutations in the injected embryo. Thus, depending on the number of embryos out 
of the 20 randomly selected presenting a smear and therefore a DSB, I selected for each gene 
the most efficient sgRNA. The chosen sgRNA was co-injected with the Cas9 protein and the 
attB/STOP cassette containing 30bp homology arms at both sides (Figure 6.2 B). In this way, 
insertion of the STOP cassette will introduce stop codons regardless of the reading frame 
allowing the generation of knock-out lines, while the attB sequence will be used to mediate 
the subsequent PhiC31 integrase-mediated integration (Figure 6.2 A). Following this strategy, 
I obtained fish carrying the cassette -in homozygosis- in the P2Y6, P2Y12 and P2Y13 locus, 
respectively (Figure 6.2 C-E). Importantly, to limit as much as possible the presence of Cas9 off 
targets, it has been crucial to do multiple outcrossing rounds and select only the genotype of 
interest. 
To investigate the role of different P2YRs in phagocytic microglia, these engineered lines have 
also been crossed into the background of several apoptotic and/or microglial reporters. Trans-
heterozygotes for these mutations have also been generated and will be used to obtain double 
knock-outs. The current status of this project is summarized in Table 6.2.  
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Figure 6.2. Generation of P2Ys knock-out lines containing the landing site for knock-in generation. 
(A) CRISPR-Cas9 technology has been used for the insertion of the attB/STOP cassette in the locus of interest 
(50-100 bp from endogenous ATG of P2Y6, P2Y12 or P2Y13 genes). The schematic shows the strategy for 
the generation of knock-outs and knock-ins by the use of CRISPR-Cas9 and PhiC31 technologies.  
(B) Sequence of the attB/STOP cassette.  
(C-E) Alignment of homozygous P2Y12 (C), P2Y13 (D) and P2Y6 (E) to the cassette sequence (homozygous 
insertion of the cassette). 
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The generation of knock-outs for these receptors allows us to investigate the role of purinergic 
signalling in establishing key features of microglia such as their number in the brain, phagocytic 
activity, rate of apoptosis and response to injury.  
  
Genotypes obtained Reporters crossed with each genotype 
P2Y12 attB/STOP – homoz. Tg(mpeg1:eGFP) 
P2Y12 38 bp del (several stops) – heteroz.  Tg(mpeg1:eGFP-caax) 
P2Y12 135 bp deletion – heteroz. Tg(NBT:secA5-BFP/RFP) 
P2Y13 attB/STOP – homoz. Tg(mpeg1:eGFP-caax);Tg(NBT:secA5-BFP) 
P2Y6 attb/STOP – homoz. Tg(NBT:dsRed) 
P2Y12 attB/STOP; P2Y6 attB/STOP Tg(NBT:NTR-mCherry) 
P2Y12 attB/STOP; P2Y13 attB/STOP Tg(mpeg1:Gal4,UAS:Kaede) 
P2Y6 attB/STOP; P2Y13 attB/STOP Tg(mpeg1:eGFP-caax);Tg(sp1b:Gal4,UAS:nls-Crimson) 
Table 6.2. List of the lines currently available. 
On the left is a list of the available genotypes. On the right is a list of the transgenic lines which have been 
already crossed with each of the genotypes listed on the left. 
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6.3.2 MICROGLIAL NUMBER DURING DEVELOPMENT IS AFFECTED IN PURINERGIC RECEPTORS 
MUTANTS  
Previous work in the lab has shown that pharmacological inhibition of purinergic receptors by 
suramin, a broad purinergic receptors inhibitor, significantly reduces the number of microglia 
in the brain without affecting the level of neuronal cell death or basal motility of macrophages 
that are outside the brain (Casano et al., 2016). Thus, to test if P2Y6, P2Y12 or P2Y13 are 
directly involved in promoting microglia brain colonization, I first determined the number of 
microglia in the optic tectum throughout development. This was assessed in individual P2Ys 
mutants and wild type (from 2 to 5 dpf) by staining with Neutral red, a pH indicator which 
labels microglia in the brain. This experiment showed that in P2Y12 KO microglial brain 
colonization is delayed (Figure 6.3). Further experiments will determine whether this is a 
microglia specific phenotype or a secondary consequence of a delay in macrophages 
production and development. Surprisingly, P2Y13 KO brains are populated by a significantly 
higher number of microglia at 4 dpf (Figure 6.3 C). This result shines new light on the 
importance of P2Y13 receptor, as it is mostly considered redundant to P2Y12. On the other 
hand, lack of P2Y6 receptor results in a drastic reduction in number of microglia (Figure 6.3 B 
and C). Moreover, also in this case at 5 dpf there is a partial rescue of the phenotype (Figure 
6.3 C).  
Preliminary results show that the number of microglia during development is affected in the 
lines generated. Further experiments will be necessary to confirm these data and investigate 
in depth the cause of those phenotypes. 
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Figure 6.3. Number of microglia during development in P2Ys knock-outs and wild type. 
(A-D) Number of microglia quantified by Neutral red positive staining in P2Ys knock outs and wild type during 
development. (A) Number of microglia throughout development in wild type (blue line), P2Y6KO (orange 
line), P2Y12KO (green line) and P2Y13KO (red line). (B) Wild type, P2Y12 KO, P2Y13 KO and P2Y6 KO 3 dpf. 
(C) Wild type, P2Y12 KO, P2Y13 KO and P2Y6 KO 4 dpf. (D) Wild type, P2Y12 KO and P2Y6 KO 5 dpf. * P value 
< 0.01; ** P value < 0.01; *** P value < 0.001; **** P value < 0.0001. 
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6.3.3 THE NUMBER OF UNCOLLECTED APOPTOTIC NUCLEI IN P2YS MUTANT REFLECTS THE 
NUMBER OF MICROGLIA  
In the brain, quantification of uncollected apoptotic nuclei visualized by using Acridine Orange 
(AO) staining, can be used to determine the rate of phagocytosis in microglia. The number of 
dying neurons was quantified at 3 and 4 dpf in P2Y6, P2Y12, P2Y13 knock-outs and wild type. 
While at day 3 wild type and mutant embryos are comparable (Figure 6.4 A), at 4 dpf P2Y12 
KO and P2Y6 KO have a significantly higher number of uncollected apoptotic cells (Figure 6.4 
B). As I have shown that in these mutants there are also fewer microglia, simply it is possible 
that these defects are due to low microglia number. Further experiments are needed to 
determine the phagocytic rate of single microglia. 
NR and AO experiments have been performed also on heterozygous mutants. The data have 
been analysed in an unbiased way, as genotypes were assigned only after quantification. This 
showed that, interestingly, heterozygous KO reflect the same tendencies as the homozygous 
KO for both number of microglia and level of apoptosis at the different developmental stages.  
 
 
Figure 6.4. Number of apoptotic nuclei during development in P2Ys knock outs and wild type. 
(A-B) Number of apoptotic nuclei quantified by Acridine Orange (AO) staining in P2Ys knock outs and wild 
type during development. (A) AO Quantification in the optic tectum, 3 dpf. (B) AO Quantification in the optic 
tectum, 4 dpf. * P value < 0.01; ** P value < 0.01; *** P value < 0.001; **** P value < 0.0001. 
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6.3.4 P2Y12 KO MICROGLIA SHOW A DEFECT IN INJURY REACTION  
A method commonly used to study microglia migration and positioning is by ablating neurons 
using a pulsed laser (Davalos et al., 2005; Haynes et al., 2006; Sieger et al., 2012). Upon 
neuronal ablations in the living zebrafish brain microglia respond, first by polarizing their 
cellular branches, then by migrating toward the site of injury (Sieger et al., 2012). ATP is a key 
signal for promoting microglial migration. Perturbing ATP distribution (Davalos et al., 2005) or 
its receptor P2Y12 (Haynes et al., 2006; Sieger et al., 2012) causes a significant delay in 
microglial response to photo ablation.  
A preliminary experiment has been performed to investigate the contribution of P2Y12 
receptor in injury response. To this aim, I started with crossing heterozygote P2Y12 fish that 
carry the attB/STOP cassette and using a UV pulsed laser I injured the brain of their progeny 
(35 embryos in total). All embryos were injured at the midline and imaged after 2 hours to 
visualize microglial migration to the site of injury. After imaging, genomic DNA was extracted 
for genotyping. To analyse microglial reaction to the injury, I defined three classes (1-3) 
depending on the phenotype:  
1. Less than two microglia reacted to the injury 
2. At least two microglia reacted to the injury, but in an unorganized way 
3. More than 3 microglia reacted to the injury, creating a circumference around the 
damaged tissue 
 
Figure 6.5. Classification of the reaction to injury in P2Y12 knock-out compared to wild type. 
Microglia migration towards UV laser ablation in the middle of the brain is impaired in P2Y12 KO embryos. 
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Interestingly, microglia of knock-outs have a significant reduced reaction to injury when 
compared to wild type embryos (Figure 6.5). This encouraging preliminary result confirmed 
the role of P2Y12 in mediating microglial responses to injury.  
Further experiments will investigate the contribution of different purinergic receptors in 
response to an injury. Quantification of the percentage of microglia reacting to the neuronal 
ablation and of the time and space covered during microglia migration will determine the role 
of each P2YR in this process.
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6.4 OUTLOOK 
In recent years microglia have emerged as multitasking specialist of the brain that interact with 
the local neuronal environment to promote its development and connectivity. A key function 
of microglia is the removal of dying neurons, both in response to brain damage, when they 
promote repair and during development, when they contribute to shaping neuronal activity 
(Loane and Kumar, 2016; Neumann, 2013). Lack of microglia has been shown to severely 
compromise proper brain functionality, particularly affecting individual behaviour and learning 
skills (Chen et al., 2010a; Loane and Kumar, 2016), further highlighting how presence and 
proper activity of those cells are essential for guaranteeing brain homeostasis.  
A proper understanding of how microglia are able to recognize their target and distinguish it 
from healthy tissue is key to be able to manipulate their activity. 
Purinergic receptors expressed on microglia bind nucleotides released by apoptotic and 
damaged cells guiding the phagocyte in the site of death. Release of different nucleotides 
activate other purinergic receptors which mediate the actual engulfment of the target. Given 
that directed migration and target engulfment both involve similar changes in cell morphology 
and cytoskeletal organization (Erb and Weisman, 2012), and engage an overlapping set of 
effectors, it is clear that these processes must be coordinated via cellular feedback 
mechanisms. The finding that these behaviours in microglia appear to be controlled by distinct 
GPCRs offers a unique opportunity to investigate this interplay by developing robust reporters 
for monitoring the activity of P2Y receptors in vivo.  
The generation of knock outs for P2Y6, P2Y12 and P2Y13 (P2YRs that are known to be 
expressed on microglia) allows the study first of all their loss-of-function phenotypes alone and 
in combination. The results obtained so far show that all individual knock-outs have 
phenotypes in terms of microglial numbers and phagocytic activity in the developing brain. 
Interestingly, preliminary observations showed that P2Y12 mutant embryos have microglia 
with normal morphology that however fail to respond to neuronal injuries induced by using a 
UV-pulsed laser. On the other hand, microglia lacking P2Y6 have an aberrant round 
morphology that is often indicative of phagocytic defects (Figure 6.6). Further experiments are 
needed to characterize in more depth these phenotypes focusing in particular on basal 
surveillance of microglia, phagocytic activity and ability to respond to injury. 
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Figure 6.6. Microglia morphology is affected in P2Y6 knock-outs. 
(A and B) Microglia cells labelled with Tg(mpeg1:eGFP) in 3 dpf wild type (A) and P2Y6 KO (B) embryos. Scale 
bar 10 µm. 
 
One key question is whether the controlled activation of these receptors is sufficient to trigger 
microglial key behaviours -such as directed migration and engulfment- “at will”. The 
homozygous knock-out lines contain the attB site that can be used to generate knock-ins. 
These acceptor lines will be used to express live reporter of P2Y signalling and optical 
perturbation tools under endogenous transcriptional regulation.  
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6.4.1 SPATIOTEMPORAL DISSECTION OF P2Y SIGNALLING IN MICROGLIA 
One key aim of this project is the development of robust in vivo reporters for P2Y signalling. A 
direct readout for GPCRs activity takes advantage of the fact that those receptors undergo 
internalization and recycling upon ligand binding. For example, by labelling the platelet P2Y12 
receptor Nisar and colleagues showed that the C-terminus of this receptor is essential to 
ensure its correct traffic, internalization and recycling necessary to maintain its responsiveness 
in vitro (Nisar et al., 2011). Similarly, live imaging of P2YRs tagged with fluorescent proteins 
through PhiC31 integration can provide a live reporter for studying P2YRs dynamics during 
microglial phagocytosis and migration. The introduction of fluorescent reporters in the 
endogenous locus will allow us to investigate the localization, expression and turnover of 
distinct P2YRs in vivo.  
Furthermore, a reliable readout for GPCRs signalling and dynamics is the use of the recently 
developed tandem fluorescent protein timers (tFTs) (Barry et al., 2016; Donà et al., 2013). 
Here, tandem fusions of two fluorescent proteins with different maturation kinetics provide a 
ratiometric visualization of protein synthesis and turnover in living animals. In the case of 
GPCRs, ligand-triggered receptor internalization results in low red/green ratios due to high 
receptor turnover. This approach was successfully used to monitor chemokine signalling during 
the migration of the zebrafish lateral line (Donà et al., 2013). Tagging the microglial purinergic 
receptors with optimized tFTs will allow signalling-triggered receptor turnover to be monitored 
in vivo. By taking advantage of these approaches we will correlate the activation of the receptor 
with distinct cellular responses and activities in response to neuronal cell death.  
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6.4.2 OPTOGENETIC APPROACHES TO INVESTIGATE P2YRS FUNCTIONS IN MICROGLIA 
The development of methods to precisely control cellular processes using light has the 
potential to revolutionize the way we address complex biological problems. Indeed, whereas 
previously we mainly relied on loss-of-function phenotypes to study gene function, now we 
can use light to switch on and off molecules in a spatial and temporal controlled manner. 
Taking an optogenetic approach (Idevall-Hagren et al., 2012; Karunarathne et al., 2013) to 
investigate P2YRs will allow testing of several key unknowns, namely if the activation of these 
receptors is sufficient to trigger specific cellular events such as migration and phagocytosis, if 
these receptors work in concert or sequentially and if their behavioural outputs depend on 
signalling duration and strength. In particular, we will pursue several overlapping approaches 
to place P2YRs signalling under light-regulated control, such as the use of rhodopsin to 
engineer P2YRs or for the generation of chimeric receptors (Airan et al., 2009; Kim et al., 2005; 
Li et al., 2005; Oh et al., 2010). An alternative optogenetic approach uses members of the opsin 
family of GPCR light-sensors to activate the same downstream G-proteins as specific receptors 
of interest (Karunarathne et al., 2013). 
The use of optogenetics will allow us to probe how microglia respond to P2YRs activation/de-
activation and their mode of action during phagocytosis. Combining optogenetic manipulation 
of P2Y signalling with the quantitative behavioural assays and live activity reporters described 
above will significantly advance our understanding microglial-neuronal interactions.
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